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Abstract
Type 2 diabetes mellitus has been diagnosed in ~21 million people in the
United States and is closely correlated with obesity, prompting the need for a
detailed understanding of adipocyte metabolism in the development of diabetes.
The intake of excess nutrients surpasses the energy requirements of the cell and
leads to increased mitochondrial stress in the adipocyte. We have shown that
this is associated with increased levels of the mitochondrial metabolite fumarate.
Fumarate can react with cysteine thiol groups to form the chemical modification
S-(2-succino)cysteine (2SC), also termed protein succination. Succination is
significantly increased in the adipose tissue of type 2 diabetic mouse models
(ob/ob and db/db) and in adipocytes matured in high glucose medium, resulting
in impaired protein function. The endoplasmic reticulum (ER) oxidoreductase
protein disulfide isomerase (PDI) is succinated in adipocytes matured in high
glucose, and we investigated if succination would alter PDI oxidoreductase
activity, directly linking mitochondrial stress and ER stress. PDI is succinated by
fumarate on both CXXC containing active sites, contributing to reduced
enzymatic activity. In the presence of prolonged ER stress the unfolded protein
response (UPR) triggers the production of the pro-apoptotic protein C/EBP
homologous protein (CHOP). Succinated PDI has decreased reductase activity in
adipocytes matured in high glucose, and in db/db epididymal adipose tissue, in
association with increased levels of the ER stress marker CHOP. PDI succination
v

and ER stress were decreased, and PDI reductase activity was restored when
exposure to chronic high glucose was limited, highlighting the importance of
calorie restriction in the improvement of adipocyte metabolic function. The
experiments completed in chapter 2 confirm succination of PDI as a novel
biochemical mechanism linking altered mitochondrial metabolism to perturbed
ER proteostasis in the adipocyte during diabetes.
Our observations in chapter 2 consistently demonstrated that CHOP
levels are elevated in all cases where fumarate and protein succination are
increased. Here we show that CHOP levels are significantly increased in
adipocytes matured in high glucose in the absence of UPR signaling and with no
sign of apoptosis. We propose that the post-translational modification S-2succinocysteine may be an alternative physiological regulator of CHOP stability
under

diabetic

conditions.

Kelch-like

ECH-associated

protein

1

(Keap1) negatively regulates CHOP degradation in the adipocyte, and Keap1 is
succinated in cancers where fumarate levels are elevated. We discovered that
while Keap1 is directly succinated in the presence of excess fumarate derived
from genetic knockdown methods, it is the oxidative modification of Keap1 that
predominates in adipocytes matured in high glucose. Notably, we also
determined that succination indirectly regulates CHOP stability through the
induction of oxidative stress. The results shown in chapter 3 demonstrate that
increased fumarate induces increased oxidative stress and that the oxidation of
Keap1 contributes to sustained CHOP stability and adipocyte dysfunction during
diabetes. The studies conducted in chapters 2 and 3 demonstrate that early

vi

biochemical changes in mitochondrial metabolism have important implications for
the

development

of

sustained

vii

adipocyte

stress.
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Chapter 1
General Introduction
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1.1 Epidemiology of Obesity and Type 2 Diabetes
A total of 29.1 million people or 9.3% of the United States population
were documented to have diabetes in the Center for Disease Control 2014
National Diabetes Statistics Report. Within this group 21 million people have
been clinically diagnosed with diabetes, and estimated 8.1 million people suffer
from undiagnosed/uncontrolled diabetes (CDC 2014). Prediabetes, a condition
that often precedes the development of Type 2 diabetes, is estimated to occur in
86 million people based on an irregular hemoglobin A1C (>6.5%) and elevated
fasting blood glucose levels (>126 mg/dL or 7 mM). Type 2 diabetes is primarily
diagnosed in adults aged 45 to 64 and is also called “adult onset” diabetes.
Unfortunately, childhood obesity and type 2 diabetes are also on the rise with a
shocking 5,089 individuals under the age of 20 reported to be newly diagnosed
with type 2 diabetes from 2008-2009. In 2012 the estimated cost of treating
clinically determined cases of type 2 diabetes was $245 billion, with direct medial
costs totaling $176 billion. Comorbidities of diabetes such as cardiovascular
disease, stroke, blindness, kidney disease and amputations worsen medical
expenses and account for ~10% of the medical costs associated with treatment
(CDC 2014).
Obesity is a major contributing factor to the development of type 2
diabetes with roughly 85.2% of diabetes patients described as overweight or
obese. Obesity is characterized by the body mass index (BMI) scale used to
categorize body mass based on a person’s weight to height ratio (BMI =
kilograms/meters2). A normal healthy person has a BMI range of 18.5 to 24.9

2

kg/m2. A BMI between 25 to 29.9 kg/m2 is classified as overweight and a BMI
greater than 29.9 kg/m2 defines the obese category. In 2011-2014 over one-third
(36.5%) of adults and 17% of children in the U.S. were considered clinically
obese. In addition, the annual medical expenditures of obese individuals are
$1,429 higher than individuals of normal healthy weight due to obesity-related
conditions including heart disease, stroke and type 2 diabetes (CDC 2014). With
the prevalence of obesity and type 2 diabetes near epidemic proportions it is
critical to understand the economic, environmental and biological factors that
induce type 2 diabetes, and to establish more effective preventative and
therapeutic strategies.
1.2 Insulin Signaling
In metabolically healthy people the pancreatic beta cell secretes insulin
in response to carbohydrate intake after a meal, prompting the uptake of glucose
into insulin sensitive tissues. The insulin tyrosine kinase receptor is a dimer
comprised of an α subunit that binds insulin at the extracellular face of the
plasma membrane and a transmembrane β subunit that facilitates intracellular
signaling. Insulin binding instigates auto-phosphorylation of the β subunit and
subsequent phosphorylation of the insulin receptor substrate (IRS) 1 and 2.
Activated IRS-1 and -2 will bind phosphoinositide 3-kinase (PI3K) to generate the
second

messenger

phosphatidylinositol

(3,4,5)-triphosphate,

leading

to

phosphorylation of Akt, also called protein kinase B. Insulin signaling via pAkt
regulates the translocation of glucose transporter 4 (GLUT4) to the plasma
membrane of skeletal muscle myocytes and adipose tissue adipocytes to
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augment glucose uptake. Nutrients are then catabolized to produce energy,
predominantly generating adenosine triphosphate (ATP). If there is a fuel
surplus, insulin will facilitate increased glycogen synthesis in the liver and
muscle, as well as lipogenesis in the adipose tissue to store glucose and fatty
acids for use during fasting and exercise. In addition, insulin acts to suppress
glucose production in the liver to restore homeostatic blood glucose levels after
consuming a meal.
The development of Type 2 diabetes is characterized by initial
hyperinsulinemia in response to insulin resistance when the muscle, liver and
adipose tissues no longer respond properly to insulin signaling, discussed below.
Impaired insulin sensitivity prompts pancreatic beta cells to produce and secrete
increasing amounts of insulin in an attempt to boost insulin signaling and lower
blood glucose levels. Over time, the beta cells fail to meet the insulin demand to
invoke a normal response in the peripheral insulin sensitive tissues. This results
in the accumulation of glucose in the blood stream due to the lack of glucose
uptake by the muscle and adipose tissue, and sustained glucose output by the
liver.
1.3 Symptoms and Treatments for Type 2 Diabetes
Impaired tissue glucose uptake increases fasting blood glucose levels in
type 2 diabetic patients, causing a variety of symptoms including recurrent
urination, increased thirst and fatigue. Further systemic complications are
common with chronic hyperglycemia and disease progression including diabetic
retinopathy, peripheral nerve damage and diabetic nephropathy. This is due to
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exacerbated GLUT-1 mediated glucose uptake into the non-insulin dependent
capillary beds of the retina and kidneys, as well as the GLUT-3 mediated uptake
of glucose in nerve cells. Glucose oxidation and the generation of reactive
metabolic intermediates are proposed to induce mitochondrial dysfunction,
oxidative stress and intracellular damage in these tissues (Brownlee, 2005).
Living with type 2 diabetes requires inconvenient and consistent monitoring of
blood glucose levels that fluctuate with meal to meal caloric intake and daily
physical activity. The primary treatment for these patients is to closely monitor
blood glucose levels throughout the day, and micromanage food consumption
and physical activity coupled to a variety of pharmacological approaches.
Pharmacological

agents

such

as

metformin,

which

reduces

hepatic

gluconeogenesis (Miller et al. 2013) and lipid metabolism (Fullerton et al. 2013),
are prescribed if lifestyle interventions do not result in sufficient glycemic control.
Sulfonylureas that stimulate the pancreas to release insulin (Thulé and
Umpierrez, 2014), and the peroxisome proliferator-activated receptor (PPAR)
agonist group thiazolidinediones (Hauner, 2002) are supplementary clinical
therapeutic agents employed to aid metformin in the reduction of blood glucose
levels. Exenatide and liraglutide are glucagon-like peptide 1 (GLP-1) analogs,
also called ‘incretin mimics’, and bind the glucagon-like 1 receptor on the islets of
Langerhans cells to stimulate insulin and inhibit glucagon release. These result in
moderately lower blood glucose levels in prolonged diabetes (Campbell et al.
2013, Fehse et al. 2005). Dipeptidyl peptidase-4 (DPP-4) is the incretin
inactivating enzyme, and DPP-4 inhibitors or gliptins have also been considered,
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but with limited evidence of efficacy, as a treatment for type 2 diabetes. In
addition, both GLP-1 agonists and DPP-4 inhibitors are under investigation as
perpetuators of pancreatitis, pancreatic cancer and heart failure (Rehman et al.
2017). Although these drugs can help to improve fasting blood glucose levels
there is still no cure for type 2 diabetes.
1.4 Adipocyte Metabolism
Preadipocytes

are

dispersed

throughout

the

adipose

tissue

of

metabolically healthy individuals, and can differentiate into mature adipocytes
allowing flexibility in the adipose tissue storage capacity.. Insulin signaling
promotes adipogenesis through suppression of forkhead transcription factor O1
leading to upregulation of peroxisome proliferator-activated receptor gamma
(PPARƴ), a key regulator of the mature adipocyte phenotype. In a state of caloric
excess white adipose tissue expands to accommodate the surplus energy in the
form of triglycerides. De novo triglyceride synthesis, also known as lipogenesis,
is mediated by insulin signaling in the adipose tissue; relieving phosphorylation
mediated inhibition of acetyl-CoA carboxylase to promote fatty acid synthesis and
triglyceride production. Insulin signaling also prevents phosphorylation and
activation of hormone sensitive lipase to inhibit lipolysis when blood glucose
levels are high. During fasting or in response to a pronounced increase in energy
expenditure, the stored triglycerides in white adipose tissue are hydrolyzed to
release free fatty acids to be used as fuel in metabolically active tissues.
Adipocyte hypertrophy and obesity occurs when the balance between energy
intake and energy expenditure is disproportionate due to excessive fuel intake.
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Adipose tissue is the healthiest site for the deposition of additional caloric energy
in the form of triglycerides (Unger et al. 2013). However, when adipose tissue
expansion reaches its threshold, triglycerides will begin to accumulate in other
organs such as the liver, resulting in non-alcoholic fatty liver disease (Schwenger
and Allard, 2014, Rosen and Spiegelman, 2014).
In addition to its role as an energy storage depot, adipose tissue is an
important endocrine organ that secretes a variety of hormones known as
adipokines. Perturbation in the levels of several adipokines is closely associated
with obesity and type 2 diabetes. Adiponectin is produced and secreted from the
adipocyte in an insulin sensitizing manner and acts to increase fatty acid
oxidation in the skeletal muscle and suppress gluconeogenesis in the liver.
Decreased circulating levels of adiponectin are an established hallmark in obese
type 2 diabetic patients (Cao et al. 2014). Leptin is another key adipokine that
functions

in

caloric

regulation

by

binding

to

the

leptin

receptor

on

proopiomelanocortin-cocaine amphetamine regulated transcript (POMC-CART)
neurons in the arcuate nucleus of the hypothalamus. This stimulates the release
of melanocortins that mediate appetite suppression. Leptin also regulates satiety
by binding its receptor on the agouti related peptide (AgRP) neurons in the
arcuate nucleus, inhibiting the release of neuropeptide Y and orexins (Abizaid
and Horvath, 2008, Hakansson et al. 1999, Stephens et al. 1995). Leptin
secretion is directly proportional to adipose tissue mass; yet despite the
hyperleptinemina

in

obese

individuals,

the

hormonal

response

hypothalamus is attenuated due to leptin resistance (Cao et al. 2014).
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in

the

Diabetes is a complex multi-organ disease involving hormonal and
metabolic mediators, and it is clear that compromised adipose tissue functionality
is a significant component of Type 2 diabetes (Cusi, 2010, Lee et al. 2016, Smith
and Kahn, 2016). The following sections highlight the recognized and proposed
contributors to adipocyte stress and dysfunction in the development of Type 2
diabetes.
1.5 Adipocyte Stress in Type 2 Diabetes
1.5a Inflammation and Insulin Resistance
Type 2 diabetes is closely correlated with increased obesity and a state
of chronic low grade inflammation in the adipose tissue, in association with
lifestyle factors such as a poor diet and lack of exercise. Adipose tissue was
typically regarded as a unassuming reservoir for triglyceride storage within
adipocytes, but is now valued as a complex organ encompassing a variety of
interacting

cell

types

including

adipocytes,

macrophages,

eosinophils,

neutrophils, endothelial cells, fibroblasts, stem cells and neuronal projections
(Cohen and Spiegelman, 2016). While some adipose tissue is necessary for lipid
storage and hormone production, the accumulation of excess adipose tissue is
associated with the secretion of pro-inflammatory cytokines. Several intracellular
inflammatory signaling responses are activated in the adipocyte including Tolllike receptor (TLR)-4 and -2, inflammasome activation, c-Jun N-terminal kinase
(JNK) and inhibitor of nuclear factor kappa-B kinase-β (IKKβ) signaling, and the
production of inflammatory cytokines due to metabolic stress (Gregor and
Hotamisligil, 2011, Solinas et al. 2010). The increased production and secretion
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of potent cytokines including tumor necrosis factor α (TNFα), interferon (IFN)-γ,
interleukin (IL)-6, IL-β and monocyte chemoattractant protein 1 (MCP1) occurs in
parallel with adipocyte hypertrophy (Berg et al. 2005). MCP1 acts to recruit
monocytes and macrophages to the site of cellular distress (Kanda et al. 2006),
resulting in the accumulation of macrophages in the subcutaneous adipose
tissue of obese type 2 diabetic patients, and in the visceral adipose tissue of
ob/ob and db/db type 2 diabetic mice (Amano et al. 2014, Haase et al. 2013,
Weisberg et al. 2003). Macrophages tend to congregate at sites of adipocyte cell
death forming crown-like structures surrounding the cellular debris and lipid
droplets for removal (Cinti et al. 2005). Importantly, obese adipose tissue
resident macrophages significantly contribute to the production of proinflammatory

cytokines,

e.g.,

TNFα

and

IL1β,

in

the

adipose

tissue

microenvironment of diabetic ob/ob and db/db mice (Xu et al. 2003). This is due
to the M1 or “classically activated” pro-inflammatory phenotype of macrophages
localized in obese adipose tissue compared to the anti-inflammatory M2 or
“alternatively activated” polarized macrophages found in lean adipose tissue
(Lumeg et al. 2007). Suzuki et al. recently described that the loss of T-helper (Th)
2 cytokine signaling from adipocytes regulates macrophage polarity and this
promotes the M1 phenotype in insulin resistant mice fed a high fat diet (Suzuki et
al. 2017). The reduced quantity of anti-inflammatory cytokines in the adipose
tissue microenvironment is also attributed to decreased resident Th2 and T
regulatory cells and a buildup of CD8+ T cells and Th1 cells that contribute to
macrophage recruitment and prolonged inflammation (Solinas et al. 2010).
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Importantly, adipose tissue inflammation is recognized as being present when
there is decreased systemic insulin sensitivity, prior to the development of Type 2
diabetes (Samuel and Shulman, 2012, Solinas et al. 2010, Suzuki et al. 2017,
Tanti et al. 1994).
Pro-inflammatory cytokines impair insulin sensitivity in tissues through
activation of JNK and IKKβ pathways (Solinas et al. 2010, Solinas and Becattini,
2016). JNK activation leads to increased phosphorylation of IRS-1 at the Ser307
residue and IRS-2 at Thr348, inhibiting the interaction and activation of IRS by
the insulin receptor via tyrosine phosphorylation in response to insulin (Aguirre et
al. 2000, Aguirre et al. 2002, Solinas et al. 2006). Under normal conditions, IRS-1
activity is diminished by mammalian target of rapamycin (mTOR) and its
downstream effector ribosomal S6 kinase 1 (S6K1) via direct phosphorylation at
residues Ser636, Ser639 and Ser307 that results in desensitization of insulin
signaling (Ozes et al. 2001). Lee et al. described that TNFα stimulation of IKKβ
induces hyperactivation of mTOR signaling and consequent insulin resistance in
hepatocytes of mice fed a high fat diet and ob/ob mice (Lee et al. 2008). Proinflammatory cytokines also increase adipose lipolysis (Kawakami et al. 1987) by
suppressing the lipolysis inhibitor fat specific protein 27 (Ranjit et al. 2011),
contributing to high levels of circulating free fatty acids. Saturated fatty acids are
able to bind TLR4 culminating in heightened IKKβ/NFkB signaling to produce
additional pro-inflammatory cytokines (Shi et al. 2006), perpetuating a positive
feedback loop to sustain systemic insulin resistance (Jauhiainen et al. 2011).
Interestingly, adipose tissue specific deletion of the phosphatase PTEN
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(phosphatase and tensin homolog), a known negative regulator of insulin
signaling, is sufficient to improve serum adiponectin levels, systemic insulin
sensitivity, hepatic p-Akt and reduce TNFα production in subcutaneous adipose
tissue (Morley et al. 2015). Therefore, reducing adipose tissue inflammation is
imperative to re-establish insulin sensitivity and normal hormonal control over
glucose homeostasis.
1.5b Endoplasmic Reticulum Stress
The endoplasmic reticulum (ER) is the intracellular organelle where
proteins designated for secretion or incorporation into the plasma membrane are
translated, folded and processed. Several chaperone and oxidoreductase
proteins reside in the ER lumen to assist with protein folding. Protein disulfide
isomerase (PDI) is an ER chaperone protein that aids in the formation of
correctly configured substrate disulfide bonds via a series of redox reactions. PDI
contains two CGHC sequence active site motifs and each cysteine plays a
crucial role in the reduction and oxidation of substrate disulfide bonds
(Appenzeller-Herzog et al. 2008). The N-terminal cysteines (Cys55 and Cys399)
in both active sites have a lower pKa (~4.5) compared to the high pKa of the Cterminal cysteines (Cys58 and Cys402) (pKa ~9.5) (Hawkins and Freedman,
1991, Karala et al. 2010, Lappi et al. 2004). This promotes the increased
nucleophilicity of the N-terminal cysteines and the reduction of PDI active site
cysteines, accompanied by the oxidation and formation of a substrate disulfide
bond (Hawkins and Freedman, 1991, Karala et al. 2010, Lappi et al. 2004). ER
oxidoreductin 1 (Ero1) acts in conjunction with FAD+ to re-oxidize PDI through

11

the shuffling of electrons via similar CXXC regulatory sites. This facilitates the
recycling of PDI active site cysteines to continue protein folding (Tu et al. 2002).
Excess reactive peroxides are produced in the ER via Ero1 re-oxidation and
these are quenched by peroxiredoxin-4 (Prx4) (Tavender et al. 2008, Tavender
et al. 2010). PDI reduces the oxidized form of Prx-4, salvaging its active site
cysteines and facilitating continued regulation of potentially harmful reactive
peroxide levels in the ER (Tavender et al. 2010, Zito et al. 2010).
A disturbance to ER homeostasis, alterations in the oxidative
environment or the accumulation of misfolded proteins, is taxing to the ER
organelle and denotes a state of ER stress. The unfolded protein response
(UPR) is activated in adipocytes during diabetes in an effort to prevent the
development of ER stress (Özcan et al. 2004). The UPR is comprised of three
separate pathways; protein kinase-like endoplasmic reticulum kinase (PERK),
inositol-requiring enzyme 1 (IRE1), and activating transcription factor 6 (ATF6).
The accumulation of misfolded proteins is first sensed by glucose related protein
78 (GRP78) causing it to dissociate from IRE1, PERK and/or ATF6. This allows
for the homodimerization and phosphorylation of the IRE1 and PERK protein
complexes. pIRE1 possesses spliceosome activity and cleaves X-box binding
protein 1 (XBP1) in the cytosol to generate the truncated isoform spliced-XBP1
(sXBP1) a transcription factor that forms homodimers or heterodimers with other
UPR proteins. Dissociation of GRP78 from ATF6 results in translocation of ATF6
from the ER membrane to the golgi apparatus where ATF6 is also cleaved. The
spliced form of ATF6 translocates into the nucleus and forms transcription factor
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complexes with sXBP1 to promote the production of additional ER chaperone
proteins to aid in protein folding (Figure 1.1). The PERK pathway serves to
temporarily inhibit protein translation via phosphorylation of eukaryotic initiation
factor α (eIF2α), this arm of the UPR is prominently activated in the 3T3-L1
adipocyte cultured in diabetic conditions (Han et al. 2013a). If the UPR is
persistent and ER stress develops, the UPR signaling will result in the production
of the pro-apoptotic protein C/EBP homologous protein (CHOP). Acute CHOP
expression induces growth arrest and DNA damage-inducible protein (GADD34)
and results in dephosphorylated eIF2α and reinstatement of protein synthesis
(Han et al. 2013b), contributing further to the already defective proteostatic
environment. The activation of the UPR and presence of ER stress in diabetes
has been well documented (Boden et al. 2008, Özcan et al. 2006) however, there
is limited mechanistic insight on the direct initiator of ER stress in the adipocyte.
In chapter 2 we investigate a novel biochemical mechanism contributing to the
development of sustained ER stress in the adipocyte during diabetes.
1.5c Oxidative Stress
Hydroxyl radicals, superoxide, hydrogen peroxide, ketoaldehydes, and
hydroxynonenal are chemically reactive molecules characterized as reactive
oxygen species (ROS). ROS are endogenously generated during cellular
metabolism and may be beneficial or detrimental, dependent upon the
concentration produced in the tissue. ROS such as hydrogen peroxide have a
physiological role in redox signaling, however, excessive production of ROS
leads to the damaging oxidative modification of cellular macromolecules (Circu et
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al. 2010). Similar to extracellular inflammatory cytokine signaling, intracellular
ROS accumulation can activate JNK and IKKβ to impair insulin signaling
(Tiganis, 2011), aiding the development of type 2 diabetes.
Mitochondria are a premier site of ROS production with the electron
transport chain, pyruvate dehydrogenase and α-ketoglutarate dehydrogenase
complexes able to generate superoxide anion (Fisher-Wellman et al. 2013,
Starkov et al. 2004). Superoxide produced via the transfer of electrons through
complexes I and III of the electron transport chain to molecular oxygen is
metabolized by manganese superoxide dismutase to hydrogen peroxide.
Hydrogen peroxide can be oxidized to form a hydroxyl radical in the presence of
ferrous iron, leading to lipid peroxidation to generate reactive unsaturated lipid
aldehydes such as 4-hydroxy-trans-2,3-nonenal (4-HNE) (Grimsrud et al. 2008).
These highly reactive aldehydes irreversibly modify protein side chains of
cysteine, lysine and histidine residues, termed protein carbonylation (Curtis et al.
2012). Total protein carbonylation positively correlates with growing adiposity and
increasing serum free fatty acid levels in obese adults (Frohnert et al. 2011),
highlighting oxidative protein damage as a severe consequence of glucotoxicity.
Importantly, a significant increase in protein carbonylation underlies the
development of insulin resistance in human adipose tissue after just 6 days of
excess caloric intake (Boden et al. 2015). Specifically, the identification of GLUT4
carbonylation in response to acute gluco-lipotoxicity (Boden et al. 2015) implied
that oxidative stress is a major contributor to the observed deficiency in glucose
uptake and decreased adipose tissue insulin sensitivity.
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Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) 4
is an abundant adipose tissue protein and has been attributed to initiate ROS
production during early stages of obesity (Han et al. 2012). Excess nutrients
increase pentose phosphate pathway (PPP) activity and NADPH levels in 3T3-L1
adipocytes (Han et al. 2012). Located in the mitochondria, NOX4 transfers
electrons from NADPH to oxygen, thus generating the radical superoxide (Block
et al. 2009). Intracellular superoxide signaling has been shown to activate the
pro-inflammatory NF-κB pathway promoting adipose tissue insulin resistance
(Kaul and Forman, 1996). Interestingly, adipose tissue specific NOX4 deficiency
lowered ROS production and inflammation, and delayed the onset of insulin
resistance in mice fed a high fat and high sucrose diet (Den Hartigh et al. 2017).
However, reduced NADPH levels due to slower PPP flux are observed when the
adipocyte has reached its maximum triglyceride storage capacity, which may limit
NOX4 driven ROS generation in later stages of obesity (Han, 2016). Overall,
sustained ROS production in the adipose tissue appears to be a significant factor
in obesity associated inflammation and insulin resistance (Houstis et al. 2006)
contributing to the onset of type 2 diabetes. Thus, it is important to understand
the mechanisms that mediate prolonged ROS production and oxidative stress in
the adipose tissue.
The cell is equipped with several redox systems including the glutathione
and thioredoxin systems in order to combat chronic oxidative stress. The
antioxidant response element (ARE) is located within the promoter region of
several antioxidant genes and regulates the facilitation of the antioxidant
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response (Rushmore et al. 1991). Nuclear factor (erythroid-derived 2)-like 2
(Nrf2) is a transcription factor that translocates to the nucleus and binds to the
ARE. Nrf2 up-regulates the transcription of several detoxification enzymes and
antioxidant

genes

including

heme

oxygenase-1,

NAD(P)H:

quinone

oxidoreductase 1, glutathione peroxidase and glutathione S-transferase. Under
normal conditions the negative regulator Kelch-like ECH-associated protein 1
(Keap1) binds the Cullin3-based E3 ligase complex and sequesters Nrf2 in the
cytosol to be tagged with ubiquitin and degraded by the proteasome (Akira et al.
2004, Kobayashi et al. 2004). Keap1 contains at least 3 cysteine residues
confirmed to be sensitive to oxidative stress (Levonen et al. 2004, McMahon et
al. 2010). The covalent modification of these cysteine residues is crucial for Nrf2
activation, disturbing Keap1/Nrf2 binding and stimulating Nrf2 stabilization and
transcriptional activity during cellular stress (Kobayashi et al. 2006). Activation of
Nrf2 is generally considered beneficial for a variety of cells as it invokes the
protective antioxidant response. Nrf2 activation upon sulforaphane modification,
that targets Keap1 redox sensitive cysteines, reduces the concentration of ROS
in endothelial cells exposed to hyperglycemic conditions (Xue et al. 2008). Nrf2
also stimulates the transcription of glyoxalase 1 leading to reductions in
methyglyoxal induced protein damage in endothelial (HMEC-1) and hepatic
(HepG2) cell lines (Xue et al. 2012).
Although Nrf2 activation is considered protective in the defense against
glycemic stress during diabetes, the enhancement of Nrf2 activity in the adipose
tissue of diabetic mice is controversial and is associated with negative metabolic
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effects. Constitutive Nrf2 activation via Keap1 knockdown decreases glucose
tolerance, lipogenic gene expression and lipid accumulation while simultaneously
increasing insulin resistance in the adipose tissue of ob/ob type 2 diabetic mice
(Xu et al. 2012). The pharmacological enrichment of Nrf2 with sulforaphane
inhibits adipogenesis in mouse embryonic fibroblasts (MEFs) in vitro (Xu et al.
2012) which is often proposed as a beneficial means to combat obesity.
However, impaired adipogenesis and lipid storage in the adipose tissue
contributes to hepatic steatosis during type 2 diabetes and after high fat diet
feeding (More et al. 2013, Xu et al. 2012). Therefore enhanced Nrf2 activity due
to defects in the Keap1 degradation pathway may actually induce harmful effects
as decreased adipogenesis does not offer any benefit when the lipid is instead
stored in other tissues such as liver and muscle.
In addition, Keap1 has also been described as a negative regulator of
the ER stress protein CHOP in adipocytes (Huang et al. 2012), as CHOP is also
degraded by the ubiquitin proteasome system (Diaz et al. 2015, Li et al. 2006).
Keap1 binding to CHOP results in polyubiquitination of CHOP due to the
recruitment of ubiquitin by the COP9 signalosome/cullin3-based E3 ligase
complex (Figure 1.2), while knockdown of Keap1 expression results in
upregulation of CHOP in adipocytes (Huang et al. 2012). In addition to oxidative
modification, Keap1 cysteines are susceptible to modification by other
electrophiles including a range of xenobiotic compounds. In chapter 3 we
propose an alternative mechanism regulating CHOP degradation and stability in
the adipocyte in response to glucotoxicity.
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1.6 C/EBP Homologous Protein
Although adipogenesis is regulated by several transcription factor
families (White et al. 2010), this section will discuss the CCAT/enhancer binding
protein (C/EBP) transcription factors as this family is highly regulated by CHOP
signaling. The C/EBP family has a firmly established regulatory role in the
development of adipocyte differentiation. In response to hormonal stimuli in
adipocyte

culture

conditions

(insulin,

dexamethasone

and

isobutylmethylxanthine), the C/EBP isoforms δ and β dimerize and upregulate
transcription of C/EBPα (Cao, 1991, Yeh, 1995) by attaching to the C/EBP
binding site in the gene promoter region (Christy et al. 1991). In turn, C/EBPα
stimulates transcription of the master adipogenic regulator peroxisome
proliferator-activated receptor gamma (PPAR-ƴ) (Rosen et al. 2002) that
promotes lipogenesis (Tontonoz et al. 1994). Deletion of the C/EBP δ, β or α
genes can be fatal and effectively stunts white adipose tissue development in
surviving mice (Tanaka et al. 1997, Wang et al. 1995). Recent evidence suggests
a significant role for the direct interaction of transcriptional cofactor cyclin C with
C/EBPα to activate adipogenesis of brown adipose tissue (Song et al. 2017). In
addition, knocking down the expression of cyclin C in 3T3-L1 fibroblasts inhibits
adipogenesis, detectable as reduced lipid accumulation and expression of the
adipogenic genes PPARƴ, C/EBPα, adiponectin and fatty acid binding protein 4
(Song et al. 2017). Overall this demonstrates the importance of C/EBP signaling
for proper adipose tissue function, as enhanced adipogenesis is essential to
accommodate the lipid overload due to excessive nutrient consumption.
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C/EBP homologous protein (CHOP) is a basic leucine zipper
transcription factor known to form heterodimers with C/EBPα and C/EBPβ family
members. Unlike C/EBPα and C/EBPβ, CHOP contains glycine and proline
substitutions in the conserved C/EBP-DNA binding region. Therefore, CHOP
binding of C/EBP isoforms suppresses gene transcription due to the inability of
the complex to interact with normal C/EBP binding sequences on the target gene
(Ubeda et al. 1996). The production of CHOP is known to be upregulated in
response to cellular stress, e.g., ER stress, DNA damage, glucose starvation,
hypoxia and oxidative stress (Carriére et al. 2004, Han et al. 2013a, Luethy and
Holbrook, 1992, Mihai et al. 2015). Importantly, ectopic expression of CHOP
following retrovirus transfection, glucose starvation, hypoxia or the induction of
ER stress reduces C/EBPα and PPARƴ production and downstream signaling to
prevent adipogenesis (Batchvarova et al. 1995, Han et al. 2013a). Consistent
with these findings, CHOP knockout mice display larger adipocytes and fat pads
compared to wild mice fed a high fat diet (Maris et al. 2012). The inhibition of
adipogenesis due to elevated CHOP expression may be detrimental in obesity,
forcing the accumulation of lipids in peripheral tissues due to the inability to
differentiate new adipocytes for energy storage.
It is increasingly recognized that CHOP has additional physiological roles
beyond its ability to regulate adipogenesis. CHOP controls the induction of cell
cycle arrest between the G1/S phase in fibroblasts (Barone et al. 1994), and the
regulation of Bcl-2 family members to promote apoptosis in cardiomyocytes,
hepatocytes, podocytes and pancreatic beta cells (Kim et al. 2008, Li et al. 2014,
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Malhi et al. 2013). Jauhiainen et al. reported that tunicamycin induced CHOP
accumulates in the cytoplasm, in addition to the nucleus, of human fibroblasts
and GOT3 sarcoma cells (Jauhiainen et al. 2012). Further gene expression
profiling by microarray and ontology analysis revealed that cytoplasmic CHOP
indirectly controls the expression of 94 different genes related to cellular
movement, development, proliferation and growth, cell cycle, cell death and gene
expression (Jauhiainen et al. 2012).
In addition, CHOP has been shown to directly bind the DNA
promoter/enhancer region of Ppara, Srebf1 and Cebpα in hepatocytes
culminating in the suppression of metabolic gene expression during stress (Chika
et al. 2013). Prasad et al. have described a novel role for CHOP as an important
mediator of phosphate movement into the mitochondria in adrenal cells. This
results

in

increased

steroid

synthesis

by

stabilizing

3β-hydroxysteroid

dehydrogenase type-2 protein conformation and its association with Translocase
Outer Membrane-22 during periods of stress due to cold temperatures (Prasad et
al. 2016). CHOP mRNA and protein levels are also increased in the tumors of a
genetic mouse model of hepatocellular carcinoma generated by mobilized
T2/Onc3 transposon and human hepatocellular carcinoma (DeZwaan-McCabe et
al. 2013). Here CHOP promotes hepatocyte cell death that provokes a proinflammatory response and fibrotic deposition. Additionally, tumorigenesis is
reduced by 50% in CHOP knockout mice treated with diethylnitrosamine
compared to wild type animals (DeZwaan-McCabe et al. 2013, Scaiewicz et al.
2013) suggesting a prominent role for CHOP to stimulate oncogenesis.
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In considering alternative roles for CHOP function beyond the
suppression of adipogenesis, we have noted an increase in CHOP as adipocytes
progress through maturation in high glucose (similar to Han et al. 2013a). In
contrast, this increase in CHOP is not sustained in adipocytes in normal glucose
despite the fact that they also progress normally through adipogenesis, nor is it
present in the adipose tissue of healthy mice versus diabetic mice. Since our in
vitro studies specifically compared adipocytes simultaneously undergoing
adipogenesis and maturation in either normal or high glucose, it suggests that
sustained CHOP unique to high glucose conditions may have an alternative role
during diabetes. Two studies examining CHOP knockout mice distinguish CHOP
as an important component of inflammation mediated insulin resistance in mice
fed a high fat diet (Maris et al. 2012, Suzuki et al. 2017).
CHOP knockout mice show a significant improvement in fasting blood
glucose levels and insulin sensitivity compared to wild type mice after high fat
diet feeding (Suzuki et al. 2017). Interestingly, while the degree of macrophage
infiltration does not change between wild type and CHOP knockout mice (Maris
et al. 2012, Suzuki et al. 2017), CHOP deficiency specifically in the adipose
tissue induces anti-inflammatory M2 macrophage polarization (Suzuki et al.
2017). In addition, the absence of CHOP in adipose tissue promotes eotaxin
production and eosinophil recruitment in the adipose tissue microenvironment of
mice fed a high fat diet (Suzuki et al. 2017). Overall, increased or sustained
CHOP levels in the absence of increased apoptosis in the adipose tissue
appears to be detrimental during diabetes. The exact mechanism by which
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CHOP regulates inflammation and insulin resistance in the adipose tissue
remains to be explored.
1.7 Protein Succination
Cysteine is one of the least common amino acids incorporated into the
primary sequence of a protein, however, it is most often included as an important
structural or active site residue governing protein function or regulation. The thiol
group of cysteine has a pKa ~8.5, while the pKa of an active site cysteine may
range from 3-6. The lower pKa value of the active site thiolate indicates the
increased reactivity of the nucleophilic cysteine residue. Our laboratory was first
to describe the Michael addition reaction between the Krebs cycle intermediate
fumarate and the thiolate group of cysteine to form a thioether bond and the
chemical

modification

S-(2-succino)cysteine

(2SC).

This

enzymatically

irreversible reaction is termed succination (Figure 1.3) (Alderson et al. 2006).
2SC was first identified in vivo in human plasma proteins where fumarate
modifies ~3.5% of total albumin from healthy individuals (Alderson et al. 2006).
We assessed the kinetics of succination in vitro after incubating fumarate with Nacetylcysteine

(pKa

~9.5)

and

commercial

glyceraldehyde-3

phosphate

dehydrogenase (GAPDH) (pKa ~6) (Alderson et al. 2006, Blatnik et al. 2008). As
predicted the succination of GAPDH was ~250 times faster than N-acetylcysteine
due to the lower pKa and increased reactivity of GAPDH cysteine residues
(Alderson et al. 2006). The degree of protein succination directly correlates with
the concentration of fumarate, and since succination is a slow chemical reaction,
the cysteines must be exposed to reasonably high levels of fumarate for a
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prolonged period (Alderson et al. 2006, Blatnik et al. 2008, Frizzell et al. 2009,
Nagai et al. 2007). Consistent with this data, decreasing intracellular fumarate
levels directly reduces protein succination (Frizzell et al. 2012, Tanis et al. 2015).
Protein succination increases ~3.5 fold in the skeletal muscle of
streptozotocin-induced type 1 diabetic rats (Blatnik et al. 2008). Matrix assisted
laser desorption/ionization – time of flight (MALDI-TOF) and ultra-performance
liquid chromatography electrospray ionization tandem mass spectrometry (UPLC
ESI-MS/MS) analysis of GAPDH isolated from the gastrocnemius muscle
confirmed a pronounced increase in the relative amount of succinated peptides
to control peptides containing active site Cys149 and peripheral Cys244 in
diabetic versus control rats (Blatnik et al. 2008). Interestingly, modification of
GAPDH by fumarate correlates indirectly with GAPDH enzymatic activity in a
dose dependent manner in vitro, and in the muscle of diabetic rats (Blatnik et al.
2008). This study was the first to describe the targeted effect of succination to
inhibit enzyme activity via direct cysteine modification by fumarate. A number of
additional functional studies on specific succinated proteins have since been
conducted in adipocytes (Frizzell et al. 2009), neurons (Linker et al. 2011),
fibroblasts (Adam et al. 2011, Ternette et al. 2013), T cells (Blewett et al. 2016),
as well as purified protein in vitro (Piroli et al. 2014). Beyond the original
identification of endogenous succination of plasma albumin, increased protein
succination has been documented in the context of several diverse disease
settings including; type 2 diabetes (Merkley et al. 2014), Leigh syndrome (Piroli
et al. 2016), renal cell carcinoma (Yang et al. 2014), tuberculosis management
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(Ruecker et al. 2017) and the pharmacological modulation of autoimmune
disorders (Blewett et al. 2016, Piroli et al. 2017 in preparation).
1.7a Type 2 Diabetes
As discussed in Section 1.4, the hyperglycemic/hyperinsulinemic state
observed during type 2 diabetes exceeds the energy needs of adipocytes. This
creates a build-up of ATP, relative to ADP, in adipocytes matured in high glucose
(Frizzell et al. 2012). Respiratory control prevents further ATP production,
reducing ATP synthase activity and the translocation of hydrogen ions back into
the mitochondrial matrix. The accumulation of hydrogen ions in the inner
membrane space increases the mitochondrial membrane potential and
contributes to reductive stress, i.e. the accumulation of increased NADH relative
to NAD+. A consequence of this ’pseudohypoxic’ state is the temporary inhibition
of the NAD+-dependent Krebs cycle enzymes and the accumulation of Krebs
cycle intermediates (Frizzell et al. 2012). Lai and Goldman reported that 3T3-L1
adipocytes matured in high glucose will release elevated concentrations of
several Krebs cycle intermediates, including fumarate, into the cell culture
medium (Lai and Goldman, 1992). We have established that intracellular
fumarate levels increase ~2.5-4 fold in adipocytes matured in high (30 mM)
versus normal (5 mM) glucose concentrations as a direct result of this
glucotoxicity driven mitochondrial stress (Nagai et al. 2007, Frizzell et al.
2012)(Figure 1.4). The presence of excess fumarate results in a pronounced
increase in protein succination in both adipocytes matured in 30 mM glucose,
and in the adipose tissue from diabetic ob/ob and db/db mice (Nagai et al. 2007,
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Frizzell et al. 2009, Thomas et al. 2012). Notably, when compared with other
tissues in the db/db model (kidney medulla and cortex, lungs, skeletal muscle,
cardiac muscle, liver and spleen) this increase in 2SC seems to be selective for
the adipose tissue (Thomas et al. 2012). This may be due to elevated fumarate in
the relatively compressed cytoplasmic volume of the adipocyte in comparison
with the total cell size, or that total tissue protein analyses cannot detect subtle
cell-type specific changes. Protein succination was not detected in the catabolic
adipose tissue of type 1 diabetic rats, and only subtle succination is observed in
the adipose tissue from mice fed a high fat diet for 12 weeks (Thomas et al.
2012). This suggests that succination is distinctly associated with the presence of
type 2 diabetes, rather than insulin resistance alone, in adipose tissue. A list of
38 total protein targets of elevated fumarate in adipocytes matured in high
glucose have been identified by strong cation exchange or high pH fractionation
followed by capillary LC-MS/MS mass spectrometry (Merkley et al. 2014).
However, the stoichiometry, structural and function significance of 2SC remains
to be determined for many of these adipocyte target proteins.
To date, we have characterized the effect of protein succination on the
function of two proteins in the adipocyte; adiponectin (Frizzell et al. 2009) and
tubulin (Piroli et al. 2014). Adiponectin is a homopolymeric protein assembled in
the endoplasmic reticulum (Liu et al. 2008, Liu and Liu, 2010) and secreted into
circulation where it regulates fatty acid beta oxidation in the skeletal muscle and
glucose homeostasis in the liver. Type 2 diabetic patients consistently exhibit
decreased plasma levels of both total and high molecular weight (HMW)
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adiponectin, and this has been linked to the development of insulin resistance
(Chang et al. 2009). Cys39 of the monomeric adiponectin isoform has been
confirmed as the site of succination, preventing the formation of adiponectin
multimers. Consistent with this, the succinated adiponectin is not secreted into
the medium of adipocytes matured in high glucose (Frizzell et al. 2009). Similar
to the in vitro profile, the succination of intracellular adiponectin was also
increased in the epididymal adipose tissue from db/db mice and was not
detected in the plasma (Frizzell et al. 2009). This study confirms that the site
specific succination of adiponectin inhibits the formation and secretion of HMW
species from adipocytes, consistent with the reduced levels of plasma
adiponectin observed in type 2 diabetes (Frizzell et al. 2009).
α and β tubulin form heterodimers that generate the basic subunits of
cytoskeletal microtubule polymers. The tubulin heterodimer is comprised of 20
cysteine residues and is consistently the most prominent succinated protein
detected by our unique anti-2SC antibody in the brain, adipose tissue, cardiac
and skeletal muscle and lung tissue from db/db mice, as well as 3T3-L1
adipocytes and C2C12 myocytes (Thomas et al. 2012 and Piroli et al. 2014).
Consistent with our previous study (Thomas et al. 2012) the degree of tubulin
succination increases only in the adipocyte under diabetic conditions and
succination of tubulin remains unaltered between control and diabetic conditions
in all other tissues examined to date (Thomas et al. 2012, Piroli et al. 2014).
Assessment of the effect of succination on tubulin polymerization in vitro showed
that physiological levels of fumarate do not influence polymerization. Using
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MS/MS mass spectrometry I identified Cys347 and Cys376 on α tubulin and
Cys12 and Cys303 on β tubulin from purified porcine brain tubulin as the precise
sites of succination. Interestingly, succination of these cysteine residues impairs
the detection ability of antibodies targeting tubulin epitopes that contain Cys347,
Cys376 or Cys303 (Piroli et al. 2014). The observed decrease in antigenantibody binding with increasing succination suggests that succination may alter
the interaction of tubulin with microtubule associated proteins (MAPs) within
these regions. In addition, these results underscore the importance of validating
antibodies with cysteine containing epitopes to ensure succination does not
affect antibody recognition.
The progressive increase in protein succination over 8 days of adipocyte
maturation occurs in parallel with increased CHOP levels and enhanced
inflammatory cytokine secretion (Tanis et al. 2015). Intriguingly, we have
observed that the ER proteins glucose related protein 78 (GRP78) and protein
disulfide isomerase (PDI) are targets of succination in 3T3-L1 adipocytes
matured in high glucose (Nagai et al. 2007). In chapter 2 we investigate the
functional significance of succination on the oxidoreductase PDI and how this
contributes to adipocyte dysfunction during diabetes. Sodium phenylbutyrate
(PBA) is a small chemical chaperone known to reduce ER stress and inhibit
adipogenesis (Basseri et al. 2009, Özcan et al. 2006). We discovered that PBA
acts to lower protein succination by reducing glucose uptake and the
mitochondrial membrane potential in adipocytes cultured in 30 mM glucose
(Tanis et al. 2015), independent of any effect on ER stress. Despite claims that
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PBA acts to reduce ER stress in diabetic animals (Özcan et al. 2006), we
detected no change in protein succination, UPR markers and greater CHOP
levels in the adipose tissue of db/db mice treated with PBA (unpublished
observations). In chapter 3 we further pursue the relationship between protein
succination and CHOP stability, independent of the UPR and ER stress, in the
adipocyte matured in high glucose.
Elimination of the fumarase gene in mouse embryonic fibroblasts
significantly increases protein succination (Adam et al. 2011) due to the inability
of fumarase to convert fumarate to malate. Our collaborators Yang et al. recently
developed and characterized the phenotype of a unique adipose tissue specific
fumarase knockout mouse (AFHKO) (Yang et al. 2016). This novel mouse model
permits the investigation of the systemic implications of increased fumarate alone
in the adipose tissue. Deletion of the fumarase gene under control of
adiponectin-Cre specifically in the adipose tissue resulted in severe mitochondrial
dysfunction in the perigonadal white adipose tissue, as evidenced by swollen
mitochondria with reduced or absent cristae and insufficient ATP production
(Yang et al. 2016). Cell death, cytoplasmic degeneration, lipid extrusion into the
interstitial space and adipose tissue macrophage accumulation was also
documented to occur in the white adipose tissue of these AFHKO mice (Yang et
al. 2016). Unexpectedly, the AFHKO mice exhibited lower fat mass compared to
controls, remained insulin sensitive and glucose tolerant and showed no change
in liver mass or liver triglyceride levels after consuming a high fat diet over 9-11
weeks (Yang et al. 2016). Surprisingly, the absence of fumarase in the adipocyte

28

appeared to be protective against high fat diet induced obesity, insulin resistance
and hepatic steatosis.
The aP2(adipocyte protein 2)-Cre and adipo(adiponectin)-Cre models
are the most effective tools available to target adipose tissue specific deletions in
vivo. An unfortunate limitation of both the aP2-Cre and adipo-Cre models is the
inability to distinguish between white adipose tissue and brown adipose tissue as
both aP2 and adiponectin are expressed in each adipose subtype. Therefore, the
consequences of defective brown adipose tissue also have to be considered
when explaining the overall phenotype of the AFHKO mouse. Brown adipose
tissue demonstrated irregular and elongated mitochondria, decreased uncoupling
protein 1 and β3 adrenergic receptor mRNA expression and impaired adaptive
thermogenesis were present in the AFHKO mouse (Yang et al. 2016). The failure
of brown adipose tissue to contribute to heat production in AFHKO mice housed
at ~22ºC resulted in active skeletal muscle-mediated shivering thermogenesis
(Yang et al. 2016). Shivering thermogenesis increases skeletal muscle energy
expenditure in AFHKO mice housed at 22ºC and results in minimal lipid
accumulation and improved insulin sensitivity, even during high fat diet feeding.
Significantly, equilibration of AFHKO mice thermoneutral conditions (30ºC)
reversed the unexpected protective effect of adipose tissue fumarase deficiency.
Further experiments in this model at thermoneutral temperatures will provide
more meaningful information on the homeostatic significance of adipose tissue
fumarase deficiency, and validates the importance of thermoneutral housing for
metabolic studies (Stemmer et al. 2015, Tian et al. 2016, Yang et al. 2016).
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1.7b Leigh Syndrome
Leigh Syndrome is distinguished by progressive neurodegeneration and
the production of lesions in the brainstem and basal ganglia (Finsterer, 2008,
Rahman et al. 1996). This fatal mitochondrial disease develops due to mutations
in the genes encoding protein subunits of complex I and VI of the electron
transport chain (Ruhoy and Saneto, 2014). Ndufs4 is an 18 kDa protein that aids
in the final assembly of complex I and was one of the first mutated genes
identified to cause Leigh Syndrome. The loss of Ndufs4 leads to a form of
complex I that lacks the NADH dehydrogenase unit, and is associated with the
accumulation of NADH and impaired movement of electrons through the electron
transport chain. Similar to glucotoxicity driven mitochondrial stress and
succination in the adipocyte, pseudohypoxia drives the accumulation of fumarate
in Ndufs4 deficient neurons. We have recently described elevated protein
succination in the brainstem and cerebellar nuclei of Ndufs4 knockout mice (Piroli
et al. 2015), particularly in the vestibular nucleus where most of the pathology is
observed. The Ndufs4 knockout mouse displays many of the clinical and
neurological symptoms detected in human Leigh syndrome (Quintana et al.
2010). We propose the fumarate accumulation and subsequent protein
modification may provide a novel biochemical link to the underlying pathology.
Voltage dependent anion channel (VDAC) 1 and 2 are transmembrane
proteins in the outer mitochondrial membrane and function as the primary
channels for the movement of ADP, ATP and other ions and metabolites
between the mitochondria and the cytosol. We confirmed that both VDAC 1 and
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2 are novel targets of succination in the brainstem of Ndufs4 knockout mice by
mass spectrometry and western blotting (Piroli et al. 2015). Further analysis by
LC-MS/MS mass spectrometry identified Cys77 and Cys48 as the endogenous
targets of succinated VDAC2 in the brainstem (Piroli et al. 2015). Current
investigations aim to understand if succination of VDAC impairs channel activity
as this may contribute further to the mitochondrial bioenergetic deficit observed in
Leigh Syndrome, potentially by reducing mitochondrial ATP export.
1.7c Cancer
Fumarase is responsible for the hydration of fumarate to malate in the
mitochondria.

Genetic

loss-of-function

mutations

in

a

fumarase

allele

predisposes patients to hereditary leiomyomatosis and renal cell carcinoma
(HLRCC) (Tomlinson et al. 2002), further loss of heterozygosity specifically
precedes the development of the aggressive renal carcinoma and results in a
significant increase in fumarate levels (Pollard et al. 2005). Fumarate has since
gained recognition as an oncometabolite, a small molecule component of normal
metabolism

whose

accumulation

signifies

metabolic

dysregulation

and

subsequently leads cells to oncogenesis (Yang et al. 2012). As expected, the
substantial increase in fumarate leads to a pronounced increase in the amount of
succinated proteins in kidney cells of a renal specific fumarase knockout mouse
model (Pollard et al. 2007). MS/MS analysis has identified 94 succinated proteins
in fumarase knockout mouse embryonic fibroblasts (MEF) and renal cysts
(Ternette et al. 2013), and 60 confirmed protein targets of 2SC in human
UOK262 and NCC-FH-1 cells and tumors (Yang et al. 2014). Selective

31

evaluation of the role of 2SC in fumarase deficient cancers identified the redox
sensitive Cys151 and Cys288 of Keap1 as prominent targets of succination
(Adam et al. 2011, Ooi et al. 2011). Modification of these precise cysteine
residues impairs Keap1/Nrf2 binding and activates the Nrf2 anti-oxidant
response. Continuous with the inhibitory effects of 2SC on protein functionality,
succination of the mitochondrial enzyme aconitase at Cys385, Cys448 and
Cys451, which are crucial for iron-sulfur cluster binding, significantly reduces
enzyme activity in vitro and in fumarase knockout MEFs (Ternette et al. 2013).
Kerins et al. have determined iron regulatory protein 2 is a target protein of
succination in UOK262 cells, and that this allows for ferritin activation to promote
the production of the pro-mitotic transcription factor Forkhead box protein M1
(Kerins et al. 2017). Additionally, fumarate inhibits demethylation of miR200ba429, an anti-metastatic miRNA cluster, promoting the expression of
epithelial-to-mesenchymal related transcription factors in fumarase deficient
MEFs (Sciacovelli et al. 2016). These studies demonstrate protein succination is
a critical link between fumarase deficiency and cell malignancy in HLRCC (Kerins
et al. 2017). Unlike non-malignant cells, protein succination is advantageous to
the cancer cell by boosting its antioxidant response and promoting metastasis, as
well promoting metabolic plasticity in fuel utilization, e.g. decreased aconitase
activity may force alternate anaplerotic fuel usage. Future investigations will
continue to focus on the contribution of 2SC in HLRCC pathology progression.
Interestingly, as fumarate is increasingly accepted as a novel oncometabolite
(Yang et al. 2012), protein succination is also actively being pioneered as a
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reliable early disease stage diagnostic marker (Chen et al. 2014, Llamas-Velasco
et al. 2016).
1.7d Fumaric Acid Esters
Fumarate esters dimethyl fumarate (DMF) and monomethyl fumarate
(MMF) (Figure 1.5) have been used to treat symptoms of autoimmune diseases,
such as psoriasis, for more than fifty years (Ghoreschi et al. 2011, Gold et al.
2012, Papadopoulou et al. 2010). In 2013 the U.S. Food and Drug Administration
approved DMF for multiple sclerosis treatment as an oral pharmaceutical drug
marketed as Tecfidera® (Linker et al. 2013). Elucidation of the complete
biochemical mechanism underlying the therapeutic benefits and side effects of
DMF and MMF has received heightened attention (Ghoreschi et al. 2011, Blewett
et al. 2016, Wu et al. 2017, Schloder et al. 2017). Fumarate esters enter the cell
where they react rapidly with available thiols, including intracellular glutathione
(Ghoreschi et al. 2011, Schmidt et al. 2010, Thiessen et al. 2010, Manuel and
Frizzell, 2013). The depletion of glutathione levels by fumarate esters increases
heme-oxygenase 1 expression and STAT1 activation that amplifies IL-10 and
impairs IL-12 and IL-23 production promoting the type II dendritic cell phenotype
(Ghoreschi et al. 2011). This induces a switch from the pro-inflammatory Th1
profile towards a favorable Th2 profile in the experimental autoimmune
encephalomyelitis (EAE) mouse model (Ghoreschi et al. 2011). Linker et al.
showed that DMF stimulates the Keap1/Nrf2 antioxidant pathway by direct
modification of Keap1 redox sensitive cysteines (Linker et al. 2011). The
induction of the antioxidant response by Nrf2 preserved neuronal health and
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axonal myelination in the myelin oligodendrocyte glycoprotein induced EAE
mouse model of multiple sclerosis (Linker et al. 2011). While Nrf2 activation
remains the dominant accepted mechanism of action of DMF, recent studies
demonstrate that DMF can act independent of Nrf2 and is therapeutically
beneficial for the treatment of multiple sclerosis models in Nrf2 knockout mice
(Peng et al. 2016). A thorough proteomic approach has uncovered 40 DMF
modified cysteines in primary human T cells, elucidating the reactivity of this
potent electrophile with immunomodulatory proteins including IKKβ, tumor
necrosis factor-α-induced protein 3 (TNFAIP3) and IL-16 (Blewett et al. 2016).
Blewett et al. further established that DMF prevents T cell activation and IL-2
production via succination of a CXXC motif on protein kinase Cθ that disrupts its
interaction with CD28 at the immunological synapse (Blewett et al. 2016).
Our laboratory has conducted a new extensive proteomics study to
investigate new neuronal targets of fumarate esters that may be affected by
treatment with Tecfidera®. I utilized bottom-up shotgun proteomics with the
Orbitrap Velos Pro to identify an additional mass of 144.1270 Da or 130.0262 Da
indicating the DMF or MMF cysteine modification on the fragment ion,
respectively (Figure 1.5). In total, we identified 4 cysteine containing peptides in
primary mouse neurons, 11 cysteines in primary rat astrocytes and 13 novel
cysteine containing peptides in differentiated N1E-115 neuroblastoma cells that
were succinated by DMF or MMF. Cofilin-1 was identified in primary astrocytes to
be succinated by MMF at Cys139. Cofilin-1 modulates the actin cytoskeleton by
depolymerizing filamentous actin and producing monomeric actin that can be
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used to reorganize the actin cytoskeleton in response to cellular dynamics.
Analysis of Colifin-1 depolymerization activity in vitro suggests that the chemical
modification of Cys139 by fumarate esters reduces its capacity to regulate actin
dynamics (data not published). We are continuing to examine the effect of
fumarate esters on additional protein targets, both in vitro and in vivo,to better
understand the positive therapeutic mechanism of DMF during multiple sclerosis.
While these diverse scenarios for fumarate accumulation provide new
information on the role of succination, the studies in this dissertation will focus on
the early mechanism of adipocyte dysfunction in diabetes. I propose that
succination of the important ER oxidoreductase protein PDI inhibits PDI
reductase activity, contributing to an accumulation of misfolded proteins and ER
stress. I also investigate succination of Ero1 that contains a similar active site
motif to PDI and may also be a prominent target for succination. In addition, I
hypothesize that decreasing protein succination with mild mitochondrial
uncouplers will relieve ER stress, identifying a new mechanism of glucotoxicity
induced adipocyte dysfunction. In chapter 3 I propose that Keap1 is succinated in
adipocytes matured in high glucose and that modification of Keap1 promotes
CHOP stability. I confirmed that CHOP accumulates in the nuclear fraction of
adipocytes matured in high glucose corresponding to decreased secretion of IL13 and that IL-13 secretion is rescued by reducing oxidative stress and CHOP
levels.
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Figure 1.1: The unfolded protein response (UPR) pathway. Homeostatic
imbalance initiated by the accumulation of misfolded proteins in the endoplasmic
reticulum (ER) activates the UPR. The UPR is comprised of three separate
pathways (1) IRE1 will splice XBP1 and (2) cleaved ATF6 in the golgi act as
transcription factors to up-regulate ER chaperone proteins. The PERK pathway
acts to attenuate translation via phosphorylation of eIF2a and continued
activation of the PERK arm results in transcriptional up-regulation of C/EBP
homologous protein (CHOP) as a terminal response to ER stress.
(http://www.human.cornell.edu/dns/qilab/research.cfm)
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Figure 1.2: C/EBP homologous protein (CHOP) degradation pathway.
The COP9 signalosome (CSN) removes the ubiquitin-like protein Nedd8 from
cullin-3 to inhibit cullin-3 activity. The CSN associated protein ubiquitin specific
protease 15 (USP15) protects Keap1 from auto-ubiquitination and degradation.
The degradation supercomplex will bind CHOP and CSN associated kinases,
casein kinase 2 (CK2) and protein kinase D (PKD), phosphorylate CHOP to
promote ubiquitination and degradation (Huang et al. 2012).
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Figure 1.3: Formation of 2-(S-succino)cysteine (2SC). The Michael addition
reaction of fumarate with cysteine residues on proteins to form 2SC (Alderson et
al. 2006).

Figure 1.4: Schematic of how glucotoxicity derived mitochondrial stress
drives the increase in protein succination and potentially endoplasmic
reticulum (ER) stress in the adipocyte during diabetes. Elevated
carbohydrate fuel supply exceeds the metabolic needs of the adipocyte leading
to an increase in the basal oxygen consumption rate and ATP: ADP ratio. The
decrease in mitochondrial ADP concentrations inhibits ATP synthase and results
in a high mitochondrial membrane potential. Electron transport is inhibited with
the accumulation of H+ in the inner membrane space of the mitochondria and the
cellular redox status shifts towards an increase in NADH concentration. The
increase in NADH: NAD+ causes an increase in fumarate and malate, consistent
with feedback inhibition of the NAD+ -dependent dehydrogenases of the
tricarboxylic acid cycle. Excess fumarate is available to react with cysteine
residues, including the succination of the ER oxidoreductase PDI. Sustained
increases in fumarate directly contribute to an increase in ER stress.
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Figure 1.5: Fumarate and fumaric acid esters structures. Chemical structures
of fumarate (116.07 Da), monomethyl fumarate (130.0262 Da) and dimethyl
fumarate
(144.1270
Da).
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Chapter 2
Succination of Protein Disulfide Isomerase Links Mitochondrial Stress and
Endoplasmic Reticulum Stress in the Adipocyte During Diabetes1

1
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2.1 Introduction
Proper protein folding and disulfide bond arrangement requires the
concerted activities of endoplasmic reticulum (ER) chaperones and isomerases,
particularly during the correction of non-native disulfide bond configurations.
Consequently, if the ER accessory protein response is compromised this will
result in an accumulation of misfolded proteins in the ER, prompting the Unfolded
Protein Response (UPR) in an attempt to maintain ER proteostasis (Kim et al.
2008, Ron et al. 2007). The continued accumulation of misfolded proteins
eventually culminates in ER stress and the well characterized upregulation of the
pro-apoptotic protein C/EBP homologous protein (CHOP) (Schröder et al. 2005).
ER stress has been documented in the adipose tissue of type 2 diabetic patients
(Boden et al. 2008, Boden et al. 2014a, Sharma et al. 2008), and is reduced
following weight loss (Gregor et al. 2009). Hyperinsulinemia, hypoxia and
inflammation have been proposed to initiate the development of ER stress in
human adipose tissue (Boden et al. 2014b, Hosogai et al. 2007). ER stress has
also been described in 3T3-L1 adipocytes (particularly through protein kinase
RNA-like endoplasmic reticulum kinase signaling) and in the adipose tissue of
type 2 diabetic mice (Han et al. 2013a, Kawasaki et al. 2012, Lefterova et al.
2009, Özcan et al. 2004). The treatment of adipocytes from obese subjects with
lipopolysaccharides, high glucose concentrations or free fatty acids has been
shown to promote ER stress in vitro (Alhusaini et al. 2010, Jiao et al. 2011).
While all of these may be physiologically relevant contributors to ER stress, there
remains limited insight on the mechanistic processes that directly cause
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disturbed protein folding in the adipocyte (Sha et al. 2011, Sun et al. 2012). In
this study we identify a novel biochemical mechanism responsible for reduced
protein folding and increased ER stress in the adipocyte during diabetes.
Protein disulfide isomerase (PDI) is the most abundant ER oxidoreductase
that facilitates the formation of correctly configured substrate disulfide bonds
(Hatahet et al. 2009, Rutkevich et al. 2010). PDI contains two active sites with
the sequence motif -CGHC- in the a and a’ domains, and both of these play
crucial roles in the reduction and oxidation of substrate disulfide bonds in the ER
(Appenzeller-Herzog et al. 2008, Hawkins et al. 1991, Karala et al. 2010, Lappi et
al. 2004). ER oxidoreductin 1α (Ero1) functions in re-oxidizing PDI using similar
CXXC active sites, to sustain oxidative protein folding (Tu et al. 2002). Sglutathionylation of PDI active-site cysteines in both HL60 leukemia cells and
SKOV3 ovarian cancer cells alters PDI protein structure and inhibits PDI
isomerase activity in vitro, leading to stimulation of the UPR and the production of
CHOP (Townsend et al. 2009, Xiong et al. 2012). In addition, nitrosative stress
induced S-nitrosylation of PDI promotes UPR activation, ER stress and eventual
cell death in cerebrocortical neurons (Uehara et al. 2006). These models
demonstrate that the post-translational modification of PDI active-site cysteines
precedes the development of ER stress. Oxidized low density lipoprotein (oxLDL)
treatment of HMEC-1 cells augments CHOP mRNA levels and ER stress
specifically due to decreased PDI reductase activity (Muller et al. 2013).
However, HMEC-1 cells that over-express native PDI are immune to the
induction of ER stress with oxLDL treatment (Muller et al. 2013). Importantly, the
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restoration of functional ER chaperone levels is sufficient to decrease CHOP
protein expression and ameliorate ER stress in the adipocyte (Liu et al. 2015,
Zhou et al. 2010), therefore it is critical to mechanistically understand how
chaperone function is altered under diabetic conditions.
We have previously confirmed that the ER residents PDI and glucoseregulated protein 78 (GRP78) are succinated by endogenously produced
fumarate in the adipocyte under high glucose conditions (Nagai et al. 2007).
Protein succination occurs when fumarate reacts non-enzymatically with cysteine
thiols to produce the irreversible modification S-2-succino-cysteine (2SC)
(Alderson et al. 2006, Frizzell et al. 2009, Nagai et al. 2007). The analysis of
proteomic targets identified to date suggests that low pK a thiols that may also be
susceptible to oxidation as well as those with increased solvent accessibility may
be most likely to react with endogenously produced fumarate (Merkley et al.
2014, Miglio et al. 2016) Protein succination is increased in the adipose tissue of
db/db mice and in 3T3-L1 adipocytes matured in high glucose (10-30 mM)
(Frizzell et al. 2009, Nagai et al. 2007). We previously demonstrated that the
ATP:ADP ratio, NADH:NAD+ ratio and the mitochondrial membrane potential are
significantly increased in 3T3-L1 adipocytes matured in high (30 mM) glucose
versus normal (5 mM) glucose concentrations (Frizzell et al. 2012, Tanis et al.
2015). In the metabolically challenged adipocyte the intracellular fumarate levels
are elevated due to glucotoxicity driven mitochondrial stress and this results in
the accumulation of succinated proteins (Figure 1.3)(Frizzell et al. 2012).
Considering that protein succination occurs as a direct result of mitochondrial
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stress in the adipocyte, and that functional PDI is critical to maintain ER
proteostasis, we propose that the succination of PDI active-site thiols would
inhibit its oxidoreductase activity, contributing to ER stress.
Mitochondrial uncouplers lower the inner mitochondrial membrane potential,
created during glucose oxidation, by shuttling protons back into the mitochondrial
matrix without generating additional ATP. Mitochondrial uncouplers are
increasingly being investigated as therapeutic strategies to protect against
coronary

heart

disease,

ischemia-reperfusion

injury,

nonalchoholic

steatohepatitis, obesity and diabetes (Kenwood et al. 2013, Long et al. 2016,
Perry et al. 2015, Zhang et al. 2016). We have previously shown that the
treatment of adipocytes matured in high glucose with mitochondrial uncouplers,
2,4-dinitrophenol (DNP) and carbonyl cyanide m-chlorophenyl hydrazone
(CCCP), reduces both the intracellular fumarate concentration and the degree of
protein succination (Frizzell et al. 2012). While DNP and CCCP are effective in
vitro, both drugs are considered toxic and are unsuitable therapeutics.
Niclosamide is a mild mitochondrial uncoupler (Satoh et al. 2016, Tao et al.
2014), approved by the US Food and Drug Administration as an anthelmintic
drug for treating intestinal infections of tapeworms. Importantly, Tao et al. have
demonstrated the beneficial outcomes of niclosamide in db/db mice after two
months of oral administration, where niclosamide lowered both blood glucose
and glycated hemoglobin levels and normalized plasma insulin levels (Tao et al.
2014). We investigated if targeting mitochondrial stress using niclosamide or a
model of simple caloric restriction would subsequently reduce protein succination
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and eliminate ER stress in the adipocyte matured in high glucose. The results of
this study provide a novel mechanistic link between mitochondrial stress and the
development of sustained ER stress, as evidenced by increased CHOP
production, in the adipocyte during diabetes.
2.2 Results
The development of mitochondrial stress as a direct result of increased
glucose oxidation (Figure 1.4) is expected to increase the basal oxygen
consumption rate (OCR) of the adipocyte under diabetic conditions. We matured
3T3-L1 adipocytes in glucose and insulin concentrations that we have previously
shown

are

physiologically

representative

of

normal

versus

hyperglycemic/hyperinsulinemic conditions (5 mM glucose/0.3 nM insulin versus
30 mM glucose/3 nM insulin) (Tanis et al. 2015). We observed a ~90% increase
in the basal oxygen consumption rate (OCR) of adipocytes matured in 30 mM
glucose compared to 5 mM glucose after 2 days of maturation (Figure 2.2B). Our
previous analyses of uncoupled respiration in adipocytes cultured in high glucose
demonstrated that the cells are operating close to their maximal respiratory
capacity, a manifestation of mitochondrial stress (Tanis et al. 2015). Metabolomic
analyses confirmed that Krebs cycle intermediates, including fumarate, were
increased in concert in high glucose conditions as a consequence of respiratory
control and

the

inhibition

of

NAD+-dependent

dehydrogenases

(Figure

2.1A)(Figure 2.2B, 2.2E). The increase in malate as well as fumarate confirms
that the adipocyte is overwhelmed due to excessive ATP production (Frizzell et
al. 2012), and immunoblotting using the anti-2SC antibody verifies that protein
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succination is significantly increased in adipocytes matured in high versus normal
glucose concentrations (Figure 2.2C)(Nagai et al. 2007). Adipocytes were
matured in 5 mM glucose and treated with 0, 2 or 4 mM dimethyl succinate
(DMS), an esterified form of the Krebs cycle intermediate succinate, to confirm
that the anaplerotic supply of an alternative intermediate could augment
endogenous fumarate production and protein succination. An anti-2SC
immunoblot confirms increased succination of target proteins in the succinate
supplemented adipocytes (Figure 2.2A). These results emphasize that
adipocytes matured in high glucose exhibit features of mitochondrial stress early
in maturation, with a subsequent increase in protein succination after 8 days of
maturation (Figure 1.3). In contrast, adipocytes that mature and accumulate lipid
normally in 5 mM glucose show no evidence of mitochondrial stress and have
limited protein succination.
Protein succination occurs as a direct result of mitochondrial respiratory
control in the metabolically challenged adipocyte (Figure 1.3)(Frizzell et al. 2012)
therefore, we hypothesized that uncoupling the inner mitochondrial membrane
using niclosamide would lower fumarate and 2SC levels. 3T3-L1 adipocytes were
matured in 5 mM or 30 mM glucose or 30 mM glucose and treated with 2 µM
niclosamide for 8 days. Metabolomic analyses substantiated the data that
uncoupling the inner mitochondrial membrane, demonstrated by the acute
increase in the basal oxygen consumption rate (Figure 2.2D)(Tao et al. 2014),
prevents the accumulation of Krebs cycle intermediates in adipocytes matured in
high glucose concentrations (Figure 2.1A)(Figure 2.2E). Immunoblotting with the
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anti-2SC antibody demonstrates that niclosamide treatment reduces the degree
of protein succination in adipocytes matured 30 mM glucose concentrations
(Figure 2.1B). The lower panels depict shorter exposure times of the same anti2SC immunoblot and highlight the decreased succination of several higher
molecular weight proteins (50-150 kDa) (Figure 2.1B). Examining the relationship
between protein folding, ER stress and glucose concentration we assessed the
levels of CHOP, Ero1 and PDI in adipocytes matured in 5 mM or 30 mM glucose.
The levels of CHOP were pronouncedly increased in adipocytes matured in high
glucose compared to normal glucose (Figure 2.2C), confirming that persistent ER
stress is selectively present in adipocytes matured under hyperglycemic
conditions (Tanis et al. 2015). It is important to note that we did not detect
differences in the protein levels of GRP78 or any components of the PERK, IRE1
or ATF6 branches of the UPR in adipocytes in normal/high glucose as the UPR is
induced as a normal function of adipocyte maturation in the presence of insulin
(Han et al. 2013a, Minard et al. 2016, Tanis et al. 2015). In order to establish a
novel link between mitochondrial stress and the sustained ER stress, we
examined CHOP protein expression levels in adipocytes matured in 5 mM, 30
mM or 30 mM glucose treated with 2 µM niclosamide for 8 days (Figure 2.1C).
The data confirms that alleviating mitochondrial stress prevents the presence of
prolonged ER stress generated by high glucose conditions. Although the
transcription of ER chaperones may be up-regulated in parallel with ER stress,
we did not detect any changes in the total protein levels of Ero1 or PDI between
groups (Figure 2.1C)(Figure 2.2C). Importantly, alleviation of both mitochondrial
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and ER stress with niclosamide corresponds to improved adiponectin secretion
(Figure 2.1D), confirming that mitochondrial stress and succination impair
adiponectin processing in the ER (Frizzell et al. 2009). These data confirm that
mitochondrial stress and protein succination influence the development of ER
stress and reduce adiponectin secretion from the adipocyte.
Lentiviral delivery of fumarase shRNA to adipocytes matured in normal
glucose was used to increase fumarate levels in the adipocyte independent of
glucotoxicity, since this prevents the hydration to malate and permits fumarate
accumulation. The successful transduction of both the scrambled control and
fumarase knockdown (FHKD) lentivirus was evaluated by monitoring green
fluorescent protein (GFP) positive adipocytes 6 days post transduction (Figure
2.4A). Adipogenesis proceeded normally in FHKD cells and was confirmed by
the elevated expression of adiponectin and peroxisome proliferator-activated
receptor gamma (PPARγ) isoforms (Figure 2.3A). Reduced serum adiponectin
species are a hallmark of type 2 diabetes. We observed a decrease in secreted
adiponectin profiles from the FHKD adipocytes versus the scrambled controls
(Figure 2.4D), similar to Yang et al. that reported lower circulating adiponectin
levels in the plasma of adipose tissue specific fumarase knockout mice
compared to control mice (Yang et al. 2016). These data again verify that
elevated fumarate and succination lead to reduced serum adiponectin levels
(Frizzell et al. 2009, Yang et al. 2016). The quantification of the triglyceride
content in control and FHKD adipocytes matured in 5 mM or 30 mM glucose
(Figure 2.3B), as well as the documented lipid accumulation by Oil Red O
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staining (Figure 2.4B) verified that knocking down the expression of fumarase
does not interfere with adipogenesis. The ~50% knockdown of fumarase levels
observed was sufficient to increase protein succination in the adipocytes (Figure
2.3A). The pronounced escalation in protein succination in the FHKD adipocytes
is directly proportional to the dramatic increase in the intracellular fumarate
production. Analysis of mitochondrial metabolites from control and FHKD
adipocytes matured in 5 mM glucose reveals a ~30 fold increase in fumarate
compared to controls (Figure 2.3C)(Figure 2.4C). FHKD adipocytes displayed
significant increases in the secretion of the pro-inflammatory cytokines TNFα, IL1α and IL-1β, as well as VEGF, versus control adipocytes (Figure 2.3D) (Figure
2.4E). This similar to the significant increases in TNFα, MCP-1 and VEGF that
we observed previously in adipocytes matured in 30 mM versus 5 mM glucose
(Tanis et al. 2015). These data suggest that elevated fumarate and protein
succination may play a role in the chronic low grade inflammatory state of
adipose tissue observed during diabetes. Elevated CHOP levels were observed
in both 30 mM glucose and FHKD adipocytes matured in 5 mM glucose (Figure
2.3E), confirming that protein succination alone functionally contributes to both
the development of ER stress and the pro-inflammatory state of adipocytes,
independent of other glucose derived metabolic stressors. In order to
mechanistically understand how succination might contribute to ER stress, we
examined the succination of PDI in adipocytes during glucotoxicity. PDI was
immunoprecipitated from adipocytes matured in 5 mM or 30 mM glucose and
examined by 2D-immunoblotting to detect succination, (Figure 2.3F, top panels)
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followed by re-probing with anti-PDI (Figure 2.3F, lower panels). Compared to
the total levels of immunoprecipitated PDI, there was significantly more
succinated PDI in adipocytes matured in high glucose. We also confirmed
increased PDI succination in fumarase knockout (Fh-/-) mouse embryonic
fibroblasts (MEFs), whose endogenous fumarate concentrations are ~5 mM
(Ternette et al. 2013) (Figure 2.5). Overall, the results confirm that PDI is
succinated in the presence of excess fumarate, potentially interfering with protein
folding.
We were also interested in determining if Ero1, the thiol-dependent protein
responsible for re-oxidizing PDI active-site cysteines, is also susceptible to
succination by fumarate. Since mammalian Ero1 also contains redox-sensitive
cysteine thiols (Inaba et al. 2010), we hypothesized that Ero1 might be a novel
target of succination in the adipocyte. We incubated recombinant Ero1α (Araki et
al. 2011) with increasing concentrations of fumarate in vitro to investigate if Ero1
is susceptible to succination. 1D-immunoblotting with anti-2SC and anti-Ero1
antibodies confirmed that Ero1 is succinated when incubated with 5 mM or 25
mM fumarate (Figure 2.6A). We next immunoprecipitated Ero1 from adipocytes
matured in 5 mM or 30 mM glucose and immunoblotted with the anti-2SC
antibody. However, Ero1 succination was not detected in the adipocytes (Figure
2.6B). The blot was re-probed with an anti-Ero1 antibody to confirm the presence
of Ero1 in the immunoprecipitates (Figure 2.6B). Therefore, while recombinant
Ero1 could be succinated in vitro, there were no detectable increases in the
endogenous succination of Ero1 in adipocytes.
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The succination of catalytically important thiols in the metabolic enzymes
GAPDH and aconitase have been shown to reduce their enzymatic activity
(Blatnik et al. 2008, Ternette et al. 2013). We hypothesized that succination at
the active-site cysteines of PDI might also reduce enzymatic activity. Incubation
of recombinant wild-type PDI (PDI-WT) with either 5 or 25 mM fumarate
increased succination of PDI compared to the unmodified control (Figure 2.7A).
Succination of PDI in vitro functionally decreased PDI reductase activity by 15%
and 21% for 5 and 25 mM fumarate respectively (n=5, **p< 0.01) (Figure 2.7A,
B). In addition, we used a mutant form of PDI (PDI FLFL) to determine if
succination of PDI active-site cysteines is essential for inhibition of PDI reductase
activity. The residues His and Lys, adjacent to either side of the C-terminal
active-site cysteines, are mutated to Phe and Leu (H55ΔF:K57ΔL and
H399ΔF:K401ΔL), respectively in both the a and a’ domains of the mutant form
of PDI (Xiong et al. 2012). While remaining enzymatically functional, these
simultaneous mutations are predicted to alter the active-site thiol pKa, and
prevent S-gluthionylation of PDI (Xiong et al. 2012). In contrast to the data
obtained with PDI-WT, the mutant PDI could not be succinated in the presence of
increasing fumarate concentrations in vitro, and its reductase activity was
unaffected (Figure 2.7C, D), indicating that active-site cysteine modification by
fumarate is necessary for inhibition of PDI reductase activity.
We confirmed that direct succination of active-site cysteines was
mechanistically responsible for the inhibition of PDI reductase activity by LCMS/MS mass spectrometry. Recombinant PDI that had been incubated in the
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presence or absence of fumarate (Figure 2.8A) was alkylated with 4-vinylpyridine
to produce a control pyridylethyl modification (CPE, +105.058 Da) on the
remaining free thiols. The tryptic precursor ion masses for control (CPE, CPE) and
succinated (CPE, C2SC, +116.011 Da) peptides were analyzed by LC-MS/MS in
order to determine the specific site of succination. We identified the MS/MS
spectrum
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corresponding

YLLVEFYAPWCPEGHC2SCK59

to

the

([M+3H]3+:

succinated
683.9882

peptide
m/z)

and

388

KNVFVEFYAPWCPEGHC2SCK403 ([M+3H]3+: 717.0033 m/z) in the recombinant

PDI sample modified by fumarate (Figure 2.8B, D), as well as each analogous
control peptide (Cys55PE, Cys58PE) (Cys399PE, Cys402PE) in the unmodified
recombinant PDI sample (Figure 2.8C, 2.8E). In the case of both active-site
peptides the succination site was confirmed to be the second (C-terminal)
cysteine, and was only detected in the PDI samples incubated with fumarate in
vitro.
While succination of PDI active-site cysteines inhibits reduction of insulin
disulfide bonds in vitro (Figure 2.8) the assay is not specific for PDI activity in cell
lysates due to the presence of other oxidoreductases. Di-Eosin-GSSG is a
fluorescent self-quenching synthetic PDI specific substrate (Klett et al. 2010,
Raturi, 2007) frequently utilized to evaluate PDI reductase activity in protein
lysates (Muller et al. 2013, Xiao et al. 2011). PDI reductase activity was
decreased by ~36% (Figure 2.9A, 2.9D n=3, *p<0.05) in adipocytes matured in
high glucose versus normal glucose, and increased succination was detected at
the molecular weight of PDI (~57 kDa, arrow, Figure 2.9B) where the total levels
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of PDI remained similar between all samples (Figure 2.9B). 1D-immunoblotting of
PDI immunoprecipitates with anti-2SC verified that succination of PDI increased
in FHKD versus control adipocytes (Figure 2.9C). The evaluation of PDI
reductase activity in FHKD adipocytes demonstrated specifically that succination
of PDI accounted for a 15% decrease in PDI reductase activity versus controls
(Figure 2.9D, n=3, *p<0.05).
PDI was enriched from adipocytes matured in 5 mM or 30 mM glucose
and analyzed by LC-MS/MS to confirm the endogenous sites of succination. A
fragment ion (y13) representative of both control precursor ions containing
active-site cysteines was detected in both adipocytes matured in 5 mM
([M+3H]3+: 680.3434 m/z) ([M+3H]3+: 670.6406 m/z) or 30 mM ([M+3H]3+:
680.3387 m/z) ([M+3H]3+: 670.6228 m/z) glucose (Figure 2.9E, 2.9F; panels 1
and 3). In contrast, the mass of the representative y13 fragment ion from each
succinated precursor ion containing active-site cysteines ([M+3H]3+: 683.3942
m/z) ([M+3H]3+: 674.3534 m/z) was only detected in adipocytes matured in 30
mM glucose (Figure 2.9E, 2.9F; panel 2 versus 4). While the fragment ion profile
was unique to these succinated peptides, the N-terminal or C-terminal location of
the succinated cysteine could not be assigned, however, modification of either
cysteine is sufficient to impair PDI function as both thiols participate in the
oxidoreductase mechanism of PDI. Importantly, these measurements confirm
that the endogenous succination of active-site cysteines in PDI selectively occurs
in adipocytes matured in high glucose.
Control and db/db mice at 15 weeks of age were used for the analysis of
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protein succination. The total epididymal fat pad weight, fasting blood glucose
and plasma triglyceride levels of the db/db mice were all elevated compared to
age matched control mice (Figure 2.10A). In order to establish if succination
impacts PDI functionality in vivo we examined PDI enzymatic activity in the
epididymal adipose tissue of db/db diabetic mice. Succinated PDI is found only in
the epididymal adipose tissue of db/db mice and is absent in the epididymal
adipose tissue of the control mice (Figure 2.10B, upper panels). Total PDI is
detectable in both the control and db/db adipose tissue samples ~57 kDa (Figure
2.10B, lower panels). Assessment of PDI reductase activity using Di-EosinGSSG in control and db/db adipose tissue demonstrated that activity was
reduced by 52.6% in the diabetic mice (n=4, *p<0.05, Figure 2.10C), while
immunoblotting

demonstrated

equal

amounts

of

PDI

(Figure

2.10C).

Immunoblotting with anti-GRP78 antibody verified our in vitro results that
emphasize no alteration in the protein levels of GRP78 in the adipose tissue
during diabetes however, probing with anti-CHOP confirmed the existence of ER
stress in the epididymal adipose tissue from db/db mice versus controls, (Figure
2.10C) (Zhou et al. 2010). The succination of PDI occurs in parallel with reduced
PDI reductase activity and the development of ER stress in the epididymal
adipose tissue of db/db mice.
We

have

reported

that

decreasing

glucotoxicity

prevents

the

accumulation of succinated proteins in adipocytes (Frizzell et al. 2012),
alleviating mitochondrial stress and permitting the turnover of succinated
proteins. In the current study, we examined if limiting chronic glucose exposure
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would be beneficial for recovery from ER stress in adipocytes. The accumulation
of succinated proteins after 4 days of maturation (Tanis et al. 2015) was
prevented when the high glucose medium was removed and replaced with
normal glucose concentrations (30→5, Figure 2.11A). Notably, CHOP levels
were also restored to those observed in normal glucose concentrations (Figure
2.11A), suggesting that limiting chronic high glucose exposure is sufficient to
ameliorate ER stress in the adipocyte. To determine the mechanism of ER stress
reduction, PDI was immunoprecipitated from adipocytes matured in 5 mM, 30
mM or 30→5 mM glucose. Immunoblotting verified that succination of PDI was
greatest in adipocytes matured in 30 mM glucose for all 8 days of maturation,
whereas 4 days of recovery under normal glucose concentrations rescued the
amount of succinated PDI (Figure 2.11B). PDI reductase activity was 60% lower
in adipocytes matured in 30 mM glucose versus 5 mM glucose, whereas the
adipocytes matured in 30→5 mM glucose displayed a 46% decrease in PDI
reductase activity (Figure 2.11C), indicating that a significant fraction of PDI
functionality had been restored. The rescue of PDI reductase activity due to
reduced succination of PDI contributes to an improved protein folding capacity,
and

diminished

levels

of

ER

55

stress

in

the

adipocyte.

Figure 2.1: Mitochondrial stress drives ER stress in adipocytes matured in
high glucose. (A) Krebs cycle metabolites were extracted from adipocytes
matured in 5 mM or 30 mM glucose or 30 mM glucose and 2 µM niclosamide for
3 days prior to quantification by GC-MS. High glucose concentrations result in
significantly increased levels of both fumarate and malate relative to the levels
quantified in 5 mM glucose (n=3/group, mean +/- SEM, *p< 0.05). (B) Adipocytes
were matured in 5 mM or 30 mM glucose for 8 days. A western blot was
performed with 30 µg of protein from duplicate representative samples using anti2SC antibody to detect succinated proteins. Molecular weight markers are shown
on the far left. (C) Adipocytes were matured in 5 mM or 30 mM glucose 30 mM
glucose with 2 µM nicolsamide for 8 days. Western blots were performed with 30
µg of protein to detect ER stress markers with anti -CHOP, -GRP78, -Ero1, and PDI antibodies. Coomassie blue stain of the blot confirms equal loading of all
samples. (D) An immunoblot probed with anti-adiponectin antibody shows the
levels of secreted adiponectin assessed in the conditioned medium collected
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after 4 hours from adipocytes matured in 5 mM or 30 mM glucose treated with 2
µM niclosamide. This is a merged image (merged between lanes 3 & 4).
Immunoblots are representative of n=3 experiments.

Figure 2.2: Quantification of additional Krebs cycle metabolites and
confirmation of increased adipocyte metabolism, the uncoupling
mechanism of niclosamide and ER stress in adipocytes matured in high
glucose. (A) 3T3-L1 adipocytes were matured in 5 or 30 mM glucose and
treated with 0, 2 or 4 mM dimethylsuccinate for 8 days. A 1D-immunoblot probed
with anti-2SC antibody displays increased protein succination, specifically
~57kDa (black arrow). Re-probing with anti-actin antibody represents equal
protein loading and molecular weight markers are shown of the left. (B and E)
Krebs cycle metabolites were extracted from adipocytes matured in 5 mM or 30
mM glucose treated with or without 2 µM niclosamide for 3 days and derivatized
prior to quantification by GC-MS. High glucose concentrations result in
significantly increased the levels of all metabolites. The increases are expressed
relative to the levels quantified in 5 mM glucose (n=3/group, mean +/- SEM, *p<
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0.05). (C) Adipocytes were matured in 5 mM or 30 mM glucose for 8 days.
Western blots were performed with 30 µg of protein to detect ER stress markers
with anti -CHOP, -Ero1, and -PDI antibodies. Anti-actin immunoblot confirms
equal loading of all samples. Immunoblots are representative of n=6
experiments. (D) The acute change in the oxygen consumption rate of
adipocytes matured in 30 mM glucose for 2 days when niclosamide is added.
0.25 µM niclosamide was used in the acute 2 hour period to confirm uncoupling
activity. The rate of oxygen consumption in adipocytes was measured by XF Flux
Analyzer (Seahorse Biosciences) and the data was normalized to the total DNA
content of the cells (n=5/group, mean +/- SEM, *p< 0.05).
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Figure 2.3: Protein succination induces ER stress independent of glucose
levels. (A) Fibroblasts were transduced with scrambled (control) or fumarase
(Fh) knockdown (FHKD) shRNA and grown to confluence. FHKD or control
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adipocytes were matured in 5 mM or 30 mM glucose for 8 days. A merged image
of the same 1D-immunoblot probed with anti-2SC and -Fh antibodies display
increased protein succination in both fibroblasts and adipocytes when Fh
expression is knocked down. The blot was stripped and reprobed with antiPPARγ antibody to confirm that FHKD 3T3-L1 fibroblasts differentiate normally to
adipocytes. The blot was reprobed with anti-α tubulin antibody as a protein
loading control. (B) Control or FHKD adipocytes were matured in 5 mM or 30 mM
glucose for 8 days. The triglyceride content was measured as described in
Materials and Methods (n=3/group, mean +/- SEM, *p<0.05). (C) Krebs cycle
metabolites were extracted from adipocytes transduced with scrambled control or
FHKD lentivirus and matured in 5 mM glucose for 3 days and derivatized prior to
quantification by GC-MS. Limited Fh expression result in significantly increased
the levels of all metabolites. The increases are expressed relative to the levels
quantified in control adipocytes that have normal levels of Fh present (n=3/group,
mean +/- SEM, *p< 0.05). (D) Secreted levels of pro-inflammatory cytokines were
measured by a mouse obesity ELISA as described in the Materials and Methods
(n=4/group, mean +/- SEM, *p<0.05). (E) Adipocytes transduced with FHKD or
scrambled control lentivirus were matured in 5 mM or 30 mM glucose for 8 days.
1D-immunoblots of duplicate samples probed with anti-2SC and -Fh antibodies
show that knocking down Fh levels increases protein succination in adipocytes to
the greatest degree versus both 5 mM and 30 mM glucose treatments when Fh
is present. Western blotting with anti-CHOP antibody confirms that ER stress is
present in both adipocytes matured in 30 mM glucose and FHKD adipocytes
matured in 5 mM glucose. (F) Protein (500 µg) from adipocytes matured in 5 mM
or 30 mM glucose was immunoprecipitated with anti-PDI antibody. The antibodyantigen complex was captured with Protein G beads. The eluted complex was
isoelectrically focused on strips with a pI range 3.9-5.1. After 2D electrophoresis
and protein transfer a western blot was performed to detect succination using
anti-2SC (upper panel), followed by re-probing with anti-PDI to verify PDI
immunoprecipitation (lower panel).
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Figure 2.4: Verification of lentivirus transduction and adipocyte
differentiation and quantification of Krebs cycle metabolites and secreted
adipokines in control and FHKD adipocytes. (A) 3T3-L1 adipocytes were
transduced with a scrambled (control) vector or FHKD shRNA coupled to green
fluorescent protein expression. Positive green fluorescent protein (GFP)
expression within adipocytes matured in 30 mM glucose for 8 days confirms
scramble (left) or FHKD (right) viral expression. (B) 3T3-L1 fibroblasts and FHKD
adipocytes matured in 5 mM or 30 mM glucose were stained with Oil Red O and
representative images (n=3) of lipid droplet accumulation are documented by
brightfield microscopy. (C) Krebs cycle metabolites were extracted from
adipocytes transduced with scrambled control or FHKD lentivirus and matured in
5 mM glucose for 3 days and derivatized prior to quantification by GC-MS.
Limited fumarase expression result in significantly increased the levels of all
metabolites. The increases are expressed relative to the levels quantified in
control adipocytes that have normal levels of fumarase present (n=3/group, mean
+/- SEM, *p< 0.05). (D) An immunoblot probed with anti-adiponectin antibody
shows the levels of secreted adiponectin analyzed in the conditioned medium
collected from control and FHKD adipocytes. (E) Secreted levels of proinflammatory cytokines were measured by a mouse obesity ELISA as described
in the Materials and Methods.
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Figure 2.5: Succination of endogenous PDI in Fh1-/- MEFs. 200 µg of cell
lysate protein from (A) wild-type (WT) and (B) Fh1-/- MEFs (1,2) was
isoelectrically focused on strips with a pI range 3.9-5.1. After 2D electrophoresis
& protein transfer a western blot was performed to detect succination using anti2SC (left panels). Enlarged 2D-immunoblot images in the pI 4.7-5.0 region of the
WT (A) and Fh1-/- (B) MEFs depict the presence of PDI at 57 kDa (pI ~4.8) in
each sample. Fh-/- MEFs contain a significant amount of succinated PDI (note 3
distinct spots in the oval region corresponding to the 3 spots labeled with antiPDI below), while there is no detectable succinated PDI in WT MEFs. Molecular
weight markers are shown on the far left. (C) Fh1-/- MEFs were matured in 25 mM
glucose for 4 days. The active site peptide of PDI containing Cys55 and Cys58
were analyzed by LC-ESI-MS/MS. The detection of the y13 fragment ion at
retention time ~32.73 minutes represents the presence of the control (CysPE,
CysPE) active site peptide in PDI (panel 1). The detection of the analogous y13
fragment ion at the retention time ~34.58 minutes represents the presence of the
succinated (CysPE, Cys2SC) active site peptide (panel 2). WT, wild type; Fh -/-,
fumarase gene knockout; MEFs, mouse embryonic fibroblasts.
63

Figure 2.6: Succination of Ero1α in vitro. (A) 2.77 µg of recombinant Ero1α (3)
was incubated in the presence or absence of the indicated fumarate
concentrations for 24 hrs. A western blot with 2.77 µg of protein was probed with
anti-2SC antibody confirmed a concentration-dependent increase in Ero1
succination when incubated with 5 mM or 25 mM fumarate. The blot was
reprobed with anti-Ero1α antibody to verify equal protein loading. (B) Protein
(500 µg) from adipocytes matured in 5 mM or 30 mM glucose was
immunoprecipitated with anti-Ero1α antibody. The antibody-antigen complex was
captured with Protein A beads. The eluted complex was subjected to 1Dimmunoblotting with anti-2SC antibody to detect succination of Ero1. However,
Ero1 succination was not detected in the adipocytes, independent of glucose
concentration. The blot was reprobed with anti-Ero1α antibody to confirm the
presence of Ero1 in the immunoprecipitated samples. Therefore, although
recombinant Ero1 could be succinated in vitro, we were not able to detect any
endogenous succination of Ero1 in the adipocytes. Immunoblots are
representative of n=4 experiments.
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Figure 2.7: Succination inhibits PDI reductase activity in vitro. (A and B)
Both the wild type and mutant recombinant PDI were incubated with indicated
fumarate concentrations for 24 hrs. A western blot with 2.77 µg of protein was
probed with anti-2SC and anti-PDI antibodies. Immunoblots are representative of
n=5. (C and D) 2.77 µg of wild type or mutant recombinant PDI were incubated in
the presence or absence of the indicated fumarate concentrations for 24 hrs. PDI
reductase activity of control and succinated PDI was assayed as described in
Materials and Methods using a fluorescent insulin turbidity assay. Fluorescence
was measured at λex = 500 nm and λem =603 nm (n=5/group, mean +/- SEM,
**p< 0.01).
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Figure 2.8: Identification of succination sites in PDI. (A) 2.77 µg of
recombinant human PDI (PDI-WT) was incubated with 0 or 100 mM fumarate at
37°C for 24 hrs. A 1D-immunoblot probed with anti-2SC antibody followed by
reprobing with anti-PDI antibody shows enhanced succination of PDI when
incubated with 100 mM fumarate. (B-E) 3 µg of recombinant PDI was incubated
in the presence (B and D) or absence (C and E) of 100 mM fumarate to
maximize succinated peptides for LC-MS detection, resolved by SDS-PAGE and
stained with Coomassie Brilliant Blue. The protein corresponding to 57 kDa was
excised from the gel, digested with trypsin and the active site peptides were
analyzed by LC-ESI-MS/MS mass spectrometry. (B and D) MS/MS spectra
showing that the C-terminal cysteines in both active site peptides
45
YLLVEFYAPWCPEGHC2SCK59 and 389KNVFVEFYAPWCPEGHC2SCK403 are the
target of succination in vitro. (C and E) MS/MS spectra showing the unmodified
peptides 45YLLVEFYAPWCPEGHCPEK59 and 389KNVFVEFYAPWCPEGHCPEK403
after alkylation with 4-vinylpyridine. m/z, mass/charge ratio; PE, pyridyl ethyl.
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Figure 2.9: Succination of PDI active-site cysteines inhibits PDI reductase
activity in 3T3-L1 adipocytes. (A) Adipocytes were matured in 5 mM or 30 mM
glucose for 7 days. 6 µg of adipocyte cell lysate protein was incubated with 1.08
µM Di-Eosin-GSSG for 1 hr. Fluorescence was measured at λex= 510 nm and
λem= 550 nm and the initial rate of reaction calculated (n=4/group, mean +/- SEM,
*p< 0.05). (B) Western blots with anti-2SC and -PDI antibodies show succination
of PDI in the adipocytes matured in 30 mM glucose (black arrow) and
representative equal amounts of PDI in each sample. An immunoblot with antiactin antibody displays equal protein loading. (C) Protein (400 µg) from control or
FHKD adipocytes matured in 5 mM glucose was immunoprecipitated with antiPDI antibody and the antibody-antigen complex was captured with Protein G
beads. The eluted complex was subjected to 1D-immunoblotting and probed with
anti-2SC (upper panel) and anti-PDI (lower panel) antibodies. (D) 6 µg of
adipocyte cell lysate protein was incubated with 1.08 µM Di-Eosin-GSSG for 1 hr.
Fluorescence was measured at λex= 510 nm and λem= 550 nm (n=3/group, mean
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+/- SEM, *p< 0.05). (E) The active-site peptides of PDI from adipocytes matured
in 5 mM or 30 mM glucose for 8 days were analyzed by LC-ESI-MS/MS. The
detection of the y13 fragment ion at retention time ~36.4 minutes represents the
presence of the control (C55PE, C58PE) PDI active-site peptide from adipocytes
matured in both 5 mM (panel 1) and 30 mM (panel 3) glucose. The detection of
the y13 fragment ion at the retention time ~36.6 minutes represents the presence
of the succinated (C55PE, C582SC) active-site peptide in adipocytes matured in 30
mM glucose (panel 4) and the absence of the succinated peptide in adipocytes
matured in 5 mM glucose (panel 2). (F) The detection of the y13 fragment ion at
retention time ~33.4 minutes shows the presence of the control (C399 PE, C402PE)
active-site peptide in PDI from adipocytes matured in both 5 mM (panel 1) and 30
mM (panel 3) glucose. The detection of the y13 fragment ion at the retention time
~35.5 minutes indicates the presence of the succinated (C399PE, C4022SC)
active-site peptide in adipocytes matured in 30 mM glucose (panel 4) and the
absence of the succinated peptide in adipocytes matured in 5 mM glucose (panel
2).
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Figure 2.10: Succination inhibits PDI reductase activity in adipose tissue of
db/db mice. (A) Epididymal fat pads were removed and weighed at the time of
sacrifice. Fasting blood glucose was measured from the tail vein and serum
triglyceride levels were measured (n=5-6 mice/group, mean +/- SEM, **p<0.01,
***p<0.001). All in vivo analysis were performed at 15 weeks of age. (B) 200 µg
of protein from control (top) and db/db (lower) mouse epididymal adipose tissue
was isoelectrically focused on a pI range 4-7. After 2D electrophoresis & protein
transfer a western blot was performed to detect succination using anti-2SC
antibody, followed by reprobing to verify PDI. Enlarged 2D-immunoblot images in
the pI 4.7-4.9 region of the control and db/db adipose tissue depict the presence
of PDI at 57 kDa (pI ~4.85) in each sample. Molecular weight markers are shown
on the far left and right. (C) 6 µg of protein from control and db/db mouse
epididymal adipose tissue was incubated with 1.08 µM Di-Eosin-GSSG for 1 hr.
Fluorescence was measured at λex = 510 nm and λem = 550 nm (n=3/group,
mean +/- SEM, *p< 0.05). A western blot with anti-PDI antibody shows
representative equal amounts of PDI in each sample. Immunoblotting 30 µg of
total protein lysate from control and db/db mouse epididymal adipose tissue with
anti-CHOP and -GRP78 antibodies of demonstrates increased levels of CHOP
and no change in the levels of GRP78 in the adipose tissue from db/db versus
control mice (representative of n=6 mice).
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Figure 2.11: Reducing glucose concentrations rescues PDI reductase
activity and ameliorates ER stress in adipocytes. (A) Adipocytes were
matured in 5 mM or 30 mM glucose for 8 days or 30 mM glucose for 4 days,
followed by a switch to 5 mM glucose for the remaining 4 days of maturation
(30→5 mM). Western blotting was performed with 30 µg of protein using anti2SC antibody to detect succinated proteins. A merged image of the same blot
displays duplicate representative samples. Molecular weight markers are shown
on the far left. An immunoblot with the identical samples was probed with antiCHOP, -PDI and -actin antibodies to detect changes in protein expression. (B)
Protein (300 µg) from adipocytes matured in 5 mM, 30 mM or 30→5 mM glucose
was immunoprecipitated with anti-PDI antibody. After 1D electrophoresis and
protein transfer a western blot was performed to detect succination using anti2SC (upper panel), followed by reprobing with anti-PDI to verify PDI (lower
panel). (C) Adipocytes were matured in 5 mM, 30 mM or 30→5 mM glucose. 6
µg of adipocyte cell lysate protein was incubated with 1.08 µM Di-Eosin-GSSG
for 1 hr after which fluorescence was measured at λex = 510 nm and λem =550 nm
(n=3/group,
mean
+/SEM,
*p<
0.05).
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2.3 Discussion
In this study we mechanistically demonstrate that succination of PDI, as a
direct result of glucotoxicity driven mitochondrial stress, contributes to the
presence of ER stress in the adipocyte. Consistent with other reports (Boden et
al. 2014b, Han et al. 2013b) we document a significant increase in the protein
levels of CHOP in adipocytes matured in high glucose medium, and notably this
occurs in parallel with an increase in protein succination, suggesting a link
between mitochondrial stress and ER stress. Niclosamide is a mild mitochondrial
uncoupler that reduces mitochondrial stress by lowering the mitochondrial
membrane potential and increasing the ADP:ATP ratio in vitro, and significantly
improves glucose homeostasis in diabetic mice (Tao et al. 2014). In Figure 2.1
we demonstrate two novel roles for niclosamide; succination of proteins,
including PDI, is decreased by directly reducing mitochondrial stress, and it
prevents increased protein levels of CHOP, indicative of protection against ER
stress in adipocytes matured under diabetic conditions. In addition, we detected
a significant improvement in high molecular weight adiponectin secretion from
adipocytes in the presence of niclosamide.
requirement

for

normal

levels

of

the

Zhou et al. have described the
ER

chaperone

disulfide-bond-A

oxidoreductase-like protein to successfully combat ER stress in the adipocyte
(Zhou et al. 2010). Our initial assessment of ER stress markers demonstrated
that increased CHOP was present, however we did not observe altered PDI or
Ero1 protein levels in the adipocytes matured in high glucose. Instead our
findings suggest that succination-mediated inhibition of the enzyme determines
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the ability of PDI to facilitate protein folding in a metabolically challenging
environment.
The mitochondrial associated ER membrane (MAM) facilitates the
passage of lipids and several ions through several defined channels (Arruda et al.
2014, Rutter et al. 2014). MAM enrichment, facilitating calcium transport, has
been reported in hepatocytes of ob/ob- and high fat diet fed mice (Arruda et al.
2014). Excess fumarate produced in the mitochondria is transported to the
cytosol and out of the cell (Lai and Gold, 1992), or it may enter the ER lumen
through the MAM, facilitating the succination of ER proteins (Merkley et al. 2014).
In this study, we have confirmed that endogenously produced fumarate
increased succination of

PDI in adipocytes matured in high glucose

concentrations, and that succination inhibits PDI reductase activity in these
adipocytes and in the adipose tissue of diabetic db/db mice. Similar to the
inhibitory effect of S-glutathionylation and S-nitrosylation on PDI enzymatic
activity (Townsend et al. 2009, Uehara et al. 2006), increasing succination of PDI
is also indirectly correlated with its reductase activity. Alongside this, we
specifically confirmed that the cysteine containing active-site peptides of PDI are
endogenously succinated in adipocytes matured in high glucose medium. The
significant reduction in PDI reductase activity contributes to disturbed protein
folding by decreasing the capabilities of the major ER oxidoreductase, ultimately
resulting in the pronounce CHOP levels sustained in adipocytes in vitro and in
vivo.
PDI-A1 is the most abundant isoform of the PDI oxidoreductase family in
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the adipocyte. Despite the fact all PDI family member (A1-A6) active-site
peptides were analyzed by MS/MS mass spectrometry, the active-site peptides
of PDI-A1 remained the most abundantly detected, suggesting that PDI-A1 has a
major role in adipocyte ER protein folding. In addition, Muller et al. have
demonstrated that increased expression of functional PDI-A1 alone is sufficient
to preclude ER stress in HMEC-1 cells (Muller et al. 2013). We originally
hypothesized that the N-terminal low pKa active-site Cys55 and Cys399 of PDI
would be more reactive with fumarate than the higher pK a C-terminal active-site
Cys58 and Cys402 (Lappi et al. 2004). However, MS/MS analysis of recombinant
PDI that had been succinated in vitro confirmed that the C-terminal Cys58 and
Cys402 are the targets of succination. The recombinant PDI mutant used was
refractory to modification by fumarate, suggesting that the pK a of at least one of
the thiols is an important determinant of reactivity to succination. Importantly,
mutation of the N-terminal, C-terminal or both active-site Cys of PDI to Ser
decreases PDI oxidoreductase activity and increases the accumulation of PDIsubstrate intermediates (Walker et al. 1996), suggesting that modification of the
active site will promote the accumulation of misfolded proteins in the ER.
Although the ER resident protein Ero1 is susceptible to succination in vitro
(Figure 2.6A), immunoprecipitation of Ero1 confirms that endogenous succination
of Ero1 is not altered between adipocytes matured in normal or high glucose
concentrations (Figure 2.6B). The reduced form of Ero1 mediates the flavindependent transfer of electrons to oxygen producing hydrogen peroxide and the
oxidized form of Ero1. Peroxiredoxin-4 (Prx-4) is responsible for regulating
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excess reactive peroxides produced in the ER via Ero1 oxidation (Tavender et al.
2008, Tavender et al. 2010). Proper functioning PDI will reduce the oxidized form
of Prx-4 to allow for recycling of Prx-4 active site cysteines and continued
moderation of reactive peroxide levels in the ER (Tavender et al. 2010, Zito et al.
2010). Overall, the inhibition of PDI reductase activity by 2SC may promote the
accumulation of oxidized Ero1, oxidized Prx-4 and elevated hydrogen peroxide
levels in the adipocyte ER and additionally contribute to oxidative stress. In other
studies we have observed that oxidized thiols (sulfenic acid form) do not react
with fumarate as readily as the thiolate (unpublished observations), providing an
explanation for the absence of succinated, but possibly oxidized, Ero1 in our
immunoprecipitations, even when the recombinant protein could be succinated in
vitro.
High glucose conditions facilitate increased metabolic stress derived in
part from fumarate, but also increased oxidative and lipotoxic stress. To
determine the contribution of fumarate and protein succination to reduced PDI
functionality, we knocked down fumarase expression and generated mature
adipocytes with elevated levels of protein succination. Strikingly, the elevation in
CHOP protein levels in FHKD adipocytes demonstrates that ER stress is a direct
negative consequence of mitochondrial stress in adipocytes. In addition, Figure
2.9 suggests that half of the total decrease in PDI reductase activity in adipocytes
matured in high glucose may be specifically attributed to increased succination of
PDI.
Chemical chaperones, such as PBA have been employed to combat ER
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stress in several rodent models of obesity and diabetes (Basseri et al. 2009,
Özcan et al. 2006), as continuous ER stress ultimately culminates in cell death
(Han et al. 2013b). The accumulation of adipose tissue macrophages as a result
of hypertrophied adipocyte death is central to the chronic low-grade inflammatory
response observed in obese adipose tissue (Giordano et al. 2013, Weisberg et
al. 2003). We have reported that greater amounts of inflammatory cytokines are
released from adipocytes matured in high glucose compared to normal glucose
levels in parallel with increased protein succination (Tanis et al. 2015). In Figure
2.3 we show that increased inflammatory cytokine secretion occurs as a result of
increased fumarate content and protein succination in the FHKD adipocyte. This
data suggests that intra-organelle stress derived from elevated mitochondrial
intermediary metabolism may be an early contributor to adipose tissue
inflammation in diabetes.
The accumulation of the mitochondrial metabolite fumarate and resultant
succination and inhibition of PDI activity uniquely links mitochondrial stress, a
decreased protein folding capacity and ER stress. The reduction of ER stress in
obese humans using chemical chaperones has had some success (Kars et al.
2010),

however,

we

have

mechanistically

demonstrated

that

targeting

mitochondrial stress is a necessary component of successfully preventing ER
stress-associated increases in CHOP. Since mitochondrial stress is a product of
nutritional overload, we reduced the glucose concentration to normal levels in
maturing adipocytes for several days, similar to a calorie restriction intervention,
and demonstrated a significant reduction in PDI succination and an improvement
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in PDI reductase activity. Stanford et al. have described the importance of
healthy adipose tissue for systemic glucose homeostasis by transplanting the
subcutaneous white adipose tissue from exercised lean animals into sedentary
animals fed a high fat diet, improving insulin sensitivity and blood glucose levels
in the sedentary animals (Stanford et al. 2015). We demonstrate that a reduction
in exposure to glucotoxicity limits CHOP production as a result of reduced
mitochondrial stress and improved PDI reductase activity. While specific agents
that prevent protein succination in adipose tissue, such as niclosamide, may
have therapeutic utility, our data clearly demonstrates that simple nutritional
interventions will restore ER oxidative protein folding capacity.
In summary, we find that the active-site cysteines of PDI are succinated
during glucotoxicity induced mitochondrial stress, reducing PDI oxidoreductase
activity and contributing to disturbed protein folding and adipocyte ER stress. The
improvement in PDI enzymatic function and the reduction in ER stress as a direct
result of reduced glucose concentration fortify the importance of emphasizing the
link between healthy dietary consumption and proper adipocyte function in the
management

of

Type
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diabetes.

Chapter 3
Succination Induces Oxidative Stress and Regulates CHOP Stability in the
Adipocyte.2

2

Manuel AM, Walla MD, Piroli GG, Frizzell N. To be submitted to Molecular Metabolism

78

3.1 Introduction
The production of C/EBP homologous protein (CHOP) as a consequence
of prolonged endoplasmic reticulum stress has been documented extensively in
the adipose tissue of diabetic mouse models and type 2 diabetic patients (Boden
et al. 2008, Kawasaki et al. 2012, Özcan et al. 2004, Schröder et al. 2005,
Sharma et al. 2008). Consistent with these observations, in chapter 2 we
described a prominent role for increased fumarate to elevate CHOP production
during sustained ER stress. CHOP signaling is regulated by casein kinase 2
phosphorylation at Ser30, inhibiting transcriptional activation in 3T3-L1 fibroblasts
and HeLa cells (Ubeda et al. 2003), and promoting the ubiquitination and
proteasomal degradation of CHOP in macrophages (Dai et al. 2016). However,
little is known about the mechanism regulating CHOP stability in the adipocyte
during normal versus diabetic conditions. CHOP levels are increased as a result
of adipogenesis and remain elevated in adipocytes matured in high glucose
(Basseri et al. 2009, Han et al. 2013a, Tanis et al. 2015). In an extension of this
observation, Tanis et al. highlighted the difference in CHOP levels between
adipocytes matured in normal (5 mM) glucose versus high (30 mM) glucose after
monitoring CHOP for up to 8 days of maturation. Interestingly, CHOP levels are
transiently elevated and then decreased in adipocytes matured in 5 mM glucose
in a time-dependent manner, in contrast they remain elevated in high glucose
(Tanis et al. 2015). The sustained increase in CHOP that is unique to high
glucose occurs in parallel with increased protein succination, and in the absence
of continued activation of the unfolded protein response (Tanis et al. 2015).
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Kelch-like ECH-associated protein 1 (Keap1) has recently been described
as a negative regulator of CHOP stability in the LiSa-2 adipocyte cell line (Huang
et al. 2012). In adipocytes, Keap1 and cullin3 E3 ubiquitin ligase form a
supercomplex with the COP9 signalosome (CSN) (Huang et al. 2012), a protein
complex containing metalloprotease that removes the ubiquitin (Ub)-like protein
Nedd8 from cullins (Hannss et al. 2011). Additionally, CSN associated kinases,
including casein kinase 2, phosphorylate proteasome substrates to regulate
protein stability (Hannss et al. 2011). Huang et al. showed that CHOP binds the
CSN/cullin3 E3 ubiquitin ligase/Keap1 supercomplex, and that this stimulates its
degradation by the proteasome in adipocytes (Figure 1.2) (Huang et al. 2012).
Using siRNA targeting the CSN1 component of the CSN reduces the formation of
the supercomplex, leading to a 2-fold increase in CHOP protein levels and
subsequent inhibition of adipogenesis in LiSa-2 adipocytes (Huang et al. 2012).
Importantly, this study also confirmed that silencing the expression of Keap1
directly impairs CHOP turnover (Huang et al. 2012). This suggests that the
modification of stress-responsive Keap1 cysteines, and subsequent Keap1
degradation, may be a significant contributor to the sustained presence of
cytoplasmic and nuclear CHOP during cellular stress.
Keap1 contains 25 cysteine residues, 3 of these (Cys151, Cys273,
Cys288) have been confirmed to be sensors of oxidative stress that result in the
stabilization of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) (McMahon et al.
2010, Levonen et al. 2004). The post-translational protein modification 2-(Ssuccino)cysteine (2SC) (Alderson et al. 2006)(Figure 1.3) has previously been
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detected on the regulatory Cys151 and Cys288 of Keap1 in fumarase knockout
mouse embryonic fibroblasts, and in neurons treated with fumaric acid esters
(Adam et al. 2011, Linker et al. 2011). The nuclear accumulation of Nrf2 and
transcriptional upregulation of Nrf2 target antioxidant genes, under control of the
antioxidant response element (ARE), directly correlates with the succination of
Keap1 (Adam et al. 2011, Linker et al. 2011). Therefore, fumarate is recognized
as a physiologically relevant electrophilic activator of Nrf2 transcription. Our
laboratory has established that fumarate levels and protein succination increase
in adipocytes cultured in high (30 mM) versus normal (5 mM) glucose
concentrations (Nagai et al. 2007), and in the white adipose tissue of type 2
diabetic db/db mice compared to lean controls (Frizzell et al. 2009, Thomas et al.
2012). In this study, I investigate if Keap1 is a target of succination in the
adipocyte, similar to published studies in the fumarase deficient model (Adam et
al. 2011), and I hypothesize that succination of Keap1 will prevent CHOP
degradation, thereby stabilizing CHOP protein levels during diabetes.
CHOP is classically known to drive a pro-apoptotic response in damaged
cells as a result of prolonged ER stress (Han et al. 2013b, Kim et al. 2008).
However, our observations thus far do not support a role for CHOP-mediated
apoptosis in adipocytes. Cell viability is not reduced in adipocytes matured in
high glucose, even when CHOP levels are elevated (Frizzell et al. 2012, Tanis et
al. 2015). In addition, the accumulation of CHOP in the absence of apoptosis has
been described in the adipose tissue of obese insulin resistant patients (Diaz et
al. 2015), and insulin resistant mice fed a high fat diet (Suzuki et al. 2017). As
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discussed in section 1.6 above, several recent reports confirm that CHOP has
alternative physiological roles distinct from apoptosis. CHOP can directly bind the
promoter/enhancer region of Ppara, Srebf1 and Cebpa in hepatocytes
culminating in the suppression of metabolic gene expression during stress,
without inducing cell death (Chikka et al. 2013). In addition, Prasad et al. have
described a novel role for CHOP as an important mediator of phosphate
movement into the mitochondria in adrenal cells. This results in increased steroid
synthesis by stabilizing 3β-hydroxysteroid dehydrogenase type-2 protein
conformation and its association with translocase outer membrane-22 during
periods of stress (Prasad et al. 2016). While CHOP is a recognized terminus for
UPR signaling, our published data coupled with the data in chapter 2 suggests
that CHOP is increased even in the absence of concomitant UPR activation in
high glucose. In this study, I investigated the mechanisms contributing to CHOP
stability in the adipocyte, with an emphasis on the role of fumarate as a novel
physiological regulator of CHOP stability. I extended these studies to examine
the impact of persistent nuclear CHOP in suppressing an important antiinflammatory response in metabolically stressed adipocytes.
3.2 Results
C/EBP homologous protein (CHOP) is upregulated in response to
hyperglycemic/hyperinsulinemic driven ER stress in adipose tissue during type 2
diabetes (Boden et al. 2008, Özcan et al. 2004)(Figure 2.12C). Our earlier
investigation documented prominent increases in CHOP protein levels in both
adipocytes matured in normal (5 mM) and high glucose (25-30 mM) in the first 2
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days of maturation (Tanis et al. 2015), presumably due to activation of the
unfolded protein response during adipogenesis (Basseri et al. 2009, Han et al.
2013a). Remarkably, this transient increase in CHOP disappears by day 3 of
maturation in normal glucose, while CHOP levels continue to increase for the
duration of maturation in high glucose (Figure 3.1A)(Tanis et al. 2015). To
determine if glucotoxicity impairs CHOP turnover versus the continuous
production of more CHOP, a cycloheximide (CHX) chase experiment was
performed using adipocytes matured in 5 mM or 25 mM glucose for 8 days.
CHOP stability was monitored over 4 hours and both CHOP and actin total
protein levels were detected by immunoblotting. Prolonged CHOP stability was
observed in the absence of protein translation solely in adipocytes matured in
high glucose (Figure 3.1B), and the proteasomal inhibitor MG132 was utilized as
a positive control for CHOP accumulation (Diaz et al. 2015). Densitometric
analysis of immunoblots from each time point revealed an 29.5% increase in
CHOP stability in adipocytes matured in high glucose versus normal glucose
after 4 hours (n=3, p<0.01)(Figure 3.1B). Previous results in chapter 2 confirmed
that lentiviral knockdown of fumarase expression results in a pronounced
increase in both intracellular fumarate levels and protein succination in 3T3-L1
adipocytes matured in a normal glucose concentration (Figure 2.5A, 2.5B, 2.5C,
2.6A). The CHX chase experiment was repeated using adipocytes transduced
with a scrambled control or fumarase knockdown (FHKD) lentivirus, and cultured
in 5 mM glucose to ascertain if protein succination directly inhibits CHOP
degradation. Similar to adipocytes matured in high glucose, after 4 hours FHKD
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adipocytes displayed a 28.5% increase in CHOP stability compared to the control
(n=3, **p<0.01)(Figure 3.1C), confirming a role for succination in the regulation of
CHOP turnover.
Complete silencing of Keap1 expression increases the steady state level
of CHOP in LiSa-2 adipocytes (Huang et al. 2012), emphasizing the importance
of Keap1 as a critical regulatory protein during CHOP turnover. We therefore
sought to determine whether the modification of Keap1 regulatory cysteines
would stabilize CHOP levels. Since Keap1 is a low abundance cytosolic protein,
both control and FHKD adipocytes were transduced with a Keap1-V5 or a
scrambled control lentivirus to obtain a sufficient amount of protein for molecular
analyses. A significant increase in protein succination in the FHKD adipocytes
was first confirmed by a western blot probed with the anti-2SC antibody (Figure
3.2A). The successful transduction using each lentivirus was verified visually
following the observation of green fluorescent protein (GFP) immunofluorescence
(unpublished observation), and by immunoblotting to detect both the V5 tag and
Keap1 (Figure 3.2A). To determine if fumarate modifies Keap1 cysteines in the
adipocyte Keap1 was immunoprecipitated from the Keap1-V5 over-expressed
control and FHKD adipocytes. The immunoprecipitates were subjected to
immunoblotting to detect 2SC levels, and the results demonstrated that Keap1 is
succinated in the presence of excess fumarate in these adipocytes (Figure 3.2B).
Replicate Keap1-V5 immunoprecipitates from FHKD adipocytes were
subjected to in gel trypsin digestion for MS/MS mass spectrometry analysis to
identify the precise cysteine residue modified by fumarate. The top panel of
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Figure 3.2C displays the identified MS spectrum corresponding to the succinated
tryptic peptide

288

C2SCE I L Q A D A R296 ([M+2H]2+: 567.7625), containing the

Keap1 regulatory Cys288 at the retention time 25.47 minutes. This result
confirmed the previous observation in Fh1-/- MEFs that Cys288 is a target of
succination (Adam et al. 2011). The mass of the analogous control precursor
peptide containing the pyridylethyl (PE) cysteine modification ([M+2H]2+:
562.2803) was detected at 16.57 minutes (lower panel, Figure 3.2C).
The antioxidant sulforaphane and the fumarate ester dimethyl fumarate
(DMF) are both recognized modifiers of the redox sensitive cysteines of Keap1,
resulting in activation of the Nrf2 signaling pathway (Hong et al. 2005, Hu et al.
2011, Linker et al. 2011). Adipocytes were treated for 3 hours with 40 µM
sulforaphane or 300 µM DMF and immunoblotting demonstrated that modifying
Keap1 redox sensitive cysteines preserves CHOP protein levels (Figure 3.2D
and 3.2E). Heme oxygenase 1 (HOX1) is an antioxidant protein upregulated
following Nrf2 transcriptional activity. Assessment of increased HOX1 protein
levels confirmed activation of the Nrf2 antioxidant pathway following the
modification of Keap1 by each compound (Figure 3.2D and 3.2E). Overall, this
data established that the modification of Keap1 cysteines by fumarate promotes
CHOP accumulation in the adipocyte.
Assessment of HOX1 levels revealed increased protein levels in both
adipocytes matured in 25 mM glucose and in the adipose tissue of db/db mice
compared to their respective controls (Figure 3.3A), concomitant with increased
Keap1 modification/Nrf2 activity. Importantly, we also observed elevated HOX1
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protein levels in the FHKD adipocytes (Figure 3.3A), reinforcing that succination
of Keap1 promotes Nrf2 downstream signaling in the adipocyte (Adam et al.
2011, Linker et al. 2011). Given that Keap1 is succinated in the presence of
excess fumarate (Adam et al. 2011)(Figure 3.2B, 3.2C), and that fumarate levels
significantly increase in adipocytes matured in high glucose (Frizzell et al. 2012,
Nagai et al. 2007), we next investigated if Keap1 is succinated in adipocytes
cultured under diabetic conditions. An immunoblot confirmed the successful
transduction and overexpression of the Keap1-V5 lentivirus in adipocytes
matured

in

5

mM

or

25

mM

glucose

(Figure

3.3B).

Surprisingly,

immunoprecipitation of Keap1 (black arrow at 73 kDa) and western blotting to
detect 2SC revealed that Keap1 is not succinated in adipocytes matured in high
glucose (Figure 3.3C), despite confirming enrichment of Keap1-V5 in the
immunoprecipitates (Figure 3.3C).
The regulatory cysteines of Keap1 are known targets of oxidation
(Kobayashi et al. 2006) and, since Keap1 did not appear to be directly modified
by fumarate in the high glucose environment; we next investigated if fumarate
indirectly regulates CHOP stability by inducing oxidative stress and the oxidation
of Keap1. Analysis of reactive oxygen species (ROS) utilizing the Amplex Red
(hydrogen peroxide) and dichlorofluorescein (DCF) assays revealed a significant
increase in ROS production in adipocytes matured in high glucose versus normal
glucose (n=3, *p<0.05) (Figure 3.3D). Importantly, a pronounced increase in
ROS levels was also observed in the FHKD adipocytes, and in adipocytes
following direct DMF treatment (n=3, *p<0.05, **p<0.01) (Figure 3.3D, 3.3E). This
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indicates that elevated fumarate is capable of inducing oxidative stress in the
adipocyte. We have previously shown that reducing the mitochondrial membrane
potential with the potent mitochondrial uncoupler carbonyl cyanide mchlorophenyl hydrazone (CCCP) reduces fumarate levels and protein succination
in adipocytes matured in 30 mM glucose (Frizzell et al. 2012). In addition, CCCP
stimulates superoxide generation in 3T3-F442A adipocytes in vitro (Carriére et al.
2004). To confirm that oxidative stress predominantly stabilizes CHOP
expression in the absence of succination we treated adipocytes matured in high
glucose with 10 µM CCCP for 6 days. An immunoblot depicts reduced levels of
2SC with CCCP treatment in high glucose, while CHOP levels remained stable
due to the presence of oxidative stress (Figure 3.3F). Importantly, the difference
in the endogenously produced fumarate levels between FHKD and high glucose
models appears to dictate which one is the more potent Keap1 modifier between
fumarate and ROS. Together these results indicate that high glucose derived
protein succination indirectly promotes CHOP stability through induction of
oxidative stress and oxidation of Keap1 cysteines.
Our laboratory has shown that the antioxidant N-acetylcysteine (NAC)
reacts slowly with fumarate to form 2SC in vitro (Alderson et al. 2006). In
addition, other laboratories have shown that glutathione (GSH) has some
reactivity with fumarate in fumarase deficient cells (Sciacovelli et al. 2016, Zheng
et al. 2015). Both GSH and NAC have a similar pKa ~9.5 and NAC is known to be
a precursor for GSH synthesis (Medved et al. 2004, Phelps et al. 1992).
Therefore, we investigated if NAC would reduce fumarate levels and protein
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succination in adipocytes cultured in hyperglycemic/hyperinsulinemic conditions
over 6-8 days. The quantification of intracellular fumarate levels following
treatment of adipocytes with 0-5 mM NAC revealed that intracellular fumarate
concentrations were decreased 2 and 2.65 fold with 2.5 and 5 mM NAC,
respectively (n=3, *p<0.05, ***p<0.001). In parallel with this Figure 3.4B
demonstrates a significant decrease in total protein succination in adipocytes
matured in high glucose in the presence of 2.5 or 5 mM NAC. This suggested
that the available thiol of NAC may react with endogenous fumarate to lower
protein succination.
Considering that the exogenous supply of NAC may also promote the
synthesis of GSH, we also measured ROS levels to examine if there was a
concomitant decrease in oxidative stress. Figure 3.4C demonstrated that ROS
production in 30 mM glucose was reduced in the presence of 1 mM NAC. Since
ROS levels were decreased with NAC treatment, we next quantified total
intracellular GSH in adipocytes matured in normal or high glucose in the
presence of 5 mM NAC for 8 days, or 100 µM DMF for 24 hours (as a positive
control to reduce GSH, Manuel and Frizzell, 2013). Total GSH levels were
reduced by 36% in high glucose versus normal glucose (n=3, *p<0.05)(Figure
3.4D). Notably, NAC protected against glucotoxicity induced oxidative stress by
improving GSH levels and reducing ROS in adipocytes cultured in high glucose
(Figure 3.4C, 3.4D). An immunoblot representative of adipocytes matured in 5
mM or 25 mM glucose in the presence or absence of NAC demonstrated a
significant decrease in both CHOP and HOX1 levels in the presence of NAC
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(Figure 3.4E). Considering that there was no evidence for direct succination of
Keap1 in high glucose conditions (Figure 3.3C), and that NAC reduces ROS
levels, it appears that oxidative stress may be the direct regulator of CHOP
stability in adipocytes.
In order to specifically delineate the contribution of fumarate towards the
induced oxidative stress and CHOP stability, we treated FHKD adipocytes
cultured in normal glucose concentrations with 5 mM or 10 mM NAC for 8 days.
Interestingly,

NAC

administration

increased

protein

succination

and

simultaneously decreased CHOP and HOX1 protein levels in FHKD adipocytes
(Figure 3.5A). In contrast to NAC treatment of glucotoxic adipocytes, the
treatment of FHKD adipocytes with 2.5, 5 or 10 mM NAC was not sufficient to
reduce fumarate levels (Figure 3.5B). The levels of intracellular fumarate are ~510 mM in fumarase deficient cancer cells (Ternette et al. 2013), and fumarate
increases 20-fold in FHKD adipocytes compared to adipocytes matured in 25 mM
glucose (Figure 3.5C). Therefore, our data demonstrates that NAC does not
react directly with the endogenously produced fumarate to reduce succination in
FHKD adipocytes, and is instead acting to reduce the oxidative stress induced by
fumarate excess. Further, the surprising increase in succination in the FHKD
adipocytes suggested that depletion of oxidative stress might allow for increased
thiol reactivity with fumarate (Figure 3.5A). To confirm if NAC was limiting thiol
oxidation, and thereby promoting the availability of thiols to react with fumarate,
we examined the levels of cysteine sulfenic acids. Mature FHKD adipocytes were
treated with 2 mM dimedone, which covalently modifies cysteine sulfenic acids,
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(Martínez-Acedo et al. 2014, Seo and Carroll, 2011) prior to cell lysis to assess
the oxidized thiol content in the presence or absence of NAC. Immunoblotting
with an antibody that detects the dimedone adduct demonstrated a significant
reduction in protein oxidation upon NAC treatment (Figure 3.5D). This confirms
that competition exists between fumarate and ROS for thiol reactivity within the
fumarase depleted cells; a decrease in thiol oxidation due to NAC addition allows
the excess fumarate to irreversibly modify more cysteines by succination (Figure
3.5A, 3.5D).
We have previously observed that oxidation and succination can compete
for the same cysteine thiol target in vitro (unpublished data). Importantly, this
increase in protein succination occurred in parallel with a decrease in both CHOP
and HOX1 levels (Figure 3.5A), further suggesting that fumarate does not directly
regulate CHOP stability and Nrf2 activation, but rather indirectly triggered these
pathways through increased oxidative stress (Figure 3.3D, 3.3E). The combined
data suggests that oxidative stress in the adipocyte, generated as a result of
glucotoxicity or specific fumarate excess, contributes to the stabilization of CHOP
protein levels since reduction of ROS promoted CHOP turnover. Interestingly, the
correction of oxidative stress in the glucotoxicity model reduced fumarate
mediated succination. In contrast, the correction of oxidative stress facilitated
enhanced protein succination in FHKD adipocytes where fumarate levels are
significantly higher.
Figure 3.6 confirms the increased presence of CHOP in parallel with 2SC
in adipocytes cultured in 25 mM glucose (Figure 3.6A), and the adipose tissue
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from db/db mice (Figure 3.6B), as well as in FHKD adipocytes (Figure 3.6C).
Contrary to the established role of CHOP to promote cleaved caspase 3
mediated apoptosis (Li et al. 2014), cleaved caspase 3 levels were unchanged in
all models (Figure 3.6A, 3.6B and 3.6C). In addition, there were no morphological
changes or loss of cells observed by light microscopy, no change in nuclear
content/structure (assessed by DAPI imaging of adipocytes) (Figure 3.6D), levels
of cleaved caspase 3 in adipocytes matured in high glucose or FHKD adipocytes
after 12 days of maturation (Figure 3.6E), or total protein content (Figure 3.6F).
Therefore, we next investigated an alternative role for CHOP as it was not
promoting apoptotic cell death, even in the mature hypertrophic adipocyte.
The cytosolic, mitochondrial and nuclear fractions were isolated by
centrifugation and immunoblotting confirmed increased succination and organelle
enrichment in each fraction (Figure 3.7A). In addition to the cytosolic
accumulation, CHOP accumulates in the nuclear fraction of adipocytes matured
in 25 mM glucose (Figure 3.7B), suggesting that CHOP continues to have a
critical role in transcription during diabetes. Interestingly, Suzuki et al. elegantly
demonstrated that silencing CHOP expression improves transcription of IL-13
mRNA and secretion in 3T3-L1 adipocytes, and in the adipose tissue of CHOP
knockout mice fed a high fat diet (Suzuki et al. 2017). The improvement in IL-13,
IL-4 and eotaxin secretion from the adipose tissue of CHOP knockout mice
modulates an anti-inflammatory M2 macrophage phenotype leading to decreased
extracellular inflammation and heightened insulin sensitivity (Suzuki et al. 2017).
Therefore, we investigated if CHOP mediated IL-13 regulation is governed by
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glucotoxicity induced oxidative stress. Conditioned medium was collected from
adipocytes cultured in 5 mM or 25 mM glucose +/- 5 mM NAC for 8 days, and
secreted IL-13 was quantified by ELISA (Figure 3.7C). While the levels of
secreted IL-13 were reduced in adipocytes matured in high glucose by 70%,
supplementation with NAC completely restored IL-13 secretion. Importantly, this
data shows that oxidative stress underlies the nuclear CHOP mediated
abolishment of IL-13 secretion in this in vitro model (Figure 3.7C).
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Figure 3.1: Succination regulates CHOP stability in the adipocyte. (A)
Western blot probed with anti-CHOP antibody shows consistent increased CHOP
levels in adipocytes matured in high glucose versus normal glucose throughout
maturation. (B) 3T3-L1 adipocytes were matured in 5 mM or 25 mM glucose or
(C) transduced with the scrambled control or fumarase knockdown lentivirus and
matured in 5 mM glucose for 8 days. Each group was subjected to protein
synthesis inhibition with 3.5 µg/mL cycloheximide (CHX) and the adipocytes were
harvested at the indicated times after addition of CHX. CHOP protein levels over
time are shown by immunoblotting with anti-CHOP antibody and Coomassie blue
staining represents equal protein loading. The graphs display the natural
logarithm of the relative levels of CHOP as a function of CHX chase time.
n=3/group,
p<0.01
at
4
hours.
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Figure 3.2: The modification of Keap1 cysteines enhances CHOP stability.
(A) Control and fumarase knockdown (FHKD) adipocytes were transduced with
the Keap1-V5 tagged or empty control lentivirus. Immunoblotting using the anti2SC antibody confirms increased protein succination in adipocytes transduced
with the FHKD versus the scrambled control lentivirus. The over expression of
Keap1 protein was confirmed via western blotting utilizing anti-Keap1 and -V5
antibodies. (B) Keap1 was immunoprecipitated with anti-V5 agarose beads from
800 μg or 400 μg of protein from control or FHKD adipocytes, respectively. A
western blot probed with anti-2SC antibody shows a significant increase in the
amount of succinated Keap1 in the FHKD adipocytes versus the control. The blot
was re-probed with anti-Keap1 and -V5 antibodies to confirm the presence of
Keap1 in each immunoprecipitate sample. (C) MS spectra showing that the
regulatory Cys288 of Keap1 is a target of succination in the FHKD adipocytes
(top panel). (D-E) Western blots with 30 μg of protein from adipocytes matured in
normal glucose and treated with 40 μM sulforaphane, 300 μM dimethylfumarate
(DMF) or 10 μM MG132 for 3 hours were probed with anti-CHOP and re-probed
with anti-heme oxygenase 1 antibody. Coomassie blue staining shows equal
protein loading.
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Figure 3.3: Protein succination induces oxidative stress to activate the
Keap1/Nrf2 pathway and stabilize CHOP. (A) Protein from mature 3T3-L1
adipocytes, control or db/db epididymal adipose tissue and control or FHKD
adipocytes was subjected to immunoblotting with anti-heme oxygenase 1 (HOX1)
antibody. Coomassie blue staining verifies equal protein loading. (B) Western
blotting with anti-Keap1 and -V5 antibodies validates the successful transduction
of the scrambled control or Keap1-V5 tagged lentivirus into adipocytes matured
in 5 mM or 25 mM glucose. (C) Protein (600 µg) from adipocytes matured in 5
mM or 25 mM glucose was immunoprecipitated with anti-V5 agarose beads. The
eluted protein was subjected to western blotting to detect succination of the total
homogenate (TH) and immunoprecipitate (IP) utilizing anti-2SC, followed by re-
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probing with anti-Keap1 and -V5 antibodies. Measurement of reactive oxygen
species was monitored using the Amplex Red and DCF assays according to the
manufacturer’s instructions outlined in the Materials and Methods section. (D)
Control or FHKD adipocytes were cultured in 5 or 30 mM glucose or (E) 5 mM
glucose and treated with 200 µM DMF. (n=3/group, mean +/- SEM, *p< 0.05,
**p<0.001) (F) Adipocytes matured in high glucose were treated with 10 µM
CCCP for 8 days. Immunoblotting with anti-2SC antibody shows decreased
protein succination and anti-CHOP antibody displays increased CHOP levels in
the
presence
of
high
glucose
and
CCCP.
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Figure 3.4: N-acetylcysteine reduces protein succination, fumarate levels
and ROS production in high glucose, and reduces CHOP levels. (A)
Metabolites were extracted from adipocytes matured in 5 or 25 mM glucose or 25
mM glucose treated with 5 mM NAC for 3 days as described in Materials and
Methods. Fumarate levels are significantly increased with glucotoxicity and
fumarate levels are returned back to normal with NAC. Data is normalized to total
protein content (µg) (n=3/group, mean +/- SEM, *p< 0.05, ***p<0.001 vs. 5 mM
glucose). (B) 30 µg of protein from adipocytes cultured in 5 or 25 mM glucose
and treated with 0, 0.5, 1, 2.5 or 5 mM N-acetylcysteine (NAC) for 8 days was
subjected to immunoblotting using anti-2SC antibody. (C) Reactive oxygen
species were quantified by the DCF assay in adipocytes matured in 30 mM
glucose with or without 1 mM NAC for 8 hours (n=4/group, mean +/- SEM,
**p<0.01). (D) Adipocytes were treated with 100 µM dimethyl fumarate (DMF) for
24 hours or 5 mM NAC for 8 days. Total glutathione levels were quantified
according to the manufacturer’s instructions as described in Materials and
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Methods (n=3/group, mean +/- SEM, *p< 0.05 vs. 5 mM glucose). (E) A western
blot was performed with anti-CHOP and re-probed with -HOX1 antibodies to
show reduced CHOP and HOX1 levels in adipocytes treated with NAC for 8
days. Coomassie staining represents equal protein loading.

Figure 3.5: Protein oxidation regulates CHOP stability. (A) An immunoblot
probed with anti-2SC, -CHOP and -HOX1 antibodies show that 5 and 10 mM Nacetylcysteine (NAC) treatment simultaneously increase protein succination and
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decreases CHOP and HOX1 levels in FHKD adipocytes. (B, C) Metabolites were
extracted from control adipocytes matured in 30 mM glucose or FHKD
adipocytes cultured in 5 mM glucose and treated with 0, 2.5, 5 or 10 mM NAC for
3 days. Fumarate levels are normalized to total protein content (µg). (D)
Dimedone labeled protein cysteine sulfenic acids are displayed with a western
blot probed with anti-cysteine sulfenic acid antibody from FHKD adipocytes
treated in the presence or absence of NAC.
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Figure 3.6: 2SC and CHOP accumulate in the absence of apoptosis.
Western blots probed with anti-2SC, -CHOP and -cleaved caspase 3 antibodies
with protein from (A) 3T3-L1 adipocytes, (B) control or db/db epididymal adipose
tissue or (C) control or FHKD adipocytes. Immunoblots probed with anti-actin
antibody and Coomassie staining displays equal protein loading. (D) DAPI
imaging with the InvitrogenTM EVOSTM FL Auto Imaging System of duplicate
adipocyte samples treated with 5 mM or 30 mM glucose 8 days. (E) Control or
FHKD adipocytes were matured in 5 mM or 30 mM glucose for 12 days. An
immunoblot probed with anti-cleaved caspase 3 antibody shows no evidence of
increased apoptosis in adipocytes matured in high glucose concentrations or in
FHKD adipocytes versus control adipocytes matured in normal glucose
concentration. (F) The total protein content (µg) of control or FHKD adipocytes
cultured in 5 mM or 30 mM glucose for 8 days was determined by the Lowry
assay.
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Figure 3.7: Accumulation of nuclear CHOP is associated with impaired IL13 secretion in high glucose. (A) Protein succination increases in the total
homogenate (T), nuclear (N), mitochondrial (M) and cytosolic (C) enriched
fractions in adipocytes matured in 25 mM versus 5 mM glucose. Organelle
enriched fractions are confirmed by immunoblotting with anti-actin (cytosolic), citrate synthase (mitochondrial) and -histone H3 (nuclear) antibodies. (B) The
nuclear fraction from adipocytes cultured in 5 or 25 mM glucose was isolated by
centrifugation and a western blot probed with anti-CHOP antibody depicts a
higher amount of CHOP in the nucleus during glucotoxicity. (C) Serum free
medium was collected after 4 hours in adipocytes treated with normal or high
glucose +/- 5 mM NAC. IL-13 levels were quantified using an IL-13 specific
ELISA as described in Materials and Methods. (n=3/group, mean +/- SEM, *p<
0.05).
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Figure 3.8: Beneficial effect of N-acetylcysteine during glucotoxicity. (A)
Glucotoxicity increases fumarate levels that results in increased protein
succination and reduced glutathione (GSH) concentrations. Augmented
succination and lower GSH levels results in the accumulation of reactive oxygen
species (ROS) that are able to react with redox sensitive cysteines on Keap1.
Oxidized Keap1 is unable to sequester Nrf2 and may be unable to form the CSN
supercomplex resulting in the accumulation of C/EBP homologous protein
(CHOP) and increased production of heme-oxygenase 1 (HOX1). (B) Nacetylcysteine (NAC) decreases fumarate concentrations and protein succination
and rescues the concentration of GSH in the adipocyte resulting in decreased
ROS levels. In the absence of oxidative stress Keap1 is able to bind the CSN
complex to promote CHOP degradation and down regulate HOX1 production by
sequestering
Nrf2
in
the
cytosol
for
protein
turnover.
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3.3 Discussion
In this study, we demonstrate that protein succination contributes to the
development of oxidative stress in the adipocyte, and that oxidative stress can
promote the accumulation of CHOP and the suppression of anti-inflammatory IL13. We also show that the anti-oxidant N-acetylcysteine (NAC) resolves oxidative
stress, reduces CHOP protein stabilization and improves IL-13 secretion. CHOP
is known to increase during the late stages of adipogenesis to restrict prolonged
adipogenic signaling after the mature adipocyte phenotype is attained (Han et al.
2013a). We confirmed this increase in CHOP protein levels following adipocyte
maturation in high glucose, however, unlike earlier studies we compared the high
glucose matured adipocytes to adipocytes matured in normal glucose (Tanis et
al. 2015). Importantly, we noted that while CHOP protein levels did increase
during early adipogenesis (1-3 days) in normal glucose, there was a decline
during the later stages (3-8 days), whereas CHOP levels were increasingly
elevated in high glucose (Figure 3.1A)(Tanis et al. 2015).
Since 3T3-L1 adipocytes matured in normal glucose differentiate normally,
evidenced by the synthesis and storage of triglycerides, it suggested that CHOP
accumulation in high glucose may have a role beyond the suppression of
adipogenesis. Notably, sustained CHOP protein levels occur in parallel with
increased protein succination (Tanis et al. 2015), suggesting a potential
association between protein succination and impaired CHOP turnover. In Figure
3.1 we demonstrate that glucotoxicity, and more specifically protein succination,
lead to decelerated CHOP turnover, implying that there is a defect in the CHOP
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degradation pathway. CHOP ubiquitination and subsequent degradation is
regulated by the formation of a COP9 signalosome/Cullin-3 E3 ligase/Keap1
supercomplex in adipocytes (Huang et al. 2012). We hypothesized that
succination of Keap1 in the presence of excess fumarate (Adam et al. 2011,
Linker et al. 2011) may disturb the interaction of CHOP with the degradation
supercomplex, leading to the accumulation of CHOP. Immunoprecipitation of
overexpressed V5 tagged Keap1 from fumarase knockdown (FHKD) adipocytes
confirmed that Keap1 is succinated (Figure 3.2B). Further mass spectrometry
analysis confirmed that the redox sensitive Cys288 in the intervening region
(IVR) of Keap1 is susceptible to modification by fumarate in FHKD adipocytes
(Figure 3.2C). The modification of cysteines within the IVR domain is predicted to
distort the tertiary structure of Keap1, impairing substrate ubiquitination and
preventing protein:protein interactions in the Cullin-E3 ligase complex (Canning
et al. 2015). Importantly, eliminating mRNA expression and protein utilizing
Keap1 siRNA stabilizes CHOP in the adipocyte (Huang et al. 2012), confirming
that Keap1 is a vital regulatory component of CHOP turnover. In support of this,
we determined that acute treatment with sulforaphane or dimethyl fumarate
(DMF), both of which act to modify Keap1 regulatory thiols, confirmed the
involvement of Keap1 cysteines as a regulator of CHOP protein longevity in the
adipocyte (Figure 3.2D, 3.2E).
In response to oxidative stress and the oxidation of Keap1 cysteines, Nrf2
translocates into the nucleus and binds to the anti-oxidant response element
(ARE) in the promotor region of the heme-oxygenase 1 gene (Alam et al. 1999).
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We verified that this pathway is active in the metabolically stressed adipocyte in
vitro, as well as in the adipose tissue of db/db diabetic mice (Figure 3.3A). In
contrast to the FHKD adipocytes, Keap1 was not directly confirmed as a target of
succination in the adipocyte matured in high glucose (Figure 3.3C), despite
prominent activation of the Keap1/Nrf2/HOX1 signaling pathway in the db/db
adipose tissue and in adipocytes cultured in 25 mM glucose (Figure 3.3A).
Considering that we could not detect Keap1 succination in the high glucose
model where fumarate is elevated in parallel with other sources of oxidant stress,
we hypothesized that Keap1 thiol oxidation was more prominent than Keap1
succination under diabetic conditions. Unpublished studies from our laboratory
have demonstrated that both oxidation and succination may compete to modify
the same cysteine thiols; therefore the modification generated would depend on
the concentration and reactivity of the oxidant or electrophile. We have also
shown that the sulfenic acid (-SOH) generated by oxidation cannot be further
succinated by fumarate in vitro, therefore fumarate does not appear to react with
already oxidized thiols.
We and others have confirmed increased ROS production in adipocytes
matured in high glucose versus normal glucose (Han et al. 2017, Houstis et al.
2006, Lin et al. 2005)(Figure 3.3D), suggesting that oxidation, rather than
succination, is indeed the principal Keap1 modification regulating CHOP stability
in the adipocyte during diabetes. Importantly we also documented that ROS
production is pronouncedly increased in FHKD adipocytes and adipocytes
treated with dimethyl fumarate (DMF) (Figure 3.3D, 3.3E), similar to the observed
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accumulation of ROS in fumarase deficient mouse kidney epithelial cells (Zheng
et al. 2015). This striking data demonstrates that the remarkable increase in
fumarate alone is sufficient to drive oxidative stress; and that mitochondrial
derived metabolite stress and oxidant stress are inextricably linked. Furthermore,
we also showed that chronic treatment with the mitochondrial uncoupler CCCP
reduces protein succination, yet also increases CHOP levels (Figure 3.3F), which
is likely due to CCCP stimulated superoxide production (Carriére et al. 2004).
Therefore, although fumarate and oxidative stress occur concurrently in the
adipocyte in high glucose, our data suggests that it is the increase in oxidative
stress that directly contributes to impaired CHOP turnover. Moreover, protein
succination indirectly contributes to CHOP stabilization through the continued
induction of oxidative stress.
Considering the known increase in ROS production in adipocytes
cultured in high glucose medium (Han et al. 2017, Houstis et al. 2006, Lin et al.
2005), we next investigated if the antioxidant N-acetylcysteine (NAC) might have
a beneficial action that would also impact the levels of protein succination. NAC
has been shown to attenuate the hyperglycemic pro-inflammatory response,
evidenced by lower plasminogen activator inhibitor-1 (PAI-1) mRNA and protein,
in the epididymal adipose tissue of diabetic mice (Lin et al. 2005). NAC treatment
(2.5 and 5 mM) reduced the excess fumarate by 2-2.5 fold in the adipocyte
matured in high glucose (Figure 3.4A). We also observed lower protein
succination following NAC treatment (Figure 3.4B), consistent with the decrease
in intracellular fumarate (Figure 2.1A, 2.1B) (Frizzell et al. 2012). Both DMF and
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endogenously produced excess fumarate directly modify glutathione (GSH) in
control or fumarase knockout mouse kidney epithelial cells, respectively (Zheng
et al. 2015). The decrease in reduced GSH concentration due to succination in
these models leads to a decrease in the GSH:GSSG ratio, elevated ROS levels
and activation of several anti-oxidant response genes including HOX1 (Zheng et
al. 2015). Figure 3.4D confirmed that DMF also lowers GSH levels in the
adipocyte (Manuel and Frizzell, 2013), suggesting that increased endogenous
fumarate may partially contribute to reduced total GSH levels in adipocytes
matured in high glucose (Figure 3.4D). NAC, a known precursor of GSH
synthesis, improved the concentration of GSH in adipocytes matured in high
glucose (Figure 3.4D). In parallel, the decrease in oxidative stress also
corresponded to reduced fumarate levels, although it is unclear if NAC reacts
directly with fumarate, or decreases other factors related to mitochondrial stress
in the adipocyte.
Hypoxia induced oxidative stress in 3T3-F442A preadipocytes is linked to
the initiation of CHOP transcription (Carriére et al. 2004), and Diaz et al. have
inferred that oxidative stress is associated with proteasomal dysfunction in
subcutaneous adipose tissue from obese insulin resistance patients contributing
to CHOP stability (Diaz et al. 2015). Lowering ROS levels with NAC (Figure
3.4C) diminished both HOX1 and CHOP protein levels in adipocytes matured in
high glucose (Figure 3.4E), representative of a potentially renewed interaction
between CHOP and the degradation supercomplex. Taken together, this
demonstrates that succination contributes to reduced GSH levels and the
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development of oxidative stress in adipocytes matured in hyperglycemic
conditions. Limiting GSH contributes to the accumulation of ROS in the
adipocyte, prompting oxidation of Keap1 and CHOP stabilization (Figure 3.8A).
NAC decreases fumarate and protein succination while simultaneously
increasing available GSH to scavenge ROS and prevent oxidation of Keap1. In
the absence of oxidative stress, Keap1 is able to sequester target substrates
such as Nrf2 (Kobayashi et al. 2006) and CHOP (Huang et al. 2012) in the
cytosol, allowing them to be tagged for proteasomal degradation (Figure 3.8B).
In contrast to adipocytes matured in 25 mM glucose, NAC actually
augmented protein succination in FHKD adipocytes (Figure 3.5A). Surprisingly
NAC treatment also had no effect on the concentrations of endogenously
produced fumarate generated in this model (Figure 3.5B). This may be related to
the excessive concentration of fumarate produced in these cells, 20 fold greater
than that in adipocytes matured in 25 mM glucose (Figure 3.5C). Interestingly,
we still observed a significant decrease in both CHOP and HOX1 expression with
NAC treatment (Figure 3.5A), despite continued increased protein succination
and high fumarate levels. Assessment of protein cysteine sulfenic acid content in
FHKD adipocytes (Figure 3.5D) revealed that reducing oxidative protein damage
with NAC decreased thiol oxidation, which in turn down-regulates CHOP levels
and Nrf2 signaling, likely by attenuating Keap1 oxidation. Remarkably, prolonged
adipose tissue Nrf2 activity has been associated with decreased lipid
accumulation,

lipogenic

gene

expression

and

glucose

tolerance

while

simultaneously increasing insulin resistance in the adipose tissue of ob/ob type 2
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diabetic mice (Xu et al. 2012). While sustained Nrf2 activity was suspected to
underlie the unhealthy phenotype in these mice, our data suggests that sustained
CHOP, also regulated by Keap1 modification, may be a more significant
contributor. Collectively, these results emphasize the importance of cysteine
oxidation as a primary regulatory factor governing Keap1:protein interactions and
CHOP stability in the adipocyte. Protein thiol oxidation indirectly correlates with
succination in FHKD adipocytes (Figure 3.5A, 3.5D) confirming that oxidation and
succination compete for thiol targets when fumarate levels are elevated. While
fumarate levels are augmented in both of the models used (high glucose and
FHKD), and it is evident that increased fumarate can further exacerbate oxidative
stress, it is also clear that both models differed dramatically in response to NAC
treatment. This is significant considering that knockdown models are frequently
employed to model metabolite stress (Nishida et al. 2015, Park et al. 2013,
Wagner et al. 2017), but these may not always exhibit the same concentrations
observed in the disease state, producing different, perhaps more pronounced,
signaling effects.
CHOP is classically known to induce apoptotic signaling via suppression
of the Bcl-2 family gene transcription in the nucleus. However, the accumulation
of CHOP in adipocytes due to proteasomal inhibition by MG132 has no effect on
the protein levels of anti-apoptotic proteins Bcl-2 or Bax (Diaz et al. 2015). In
addition, wild type and CHOP knockout mice fed a high fat diet display similar
expression of apoptosis-related proteins Bcl-2 and CD95 and show no change in
the ratio of TUNEL-positive cells to total nuclei (Suzuki et al. 2017). These
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studies emphasize the absence of immediate CHOP-mediated apoptosis in
obese adipocytes. Figure 3.6 supports these studies as we find that CHOP levels
are indirectly proportional to cleaved caspase 3 protein levels in adipocytes
matured in high glucose, adipose tissue from db/db mice and FHKD adipocytes
at 8 or 12 days of adipocyte maturation. Giordano et al. have described
increases in caspase-1 mRNA and over activation of the nucleotide-binding
oligomerization domain-like receptor-3 (NLRP3) inflammasome in obese adipose
tissue (Giordano et al. 2013). This leads to hypertrophic adipocyte death by
pyroptosis, rather than CHOP induced apoptosis, in the visceral adipose tissue of
ob/ob and db/db mice and subcutaneous adipose tissue of mice fed a high fat
diet (Giordano et al. 2013).
Investigation into the functional role of CHOP in obese adipocytes led
Suzuki et al. to determine that stabile CHOP signaling suppresses IL-13 and IL-4
mRNA transcription, promoting M1 macrophage polarization in mice after 6
weeks of high fat diet feeding (Suzuki et al. 2017). Eosinophils are the major
source of IL-4 in the adipose tissue microenvironment while healthy adipose
tissue secrets modest levels of IL-4. CHOP knockout mice display upregulated
transcription of eotaxins and increased eosinophil recruitment resulting in
increased IL-4 levels and attenuated inflammation in the adipose tissue
microenvironment (Suzuki et al. 2017). In addition, CHOP knockout mice have
improved insulin sensitivity after consumption of a high fat diet (Suzuki et al.
2017). This study emphasizes an important role for CHOP to promote adipose
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tissue inflammation linked to insulin resistance during high fat diet feeding
(Suzuki et al. 2017).
Notably, adipose tissue IL-13 secretion increases in mice fed a high fat
diet for 13 weeks in response to exogenous TNFα and IL-1β inflammatory
signaling (Kwon et al. 2014). Elevated IL-13 production observed in obese versus
lean omental human adipose tissue is predicted to attenuate the inflammatory
immune cell response to implement the ‘low-grade’ inflammation hallmark of
obesity (Kwon et al. 2014). We confirmed that accumulation of CHOP specifically
in the nuclear fraction of adipocytes matured in high glucose (Figure 3.7B)
correlates with impaired IL-13 secretion during the onset of adipocyte
hypertrophy (Figure 3.7C). This data suggests that CHOP may regulate IL-13
mRNA transcription at an early stage of obesity to initiate a pro-inflammatory
immune cell response in the adipose tissue microenvironment. Notably, we
demonstrated that NAC mediated suppression of oxidative stress (Figure 3.4C)
reduced CHOP expression (Figure 3.4E) and rescued IL-13 secretion (Figure
3.7C),

possibly

reducing

the

pro-inflammatory

environment.

Chromatin

immunoprecipitation sequencing identified GATA3, a zinc finger transcription
factor, and STAT5a bound to the promotor region of IL-13 resulting in the
upregulation of IL-13 mRNA transcription (Wei et al. 2011). Interestingly, GATA3
is expressed in white adipose tissue (Tong et al. 2000) and forms transcription
factor complexes with C/EBPα and C/EBPβ to inhibit adipogenesis (Tong et al.
2005). Future studies will investigate if CHOP directly binds anti-inflammatory
transcription factor complexes such as GATA3 or STAT5a (Zhu, 2015) or the
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DNA promotor region to suppress IL-13 mRNA production and secretion (Figure
3.7C) (Suzuki et al. 2017).
In summary, we find that increased fumarate levels and protein
succination are coupled to elevated oxidative stress; and that this leads to
oxidative protein damage and impaired CHOP turnover in the adipocyte.
Sustained CHOP protein levels in the nucleus correlates with decreased
secretion of the anti-inflammatory cytokine IL-13. The improvement in IL-13
secretion following NAC treatment is a direct result of limiting oxidant-mediated
CHOP stabilization, emphasizing the importance of the intracellular oxidative
environment for healthy adipocyte function.
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Chapter 4
Summary and Future Directions
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4.1 Summary
Adipose tissue is an important endocrine organ responsible for energy
storage, insulation, protection and the secretion of adipokines that help regulate
systemic nutrient homeostasis. The accumulation of excess adipose tissue is
associated with the secretion of pro-inflammatory cytokines and insulin
resistance. Type 2 diabetes is frequently associated with obesity and ~29 million
Americans are either diabetic or have pre-diabetes. Due to the growing number
of individuals affected by obesity and type 2 diabetes, it is critical to understand
the complex origins of disease pathology. The mechanistic studies investigated
here increase our knowledge regarding the biochemical contribution of excessive
caloric intake to the metabolic dysfunction known to occur in adipose tissue.
Overall, I explored the contribution of nutrient excess to alterations in the posttranslational regulation of protein stability and function, and how this impacts
adipocyte dysfunction.
Protein succination occurs when a thioether bond is formed between the
Krebs cycle intermediate fumarate and the thiol groups of cysteine residues to
form S-(2-succino)cysteine (2SC) (Figure 1.3). The accumulation of fumarate and
2SC increases in adipocytes matured in high glucose and in adipose tissue from
type 2 diabetic (db/db) mice, due to glucotoxicity driven mitochondrial stress
(Frizzell et al. 2012) (Figure 1.4). Protein disulfide isomerase (PDI) is an
abundant endoplasmic reticulum (ER) oxidoreductase that is responsible for the
successful formation of disulfide bonds in the majority of proteins in the ER. In
chapter 2 I identified the active site cysteines of PDI as the targets of succination
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in adipocytes matured in high glucose.
The use of a fumarase knockdown model (FHKD) to directly increase
endogenous fumarate production facilitated determination of the impact of
metabolite stress on PDI activity. Direct succination of PDI active site cysteines
inhibits PDI reductase activity interfering with normal protein folding and
contributing to the documented increase in the unfolded protein response (UPR)
and ER stress (Figure 4.1) in the adipose tissue of diabetic patients (Boden et al.
2014b, Hosogai et al. 2007). Notably, adipose tissue secretory function is not
decreased for all secreted proteins. During diabetes there is increased secretion
of leptin, retinol binding protein 4 (RBP4) and inflammatory proteins in parallel
with adipose tissue expansion. However there are paradoxical decreases in the
secretion of adipsin, omentin, vascular endothelial growth factor (VEGF) as well
as the thiol dependent hormone adiponectin (Deng and Scherer, 2010). We have
previously shown that the critical cysteine for adiponectin oligomerization is
succinated in diabetic adipose tissue and adipocytes (Frizzell et al. 2009). Taken
together, our data suggests that protein succination is a relevant negative
regulator of protein folding and oligomerization during diabetes.
During our studies on adipocyte protein folding capacity, we noted that
the protein levels of the ER stress marker C/EBP homologous protein (CHOP)
were elevated, yet we found limited evidence for a pronounced up-regulation of
the unfolded protein response (UPR) in diabetic conditions (versus normal
glucose). This is in agreement with more recent publications documenting the
presence of UPR activation in the presence of insulin, since the normal response
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to insulin both in vivo and in vitro would include increased proteostasis (Boden et
al. 2014b, Minard et al. 2016). Therefore, we continued to examine the persistent
up-regulation of CHOP in diabetic conditions (Figure 3.1A). CHOP is a negative
regulator of transcription and we confirmed that it was accumulating in the
nucleus of adipocytes matured in high glucose. While increased levels of CHOP
are normally associated with prolonged ER stress and the induction of apoptosis,
we found no evidence for an association between CHOP and increased
apoptosis (Figure 3.6).
Kelch-like ECH-associated protein 1 (Keap1) is a negative regulator of
CHOP stability and Figure 3.1 demonstrates that CHOP turnover is impaired in
adipocytes cultured in high glucose. The modification of Keap1 regulatory
cysteines promotes the accumulation of CHOP protein levels. We identified
Cys288 as the target residue for Keap1 succination in FHKD adipocytes, but
surprisingly Keap1 was not directly succinated in high glucose conditions where
fumarate is also increased, although to a lower extent than the FHKD model. We
further demonstrated that it is oxidative stress and the accumulation of reactive
oxygen species that leads to oxidation of Keap1 and the accumulation of CHOP
protein levels in high glucose conditions. Interestingly, we also documented that
increased fumarate promotes oxidative stress; therefore elevated fumarate can
regulate Keap1/CHOP indirectly through the production of ROS. Boden et al.
recently demonstrated the significance of adipose tissue oxidative stress in the
acute development of insulin resistance in humans, independent of ER stress
and inflammation (Boden et al. 2015). Our data elegantly demonstrates that both
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oxidative stress and metabolite stress occur simultaneously, and further explains
how increased fumarate levels as diabetes develops may exacerbate the existing
oxidative stress. In further considering the implications of sustained CHOP levels
in the nucleus, we demonstrate that CHOP may contribute to the inhibition of IL13 production and secretion during adipocyte dysfunction (Figure 3.7C, 4.1).
In summary, the data obtained here demonstrates that elevated fumarate
contributes to impaired protein folding and altered functionality in parallel with
oxidative modification and inflammatory stress. Fumarate levels and protein
succination are lowered following the reduction of high glucose levels,
demonstrating that metabolite stress, like obesity and inflammation, can be
resolved following caloric restriction.
4.2 Future Directions
It will be important to extend these studies on the role of succination in
adipocyte pathophysiology to human adipose tissue. In particular, we are
interested in investigating if other isomers of the PDI family, such as ERp57, are
targets of succination and whether this affects protein glycosylation in the
adipocyte. Continuous with our results regarding caloric restriction, it will also be
beneficial to confirm that caloric restriction and/or exercise decreases protein
succination and CHOP levels in the adipose tissue of type 2 diabetic mice and
patients.
Our results on the increased production of ROS as a result of protein
succination are insightful and exciting; suggesting that fumarate indirectly
regulates the oxidative modification of proteins. Figures 3.3 and 3.4 suggest that
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protein succination alone is sufficient to induce oxidative stress and activate the
Keap1/Nrf2 antioxidant response pathway in the adipocyte. Interestingly,
reducing protein succination with the antioxidant and glutathione precursor Nacetylcysteine (NAC) ameliorates ROS production and lessens the Keap1/Nrf2
oxidative stress response in adipocytes matured in high glucose. The precise
mechanism by which NAC simultaneously reduces protein succination in the
adipocyte has not been described, but it may involve the production of
succinated NAC or succinated glutathione and we plan to develop methods to
detect this.
We have noted in unpublished observations that oxidized thiols (sulfenic
acid) will not react with fumarate in vitro. Figure 3.5 shows that NAC reduces
protein oxidation in FHKD adipocytes (where fumarate levels are 20-fold greater
than in high glucose), but simultaneously increases protein succination. Our data
demonstrates that pronouncedly elevated fumarate levels, such as those
observed in fumarase deficient renal cell carcinoma or fumaric aciduria, both
contribute to and compete with the oxidative modification of proteins. While the
use of antioxidants in these conditions might actually reduce oxidative stress,
they are also likely to propagate the irreversible succination of other proteins. We
would predict that treating adipocytes matured in high glucose with the
antioxidants superoxide dismutase (SOD) or MitoQ might also decrease the
amount of oxidized protein thiols and this may be more beneficial in situations
where fumarate levels are not elevated to the extent that they are in models of
fumarase deficiency. The combined assessment of protein oxidation, succination
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and fumarate levels in adipocytes treated with SOD and MitoQ during maturation
in high glucose or the fumarase knockdown model will further confirm whether
endogenous fumarate and ROS compete to react with the same thiol targets.
Our laboratory is currently working to produce a tamoxifen inducible
adipose tissue specific fumarase knockout mouse to delineate the whole-body
ramifications of augmented adipose tissue fumarate production in vivo.
Preliminary data generated from our laboratory demonstrates that CHOP levels
increase in the white adipose tissue from another fumarase knockout model
(Yang et al. 2016). We will continue to investigate several additional roles for
CHOP in the regulation of metabolism and inflammation in this model and in
human adipose tissue from diabetic patients. We are currently planning
chromatin immunoprecipitation (ChIP) studies to detect genes directly regulated
by CHOP-DNA interactions in adipocytes matured in high glucose.
Lastly, our laboratory has confirmed that succination increases on ~40
different proteins in the adipocyte during diabetes. We will continue to investigate
the significance of other identified sites, and specifically pursue the stoichiometry
of protein succination by multiple reaction monitoring mass spectrometry. We are
committed to further understanding the quantitative significance of protein
succination in the complex network of metabolic stressors occurring present
during type 2 diabetes.
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Figure 4.1. Mitochondrial stress drives adipocyte dysfunction during
diabetes. The resultant accumulation of fumarate due to mitochondrial stress
leads to increased protein succination. Succination of the important endoplasmic
reticulum oxidoreductase protein disulfide isomerase (PDI) results in the
accumulation of misfolded proteins and the ER stress markerf C/EBP
homologous protein (CHOP). Additionally, succination promotes oxidative stress
and the build-up of reactive oxygen species (ROS). The modification of Kelch-like
ECH-associated protein 1 (Keap1) by ROS coincides with impaired CHOP
turnover and the accumulation of CHOP in the nucleus. Nuclear CHOP
accumulates in parallel with downregulation of IL-13 mRNA transcription and
enhances
adipocyte
inflammation.
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Chapter 5
Materials and Methods
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Materials. Unless otherwise noted, all chemicals were purchased from Sigma
Aldrich (St. Louis, MO). Anti-2SC antibody was prepared by Eurogentec
(Fremont, CA). Insulin was purchased from Bio Ab Chem (Ladson, SC) for in
vitro studies. Tween-20 and Criterion™ TGX™ Precast Gels were from Bio-Rad
(Hercules, CA). Polyvinylidene fluoride (PVDF) was purchased from GE
Healthcare (Fairfield, CT). L-glycine and sodium dodecyl sulfate (SDS) were
purchased from Fisher Scientific (Waltham, MA). All materials for the Seahorse
XF24 were purchased from Seahorse Bioscience (Agilent, Santa Clara, CA)
except insulin, glucose and pyruvate. The CyQuant® assay was from Invitrogen
(Grand Island, NY). The PROTEOSTAT® PDI assay kit was purchased from
Enzo Life Sciences Inc. (Farmingdale, NY) and the Di-Eosin-GSSG was
generously provided by Dr. Bulent Mutus, University of Windsor, Ontario,
Canada.
Animal Models. Male db/db mice (BKS.Cg-Dock7m +/+ Leprdb/J, JAX 000642)
and heterozygote control mice were purchased from Jackson Laboratories (Bar
Harbor, ME). The mice were obtained at 5-6 weeks of age and allowed to
acclimate 1-2 weeks with unrestricted access to food and water before initiation
of experimental monitoring. Blood glucose levels were measured at 15 weeks of
age after an overnight fast by collecting tail vain blood using a Bayer Contour®
(Whippanny, NJ) blood glucose meter for all groups. A glucose oxidase assay
was also performed to obtain values for db/db mice as some of these surpassed
the range of the glucometer. The animals were sacrificed at 15 weeks of age
using CO2 asphyxiation and epididymal adipose tissue was removed and frozen
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on dry ice.
Protein Extraction from Adipose Tissue. Adipose tissue was added to 0.5 – 5
mL radio immunoprecipitation assay (RIPA) buffer and sonicated 4 times for 30
seconds each. The tissue was incubated on ice for 10 minutes and centrifuged at
5000 rpm for 10 minutes at 4°C. A supernatant, infranatant and pellet were then
visible. The infranatant volume was extracted using a needle and syringe.
Acetone (9x volume) was then added to each infranatant sample. The samples
were vortexed, allowed to sit on ice for 10 minutes and then centrifuged at 2000
rpm for 10 minutes at 4°C. The acetone was removed completely and the protein
pellets were re-suspended in 0.5 mL of RIPA buffer and sonicated two times for
30 seconds each. The protein concentration was determined using the Lowry
method.
Cell Culture. 3T3-L1 murine fibroblasts were purchased from American Type
Culture Collection (Manassas, VA) and maintained up to 7 passages in
Dulbecco's Modified Eagle Medium (DMEM) containing 5 mM glucose, 1%
penicillin/streptomycin (CellGro, Corning Life Sciences, Tewksbury, MA) and
10% Fetal Calf Serum (FCS) (Thermo Scientific, Waltham, MA) at 37°C with 95%
humidity and 5% CO2. The medium was changed every 48 hours, with glucose
supplementation at 20-24 hour intervals. At 70-80% confluence the fibroblasts
were trypsinized (Thermo Scientific, Waltham, MA), neutralized with excess
DMEM and collected by centrifugation at 1000 rpm for 5 minutes at 25°C. The
fibroblasts were then re-suspended in DMEM for each new passage.
3T3-L1 fibroblasts were seeded at densities of 20,000, 50,000, 90,000
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and 300,000 cells/ well for 24-well, 12-well, 6-well plates and 10 cm2 petri dishes
respectively. 3T3-L1 fibroblasts were induced to differentiate to adipocytes 24
hours post-confluence (~4-5 days) in DMEM with 1% penicillin/streptomycin
(CellGro), 10% Fetal Bovine Serum (FBS) (Atlanta Biologicals, Flowery Branch,
GA), 3-isobutyl-1 methylxanthine (0.5 mM), dexamethasome (IBMX) (0.3 µM),
insulin (10 µg/mL) and glucose (30 mM) for 72 hours at 37°C with 95% humidity
and 5% CO2. The differentiation medium was removed at maturation day 0, the
cells were washed with PBS and maturation DMEM containing DMEM with 1%
penicillin/streptomycin (CellGro), 10% Fetal Bovine Serum (FBS) (Atlanta
Biologicals, Flowery Branch, GA), 5 mM glucose/0.3 nM insulin or 30 mM
glucose/3 nM insulin was applied. These conditions were selected as we have
observed that adipocytes cultured in normal glucose/insulin are a more
appropriate control for the high glucose/insulin (diabetic) conditions (Tanis et al.
2015). The medium was changed every 48 hours and the adipocytes were
matured for 5, 8 or 12 days. Adipocytes were treated with 2 µM niclosamide upon
standard medium change. 10 µM MG132 or 40 µM sulforaphane was added to
the maturation medium 3 hours prior to harvest. Adipocytes matured in normal
glucose and insulin concentrations were treated with 2, 4 or 6 mM dimethyl
succinate for 8 days or 100 µM dimethyl fumarate for 3, 6 or 24 hours. Cells
cultured in 5 mM glucose were supplemented with 5-6 mM glucose daily and 5
hours prior to protein harvest in maintain glucose levels.
Lentiviral Vector Production. The lentiviral vectors were prepared by the
University of South Carolina Viral Vector Facility. Lentiviral vectors were

126

generated using a transient transfection protocol, as described in Kantor et al.,
2011. TRC2 Fh1 shRNA, clone- TRCN0000246831 or SHC202 MISSION TRC2
pLKO.5-puro non-mammalian shRNA control plasmids (Sigma/Aldrich, St. Louis,
MO) were used to generate the lentiviral vectors. The vectors also contained a
puromycin resistance gene. 15 μg vector plasmid, 10 μg psPAX2 packaging
plasmid (Addgene #12260, Cambridge, MA), 5 μg pMD2.G envelope plasmid
(Addgene #12259, Cambridge, MA) and 2.5 μg pRSV-Rev plasmid (Addgene
#12253, Cambridge, MA) were transfected into 293T cells. The filtered
conditioned medium was collected and stored at -80°C until use. The Keap1-V5
overexpression plasmid was kindly provided by Anil Jaiswal, University of
Maryland. The plasmid sequence was validated by PCR and cloned into a
lentiviral vector containing green fluorescent protein (GFP) (pLenti-CMV-KEAP1IRES-GFP). A vector containing the Keap1-V5 sequence in the opposite
orientation was used as a control. The vector was produced as described above
and the filtered conditioned medium was stored following titer determination.
Lentiviral Vector Transduction. 3T3-L1 fibroblasts were incubated overnight
with 150 µL of filtered conditioned medium containing Fh1 shRNA or control
lentivirus. Successfully transduced fibroblasts were selected using 1 µg/mL
puromycin. The selected fibroblasts were propagated until confluent, then
differentiated to adipocytes and matured for 8 days in 5 or 30 mM glucose as
described above. 3T3-L1 fibroblasts or FHKD fibroblasts were differentiated as
described above and transduced with the Keap1-V5 plasmid on maturation day
1. Over-expression of the Keap1 protein was monitored in adipocytes via green
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fluorescent protein through 5 or 8 days of maturation. Successful maturation in
both glucose concentrations was confirmed by the accumulation of lipid droplets
in the adipocyte by light microscopy (Nagai et al. 2007, Tanis et al. 2015).
Seahorse Extracellular Flux Analyzer 24. 3T3-L1 fibroblasts were plated in V7microassay plates on 0.2% gelatin at 10,000 cells per well. 150 µL of medium
was added after 24 hours. Fibroblasts were differentiated as described above
and matured for 2 days in 5 mM or 30 mM glucose.
An XF calibrant cartridge was hydrated 24 hours prior to analysis in XF
calibrant solution pH 7.4 at 37°C with 0% CO2. The cells were washed with 750
µL of XF assay buffer pH 7.4 and 600 µL of XF Assay Medium pH 7.4 (Agilent
Technologies, Santa Clara, CA), supplemented with 5 mM or 30 mM glucose, 0.3
or 3 nM insulin, and 1 mM sodium pyruvate, was added to replace the culture
media 1 hour before the analysis (Tanis 2015). 0.25 µM niclosamide was added
to adipocytes by XF analyzer injection after 4 measurements of the basal oxygen
consumption rate (OCR). All measurements involved a mixing (3 minutes), a wait
(2 minutes) and a measure (3 minutes) period after the addition of the normal
medium or the 0.25 µM niclosamide. The OCR data was normalized to the total
DNA or protein content of the wells using the CyQuant® Assay (Invitrogen,
Grand Island, NY) or Lowry assay, and the data was expressed in
pmoles/minute/ng DNA or µg protein (Tanis et al. 2015).
Oil Red O Staining. 0.5 grams of Oil Red O was thoroughly mixed in 100 mL
isopropanol and diluted 6:4 in nano-pure distilled water. The dye was allowed to
stand for 10 minutes and filtered through Whatman No.1 filter paper. 100%
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confluent 3T3-L1 fibroblasts and differentiated FHKD adipocytes were fixed for 1
hour in 4% formaldehyde. The cells were washed with PBS, stained with the Oil
Red O dye for 1 hour and washed with water. The lipid droplets were visualized
by brightfield microscopy and the images were obtained with an InvitrogenTM
EVOSTM FL Auto Cell Imaging System (Thermo Fisher Scientific, Waltham, MA).
Amplex Red Assay. FHKD or scrambled control adipocytes were matured in 5
mM or 30 mM glucose in serum free and phenol red free medium for 2.5 hours
on day 0 of maturation. The fluorescent Amplex® UltraRed Reagent was
resuspended in 1 mL of sterile DMSO and diluted to a 333 µM stock in DMSO.
0.5 U/mL horseradish peroxidase and 10 µM Amplex UltraRed Reagent was
added directly to the maturation medium/well. The fluorescence was recorded at
490ex nm and 585em nm every hour for 4 hours. Relative fluorescent units were
normalized to total protein content per well following determination by the Lowry
assay.
Dichlorofluorescein (DCF) Assay. FHKD or scrambled control adipocytes were
matured for 2 days in 5 mM or 30 mM glucose medium. The cells were rinsed
with sterile PBS and incubated for 45 minutes at 37°C with 500 µL serum free
phenol red free medium and 0.0065 µg/µL DCF. The DCF containing medium
was removed and the cells were returned to maturation medium with serum free,
phenol red free DMEM. Relative fluorescent units were measured at 485ex nm
and 535em nm every 30 minutes for 4 hours.
Cycloheximide Pulse Chase. 3T3-L1 control or FHKD adipocytes were matured
in 5 mM or 30 mM glucose for 8 days. Adipocytes (triplicate samples/group) were
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harvested at time point 0 hours and 3.5 µg/mL cycloheximide was added to four
additional groups, harvested every hour for 4 hours. 10 µM MG132 was added to
a separate group of adipocytes for 4 hours.
Glutathione Quantification. Adipocytes were matured for 8 days in the
presence of 5 mM or 30 mM glucose with 0, 2.5 or 5 mM NAC, or 100 µM
dimethyl fumarate (DMF) for 24 hours. Cells were harvested in 5% salicyclic acid
sonicated, allowed to sit on ice for 10 minutes and centrifuged at 14,000 rpm,
+4*C for 10 minutes. The supernatant was removed and diluted 1:5 with assay
buffer and then diluted 1:6 with sample diluent buffer supplied by the
commercially available kit (Arbor Assay Glutathione Fluorescent Detection Kit,
Ann Arbor, MI). Total glutathione levels were quantified according to the
manufacturer’s instructions.
Metabolite Quantification. The quantification of fumarate was performed by
GC-MS at the David H. Murdock Research Institute (DHMRI, Kannapolis, NC).
Metabolite extraction was performed in an adaptation of previous methods (Piroli
2016). Adipocyte lysates harvested in methanol from confluent 10 cm2 petri
dishes were washed three times with ice-cold PBS followed by the immediate
addition of 20 volumes ice-cold chloroform:methanol (2:1). The samples were
vortexed and allowed to stand on ice for 10 min with intermittent vortexing prior to
addition of 0.2 volumes H2O. The samples were sonicated and allowed to stand
on ice for an additional 2 min, followed by centrifugation at 3,220 x g for 20 min.
The aqueous supernatant was transferred into a clean tube and dried under air.
The extraction was repeated an additional time by adding equal parts of
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methanol and deionized water, centrifuging, and transferring the aqueous layer
into the respective tube to dry. The protein interface for each sample was
removed for quantification of protein by the Lowry assay.
Prior to derivatization the extracts were resuspended in ethyl acetate and
transferred to GC-MS vials. The samples were dried with N2, and an internal
standard (100 μM succinate-13C4, Cambridge Isotope laboratories, Inc.) was
added to each of the samples and fumarate standards. The samples and
standards were derivatized with 200 μl of methylamine (20 mg/ml in pyridine,
M.P. Biomedicals, Solon, OH) at 30°C for 90 min, followed by drying under N2.
This was followed by the addition of 120 μl of N-methyl-N-(trimethylsilyl)
trifluoroacetamide (MSTFA, Sigma, St. Louis, MO) with 1% trimethylchlorosilane
(TMCS, Sigma, St. Louis, MO); the mixture was incubated at 70°C for 60 min.
The derivatized product was stored in a -20°C freezer for one hour. A 100 μl
aliquot of the prepared product was transferred to a deactivated glass insert in a
2 ml glass vial (Agilent Technologies, Santa Clara, CA) for GC/MS analysis. An
Agilent 7890A GC system, coupled to an Agilent 5975C electron ionization (EI)
mass selective detector (MSD) was used to analyze the TMS-derivatized
samples. A column with dimensions 30 m × 0.25 mm I.D., 0.25 μm film thickness
(Restek, Bellefonte, PA) was used, and the column operation conditions were as
follows: helium carrier gas at 1.0 ml/min; GC oven temperature program of 70°C
(2 min), 70-100°C (30°C/min, 1 min), 100-140°C (10°C/min, 4 min), 140-188°C (4
°C/min, 12 min), 188-280°C (5 min), with a transfer line temperature of 270°C.
The GC-MS was operated under a splitless mode (inlet at 250°C). The mass
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spectrometry was performed at an electron energy of -70 eV and the ion source
temperature was 230°C. Selected ion monitoring (SIM) was performed for
fumarate and the peak areas obtained were normalized to the added internal
standard. Absolute quantitation was performed based on standard curves
obtained from the normalized reference standards, and the final metabolite
concentrations were normalized to the protein content of the cells.
Protein Extraction from Cells. All samples and reagents were kept on ice
during protein harvest. The cells were washed 3 times with phosphate buffered
saline (PBS) solution, collected in RIPA buffer and sonicated 3 times (10
seconds) at 30 second intervals. Acetone (9 volumes) was added to each sample
and the samples were vortexed and incubated on ice for 10 minutes. A protein
pellet was generated after centrifugation at 2000 rpm for 10 minutes at 4°C. The
supernatant was removed and the protein was re-suspended in RIPA buffer and
sonicated 2 times for 30 seconds. Protein concentration was determined by the
Lowry method and the samples were stored at -70°C.
Intracellular Organelle Fractionation. 3T3-L1 adipocytes were matured for 8
days as described above. On ice, the cells were washed 3 times with ice cold
PBS and once with homogenization buffer (detailed in Appendix A). The cells
were scraped into 500 µL of homogenization buffer+ (detailed in Appendix A) and
lysed using a glass homogenizer 20 times before passing each lysate through a
25 gauge needle 6 times on ice. The samples were centrifuged at 500 x g for 10
minutes at +4ºC to generate the nuclear pellet, and the supernatant was
removed and re-centrifuged at 10,000 x g for 20 minutes at +4ºC to produce the
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mitochondrial rich pellet and cytosolic supernatant.
Measurement of Triglycerides and Inflammatory Markers in 3T3-L1
Adipocytes. Control and FHKD adipocytes were matured in 5 mM or 30 mM
glucose concentrations for 8 days and harvested in PBS. The triglyceride
concentration was measured in 10 μL aliquots of cell lysates utilizing the
InfinityTM Triglycerides assay kit (Thermo Fisher Scientific, Waltham, MA),
according to the manufacturer’s instructions. The media on scrambled control or
FHKD 3T3-L1 adipocytes matured for 6 days was replaced with serum-free
DMEM for 6 hrs prior to collection of conditioned media. Pro-inflammatory
cytokines in serum-free conditioned media were analyzed by ELISA according to
the manufacturer's instructions (Mouse Obesity ELISA, Signosis, Santa Clara,
CA). Secreted IL-13 levels were determined by the abcam® Mouse ELISA kit
according to the manufacturer’s instructions (Interleukin-13 Mouse ELISA,
abcam®, Cambridge, UK).
Western Blotting. 15-30 μg cell lysate protein and 30-100 μg mouse epididymal
fat protein was diluted to 20 μL total volume with nano-pure deionized water and
incubated with 5-7 μL 4X Laemmli loading buffer at 95°C for 15 minutes. The
samples were centrifuged at 5000 rpm for 10 seconds and then loaded on 7.5%,
12% or 18% gels and electrophoresed at 200 volts for 60 minutes. The protein
was transferred to a PVDF membrane in transfer buffer (0.1% Tris Base, 20%
methanol, 79.9% nano-pure deionized water) at 250 mA for 100 minutes or 40
mM overnight at 4°C. The membrane protein loading was visualized with
Ponceau Red, followed by blocking in 5% bovine serum albumin (BSA) or 5%
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non-fat milk for 1 hour at room temperature, or overnight at 4°C according to the
antibody manufacturer’s recommendations. Primary polyclonal antibodies to actin
(sc-1616), Ero1α (sc-365526), GRP78 (sc-1051) and PDI (sc-30932) were from
Santa Cruz Biotechnology Inc. (Dallas, TX). Polyclonal antibodies to cleaved
caspase 3 (#9664), fumarase (#4567), PPARγ (#2435) and Keap1 (#4617) were
from Cell Signaling (Danvers, MA). The anti-adiponectin antibody was from R&D
Systems (AF1119) and the anti-hemeoxygenase1 antibody was from Enzo Life
Sciences (ADI-SPA-896D) (Farmingdale, NY). The histone-H3 antibody (05928)
was from Merck Millipore (Billerica, MA). Monoclonal antibodies to PDI (MA3019) and CHOP (MA1-250) and the anti-V5-HRP linked (MA5-15253) antibody
were from Pierce (Rockford, IL). The monoclonal C/EBPα (#8178) and citrate
synthase (#14309) antibodies were from Cell Signaling (Danvers, MA). The
polyclonal anti-2SC antibody was prepared as described previously (Nagai et al.
2007). Chemiluminescent substrate (Thermo Pierce, Rockford, IL) was utilized
followed by detection on photographic film (Denville Scientific, Metuchen, NJ).
Immunoblots were stripped (62.5 mM Tris, pH 6.8, 2% SDS and 0.7% (v/v) beta
mercaptoethanol) for 20 minutes at 67°C prior to re-probing with new primary
antibodies. Image J software (National Institute of Health) was used to quantify
band intensity by densitometry.
2-Dimensional Polyacrylamide Gel Electrophoresis. 150-200 μg of protein
was acetone precipitated from wild-type or Fh1-/- MEFs, control and db/db
adipose tissue, or total PDI immunoprecipitate were re-suspended and incubated
for 10 minutes in rehydration buffer (7 M urea, 2M thiourea, 2% CHAPS, 1% IPG
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buffer, and 50 mM dithiothreitol (DTT), 3.0% DeStreak, 0.5% ampholytes) at
room temperature followed by centrifugation at 10,000 rpm for 5 minutes. Each
sample was pipetted into an 11 inch strip and absorbed overnight into IPG strips
with a pI range of 3.9-5.1, 4-7 or 3-10 (BioRad, Richmond, CA) in mineral oil.
Each IPG strip was placed gel side up on the Ettan™ IGPphor II with a thick
paper salt bridge soaked in 150 µL nano-pure deionized water at each end. The
electrode was placed on top of the paper salt bridge that overlapped with the IGP
strip and the strips were focused to 12,000-14,000 total volt hrs and frozen at 70°C. The next day, 50 mg of DTT and 125 mg of iodoacetamide were each
dissolved in 5 mL of equilibration buffer. The IPG strips were allowed to thaw for
5 minutes at room temperature and incubated with 2 mL of DTT equilibration
buffer for 15 minutes followed by 15 minutes incubation with 2 mL of
iodoacetamide equilibration buffer. During this time the agarose sealing solution
was melted in the microwave, a 4-20% 11 cm IPG+1 Criterion™ TGX™ gel was
placed into the electrophoresis tank and all excess water at the top of the gel was
absorbed by filter paper. Extra equilibration buffer was rinsed off the strips in 1x
SDS running buffer and the strips were placed onto the gel with 300 µL agarose
sealing solution pipetted around each strip. The tank was filled with 1x SDS
running buffer and western blotting was performed as described above.
Protein Immunoprecipitation. 500-1000 µg adipocyte cell lysates was diluted to
500 µL total volume with immunoprecipitation buffer or PBS with 2 µL protease
inhibitor, sonicated for 30 seconds and incubated (rotating) with 10 µL of washed
Protein G or A agarose beads for 30 minutes. The samples were centrifuged at
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5000 rpm for 5 minutes at 4°C and the supernatant transferred to a new clean
tube while the beads were discarded. 4-5 µg of anti-PDI, -Ero1α or -CHOP
antibodies were added to the supernatant and allowed to rotate overnight at 4°C.
15 µL of Protein G or A agarose beads were washed with 800 µL of PBS,
centrifuged at 5000 rpm for 5 mins, re-suspended in 30 µL of PBS and added to
each sample with 1 µL protease inhibitor. The samples incubated on the rotating
wheel for 3.5 hours at room temperature, centrifuged at 5000 rpm at 4°C for 5
minutes and the supernatant was collected and frozen at -70°C. The beads were
washed 4 times with PBS or PBS with 0.1% Tween-20, re-suspended in 2-4x
loading buffer and boiled at 95˚C for 8 minutes to remove the bound antibodyantigen complex prior to immunoblotting. Keap1 was immunoprecipitated from
control and FHKD adipocytes matured for 6 days that overexpressed the V5Keap1 plasmid. 400-800 µg of protein was diluted in 350 µL PBS and sonicated
for 30 seconds. 15 µL of V5-antigen linked agarose beads were washed 4x with
PBS, the protein samples were added to the beads and incubated on the rotating
wheel for 1.5 hours. The beads were washed 5 times with PBS and incubated
with 2x loading buffer at 100°C for 5 minutes to remove the antibody-antigen
complex.
Detection of Ero1 Succination. Ero1α immunoprecipitated from 3T3-L1
adipocytes was resolved by electrophoresis and immunoblotted with anti-2SC
and anti-Ero1α antibodies. Recombinant Ero1α isolated from Escherichia coli
strain BL21(DE3) was generously provided by Dr. Kazutaka Araki (Kyoto Sangyo
University, Japan)(Araki et al. 2011). 2.77 µg protein was incubated in 0.1 M
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potassium phosphate buffer with 2 mM ethylenediaminetetra acetic acid (EDTA),
100 µM diethylenetriaminepentaacetic acid (DTPA) and either 0, 1, 5 or 25 mM
fumarate at 37°C for 24 hours prior to SDS-PAGE and immunoblotting with anti2SC and anti-Ero1 antibodies.
Protein

Succination

Identification

by

Mass

Spectrometry.

For

the

identification of succination sites in PDI, 2.0 µg of recombinant PDI was
incubated with 100 mM fumarate for 24 hrs at 37°C. The sites of endogenous
succination of PDI were investigated following immunoprecipitation of PDI from
adipocytes matured in 5 mM or 30 mM glucose for 8 days. Endogenous
succination of Keap1 was identified following immunoprecipitation of the V5
tagged Keap1 protein over-expressed in FHKD adipocytes for 6 days. In all
cases, samples were resolved by SDS-PAGE, and the gels were stained with
Coomassie Brilliant blue. After de-staining overnight, the protein was excised
from the gel and washed in 20% methanol and 7% acetic acid solution to entirely
remove the Coomassie blue stain. The samples were washed with 200 µL of 100
mM ammonium bicarbonate (pH 7.4) and dehydrated via acetonitrile and vacuum
centrifugation for 3 minutes. The gel pieces were allowed to rehydrate in 10 mM
DTT for 30 minutes at room temperature, followed by alkylation by 170 mM 4vinylpyridine in methanol for 30 minutes. Next, the protein samples were washed
twice with 100mM ammonium bicarbonate (10 minutes) and acetonitrile (5
minutes) and completely dehydrated in the speed vacuum centrifuge for 3
minutes. The gel pieces were rehydrated on ice in 50 mM ammonium
bicarbonate buffer with 2 pmol of Promega sequencing grade modified trypsin
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(Promega, Madison, WI) and the protein was digested overnight at 37°C.
Peptides were then extracted from the gel using 4% formic acid and 20%
acetonitrile solution and were concentrated to a total volume less than 15 µL in
the speed vacuum centrifuge prior to MS/MS analysis. Selected ion monitoring
was performed to identify select pyridylethylated and succinated cysteine
containing tryptic peptides. 1 µL of the digested samples were analyzed on a
Dionex Ultimate 3000-LC system (Thermo Scientific, Rockford, IL) coupled to a
Velos Pro Orbitrap mass spectrometer (Thermo Scientific, Rockford, IL). A 75-µm
C18 stationary-phase LC column was used with a 60-min gradient from 2%
acetonitrile in 0.1% formic acid solution (solvent A) to 70% solvent A and 30%
solvent B (40% water in acetonitrile containing 0.1% formic acid). The Orbitrap
was operated in data-dependent MS/MS analysis mode and excluded all ions
below 200 counts. An inclusion list of up to 6 abundant isotopic masses +/- 3
amu was used to select the specific peptides for selected resonance monitoring
and determination of the site of modification. To further identify specific
succinated sites MRM was used to monitor select pyridylethylated and
succinated tryptic peptide masses of interest (generated using Protein Calculator
software) for CID (collision-induced dissociation)-MS/MS analysis. The datadependent and CID-MS/MS data were analyzed using Proteome Discover 1.4
software with SEQUEST search engine against the uniprot_database October
2014 (Mus musculus 52,474 proteins). The CID-MS/MS data was sequenced
manually using Thermo Xcalibur 2.2 software to confirm the modified peptides.
The variable modifications of methionine oxidation, proline hydroxylation,
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cysteine pyridylethylation (CPE, 105.058 Da) or cysteine succination by fumarate
(C2SC, 116.011 Da) were considered in each data search.
PDI Reductase Activity Assays. Recombinant PDI-wild type (WT) and a mutant
form of PDI (PDIFLFL) were generously provided by Dr. Danyelle Townsend
(Medical University of South Carolina, Charleston, SC). 13.85 µg of recombinant
PDI-WT or PDIFLFL was incubated in 0.1 M potassium phosphate buffer (pH 7)
with 2 mM EDTA and 0, 1, 5 or 25 mM fumarate for 24 hours at 37°C. PDI
reductase activity was monitored according to the PROTEOSTAT® PDI assay kit
instructions (Enzo Life Sciences, Inc. Farmingdale, NY). Di-Eosin-GSSG was
generously provided by Dr. Bulent Mutus, University of Windsor, Ontario,
Canada. 6 µg of protein lysate from 3T3-L1 adipocytes or control and db/db
adipose tissue was incubated with 1.06 µM Di-Eosin-GSSG, 5 µM DTT and 100
µM DTPA in 0.1 M potassium phosphate buffer, pH 7. Fluorescence was
measured kinetically (30 sec intervals) on a TECAN Safire2 microplate reader at
λex= 510 nm and λem= 550 nm.
Data Analysis. All statistical analysis were preformed using the Sigmaplot 11
software, using the student t-test (n=3, *p< 0.05, or **p<0.01, ***p<0.001). PDI
reductase activity in vitro and glutathione measurements were analyzed using a
one

way

ANOVA

(*p<0.05,
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**p<

0.01).
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Appendix A
Buffer Preparations
Radio Immunoprecipitation buffer
50 mM Tris-HCl pH 7.4, 150 mM NaCl, 2mM EDTA, 0.5% sodium deoxycholate,
0.1% SDS, 1% Triton-X. Dissolve in 200 mL with DI water and store at +4. On
the day of use, add 2 mM sodium orthovanadate, 2 mM sodium fluoride and
protease inhibitor cocktail at 1:1000 dilution.
Sigma Rabbit anti-PDI antibody - IP buffer
Dissolve 10 mM Tris-Base pH 8, 0.1 mM EDTA, 150 mM NaCl and 0.25%
Tween-20 in nano-pure water. Add 2 µL protease inhibitor/ sample on the day of
use.
10x Wash buffer
200 mM Tris-HCl pH 7.4 in 1 mL DI water. 0.05% Tween-20 was added to 1x
wash buffer.
10x Transfer buffer
250 mM Tris- HCl and 1920 mM glycine dissolved in 1 mL DI water.
1x Transfer buffer
700 mL DI water, 200 mL methanol and 100 mL 10x Transfer buffer
10X SDS running buffer
250 mM Tris-HCl, 1920 mM glycine and 1% SDS was added to 1 mL DI water.
Stripping buffer
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Add 3.785 grams Tris-Base to ~400 mL nano-pure water pH 6.8. Dissolve 10
grams SDS and bring the final volume to 500 mL with nano-pure water. Before
stripping add 7 µL beta-mercaptoethanol/1 mL stripping buffer used.
4x Laemmli loading buffer
Dissolve 0.969 grams Tris-Base in 10 mL nano-pure water and pH 6.8. Add
2.468 grams DTT, 3.2 grams SDS, 16 mL glycerol and ~8 milligrams
bromophenol blue for color. Store at -20ºC.
Homogenization buffer for intracellular organelle separation
Dissolve 0.0484 grams Tris-Base in 30 mL nano-pure water and pH 7.4. Add
0.084 grams MOPS, 0.0156 grams DTPA, 0.0152 grams EGTA and 2.74 grams
sucrose. Bring the total volume to 40 mL with nano-pure water. Immediately
before use, add 2 mM sodium orthovanadate, 2 mM sodium fluoride and
protease inhibitor cocktail at 1:1000 dilution (homogenization buffer+).
Coomassie Stain
Stir 400 mL nano-pure water, 100 mL glacial acetic acid and 500 mL methanol
for 10 mins. Add 2.5 grams Coomassie Brilliant Blue R-250 (*Do not use G-250*)
and stir for at least 2 hours at room temperature. Filter staining solution using a
0.45 µm Zap Cap and vacuum aspirator.
Coomassie Destain
Mix 100 mL methanol, 830 mL nano-pure water and 70 mL acetic acid
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Appendix B
3T3-L1 Cell Culture Methods
- Put on gloves and spray your hands with 70% alcohol!
- All cell culture experiments should be done in the cell culture fume hood.
- Do NOT open any sterile cell culture plate, container, medium, insulin,
glucose…. (etc.) outside of the cell culture fume hood.
- All glass and plastic pipette tips should be autoclaved and dried before using for
cell culture experiments.
- NEVER touch the tip of your cell culture pipettes on another surface!!!! (e.g., the
bottle of medium, the side of the cell culture plate, the surface of the fume
hood….etc.). If the pipette tip does touch another surface throw out the pipette tip
and replace it with a new clean tip.
- Clean the fume hood surface where you will be working with 70% alcohol prior
to use.
- Every piece of equipment you will need (pipettes, tubes, medium… etc.) should
be cleaned with 70% alcohol before placing the item into the cell culture fume
hood.
Thawing 3T3-L1 fibroblasts
1) Place the 1L container of 1g/L glucose DMEM +FCS medium in the cell
culture water bath for ~15 minutes.
2) When the FCS medium is warm take the bottle out of the water bath and
wipe off any residual water on the outside of the bottle. Then spray the
outside of the bottle with 70% alcohol and wipe with a paper towel. Place
the bottle into the fume-hood.
3) Clean one 15 mL tube, one T-75cm2 flask, the 1000 µL pipette and the
mechanical pipette with 70% alcohol and place in the fume-hood. You will
also need a few 10 mL sterile pipettes located in the top drawer next to the
cell culture freezer.
4) Pipette 6 mL of FCS into the 15 mL tube and 10 mL of FCS into the T75cm2 flask. Now the work station is set-up and you are ready to get out
the vial of cells.
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5) Slowly pull the rack out of the nitrogen tank and remove one vial of (P2 or
P3) 3T3-L1 fibroblasts from the box. Leave the vial of cells on the
countertop while you return the rack of boxes to the liquid nitrogen tank.
6) Allow the vial of cells to thaw at room temperature in the cell culture fume
hood, ~10 minutes. Immediately after the cells have thawed, pipette the
cells from the vial into the 6 mL of FCS in the 15 mL tube. Centrifuge
(located in the Frizzell lab) the 15 mL tube containing the cells at 1000
rpm for 5 minutes at room temperature. A 15 mL balance tube of water is
located next to the centrifuge in the Frizzell lab. After centrifugation there
will be a SMALL white pellet on the bottom of the 15 mL tube containing
the cells.
7) Aspirate all of the medium on top of the pellet using the glass pipettes
located in the tall metal cylinder in the fume hood. DO NOT DISTURB
THE CELL PELLET.
8) Re-suspend the cell pellet in 5 mL of FCS medium by pipetting up and
down ~3 times or just until the pellet is completely dissolved.
9) Pipette all 5 mL of re-suspended cells into the 10 mL of FCS in the T75cm flask. Gently swirl the medium in the flask to mix all the cells into the
medium evenly. Label the flask (P3) 3T3-L1 fibroblasts and today’s date.
Place the flask into the cell culture incubator.
Cell Culture- Passaging Cells
1L container of 1g/L glucose DMEM +FCS medium and sterile PBS warmed to
~37°C in the cell culture water bath
Trypisin- let thaw in the cell culture water bath
15 mL tube
new flask
correct number of plates

mechanical pipette
200 µL and 1000 µL pipettes
Sterile 10 mL cell culture pipettes

1) When the PBS and FCS medium is warm take the bottles out of the water
bath and wipe off any residual water on the outside of the bottle. Then
spray the outside of the bottle with 70% alcohol and wipe with a paper
towel. Place the bottle into the cell culture fume hood.
2) Clean all tools with 70% alcohol and place them into the cell culture fume
hood.
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3) Place the flask of cells into the cell culture fume hood.
4) Turn the flask upside down and gather all of the medium into the back
corner of the flask. Aspirate the FCS medium from the flask and pipette a
sufficient amount of sterile PBS onto the cells in the flask. Gently swirl the
PBS around the flask to wash the cells and aspirate the PBS.
5) Pipette trypsin onto the flask and place the flask back into the cell culture
incubator for ~3 minutes.
a. 25 cm2 flask; 1.5 mL trypsin
b. 75 cm2 flask; 4 mL trypsin
c. 150 cm2 flask; 6 mL trypsin
6) Gently tap the bottom of the flask and use the microscope the make sure
the cells have detached from the flask and are floating in the trypsin
medium.
7) Pipette enough FCS into the flask to bring the total volume of cells to 12
mL (use the FCS to wash the cells completely off the bottom of the flask).
Pipette all of the cells/trypsin/FCS into the 15 mL tube and centrifuge at
1000 rpm for 5 minutes at room temperature. A 15 mL balance tube of
water is located next to the centrifuge in the Frizzell lab. After
centrifugation there will be a small white pellet on the bottom of the 15 mL
tube containing the cells.
8) Aspirate all of the medium on top of the pellet. DO NOT DISTURB THE
CELL PELLET!
9) Re-suspend the cell pellet in FCS medium by pipetting up and down ~3
times or just until the pellet is completely dissolved.
10) Cell Density: pipette 15 µL of cells into the hemocytometer and place on
the microscope. Count the number of cells in each quadrant of the
hemocytometer and calculate the average number of cells/ quadrant.
Example:
Average 50 cells/0.1 µL = 500 cells/ 1 µL (concentration of cell in
the 15 mL tube)
If you want to plate 50,000 cells/ well…
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50,000/500 cells/µL = 100 µL of cells should be pipetted onto each
well
11) Pipette FCS medium onto each well and a new flask. Pipette the desired
density of cells directly into each well and the flask. Gently swirl/mix the
cells and medium thoroughly. Label each plate and the flask with today’s
date, the passage number and type of the cell. Place the flask into the cell
culture incubator.
Cell Culture – Feeding Cells
*Place the tip of the cell culture pipette close to the wall of each well and slowly
drip/pipette the cell culture medium down the side of each well.
24-well plate; 500 µL/well
12-well plate; 1 mL/well

6-well plate; 3 mL/well
10 cm2 petri dish; 10 mL/dish

3T3-L1 Fibroblasts
Medium: 1g/L glucose DMEM + 10% Fetal Calf Serum + 1% (100x)
Penicillin/streptomycin
1) Plated fibroblasts are fed every 48 hours until 100% confluent.
2) Wait 24 hours after wells are 100% confluent before differentiation
Differentiation
Medium: 1 g/L glucose DMEM + 10% Fetal Bovine Serum + 1% (100x)
Penicillin/streptomycin
1/1000 dilution Dexamethasome

1/100 dilution 1mg/mL insulin

1/1000 dilution IBMX

25 mM glucose

1) Slowly aspirate fibroblast medium (FCS)
2) Add a sufficient amount of sterile PBS to each well, gently swirl plate and
aspirate PBS off each well
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3) Add differentiation medium to each well and place the cells back into the cell
culture incubator for 3 days.
3T3-L1 Adipocyte Maturation
Sterile 1 M glucose and 172 nM insulin stocks must be pre-made
5mM glucose medium: 1 g/L glucose DMEM + 10% Fetal Bovine Serum + 1%
(100x) Penicillin/streptomycin + 0.3 nM insulin
25 mM glucose medium: 1 g/L glucose DMEM + 10% Fetal Bovine Serum + 1%
(100x) Penicillin/streptomycin + 3 nM insulin + 20 mM glucose
1) Slowly aspirate differentiation medium
2) Add a sufficient amount of sterile PBS to each well, gently swirl plate and
aspirate PBS off each well
3) Add maturation medium to each well and place the cells back into the cell
culture incubator for 2 days
4) The maturation medium must be changed every 48 hours throughout the
duration of the experiment
Harvesting Cells
1) Label the correct number of 1.5 mL eppendorf tubes (immediately freeze
samples after harvest) or 15 mL tubes (immediately acetone precipitate
after harvest).
2) Add 2 mM NaF, 2 mM sodium orthovanadate (SOV) and 1:1000 protease
inhibitor to RIPA buffer (RIPA+ buffer).
a. Stocks of 500 mM NaF and 500 mM SOV and protease inhibitor
are all found in the -20 freezer.
b. Boil the SOV for ~ 7 minutes in the 95°C heating block before you
add it to the RIPA buffer. Discard the boiled SOV after use in the
trash can. NaF and protease inhibitor may be re-frozen to use
again in the -20°C freezer.
c. You will need 200 µL of RIPA+ buffer/ well on a 6-well plate
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d. You will need 500 µL of RIPA+ buffer/ 10 cm plate
3) Place PBS on ice
a. A stock container of PBS should already be made up in the +4
fridge
b. You will need total ~100 mL PBS/ 6 well plate
c. You will need total ~30 mL PBS/ 10 cm plate
4) Wash cell scraper with alcohol pad (wash scraper between each different
groups of samples)
5) Take your ice bucket to the cell culture room and remove one 6-well plate
from the cell culture incubator. Place the plate IMMEDIATELY on ice and
bring the ice bucket back to your lab bench.
6) Discard the cell culture medium into the 1L waste container
7) Wash each well 3x with ICE COLD PBS. Discard PBS into the waste
container after each wash.
8) Tilt the plate on ice and pipette off the residual PBS
9) Add 200 µL of RIPA+ buffer to each well and rock the plate around so the
buffer covers the entire well. Open your labeled eppendorf tubes.
10) Tilt the plate downward and scrape the cells toward the bottom of the well
into the RIPA+ buffer. Keep the plate tilted, do NOT lay the plate flat again
11) Pipette the cells into the open tubes and place immediately on ice.
12) Freeze the samples in the -80°C freezer or sonicate and acetone
precipitate
the
sample.
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Appendix C
List of Manuscripts Derived from Dissertation Work
Peer-Reviewed Journal Articles
1. Allison M. Manuel, Michael D. Walla, Boris Kantor, Gerardo G. Piroli, Norma
Frizzell. Succination Promotes Oxidative Stress and CHOP Stability in the
Adipocyte. Molecular Metabolism (In preparation)
2. Gerardo G. Piroli*, Allison M. Manuel*, Tulsi Patel, Michael D. Walla, Jingtian
Wang, Liang Shi, Scott A. Lanci, Ashley Galloway, Pavel I. Ortinski, Deanna S.
Smith, Norma Frizzell. Protein Succination by Dimethylfumarate Mediates
Neuroprotective Responses Independent of Keap1 Activation. Mol. Cell
Proteomics (In preparation)
3. Manuel AM, Walla MD, Faccenda A, Martin SL, Tanis RM, Piroli GG, Adam J,
Kantor B, Mutus B, Townsend DM, Frizzell N. (2017) Succination of Protein
Disulfide Isomerase Links Mitochondrial Stress and Endoplasmic Reticulum
Stress in the Adipocyte During Diabetes. Antioxid Redox Signal PMID: 28376661
4. Piroli GG, Manuel AM, Clapper AC, Walla MD, Baatz JE, Palmiter RD,
Quintana A, and Frizzell N. (2015) Succination is increased on select proteins in
the brainstem of the Ndufs4 knockout mouse, a model of Leigh syndrome. Mol.
Cell Proteomics 15: 445-461 PMID: 26450614
5. Piroli GG, Manuel AM, Walla MD, Jepson MJ, Brock JW, Rajesh MP, Tanis
RM, Cotham WE, Frizzell N. (2014) Identification of Protein Succination as a
Novel Modification of Tubulin. Biochem J 462: 231-45. PMID: 24909641
6. Manuel AM, Frizzell N. (2013) Adipocyte protein modification by Krebs cycle
intermediates and fumarate ester-derived succination. Amino Acids 45: 12431247. PMID: 23892396
Literature Review
7. Manuel AM, Frizzell N (2014) What KEAPS Adipocytes Stressed During
Diabetes? IMARS Highlights 9: 9-13
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